<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.TrialResultsOutput xmlns:ns2="local" hits="10" offset="0" totalResults="135474"><Filters total="48"><Filter label="Trial Technologies" name="trialTechnologies" total="100"><FilterOption id="762" count="71328" label="Small molecule therapeutic"></FilterOption><FilterOption id="648" count="48616" label="Intravenous formulation"></FilterOption><FilterOption id="585" count="47455" label="Oral formulation"></FilterOption><FilterOption id="740" count="40063" label="Infusion"></FilterOption><FilterOption id="761" count="35409" label="Biological therapeutic"></FilterOption><FilterOption id="595" count="31667" label="Tablet formulation"></FilterOption><FilterOption id="746" count="27013" label="Solution"></FilterOption><FilterOption id="751" count="20529" label="Film coating"></FilterOption><FilterOption id="586" count="20514" label="Capsule formulation"></FilterOption><FilterOption id="898" count="16954" label="Formulation powder"></FilterOption><FilterOption id="750" count="16270" label="Freeze drying"></FilterOption><FilterOption id="85" count="15054" label="Protein recombinant"></FilterOption><FilterOption id="573" count="14939" label="Immunoglobulin-G"></FilterOption><FilterOption id="647" count="14105" label="Subcutaneous formulation"></FilterOption><FilterOption id="1647" count="11216" label="Natural product"></FilterOption><FilterOption id="1263" count="8916" label="Immuno-oncology"></FilterOption><FilterOption id="169" count="8852" label="Monoclonal antibody humanized"></FilterOption><FilterOption id="1652" count="8214" label="Prodrug"></FilterOption><FilterOption id="80" count="6861" label="Peptide"></FilterOption><FilterOption id="766" count="6700" label="Parenteral formulation unspecified"></FilterOption><FilterOption id="902" count="6263" label="Orally disintegrating tablet"></FilterOption><FilterOption id="594" count="6111" label="Oral suspension formulation"></FilterOption><FilterOption id="168" count="5104" label="Monoclonal antibody human"></FilterOption><FilterOption id="651" count="4499" label="Intramuscular formulation"></FilterOption><FilterOption id="175" count="4341" label="Drug combination"></FilterOption><FilterOption id="166" count="4019" label="Chimeric monoclonal antibody"></FilterOption><FilterOption id="745" count="3809" label="Suspension"></FilterOption><FilterOption id="603" count="3640" label="Systemic formulation unspecified"></FilterOption><FilterOption id="593" count="3501" label="Oral liquid formulation"></FilterOption><FilterOption id="589" count="3409" label="Sustained release formulation"></FilterOption><FilterOption id="894" count="3166" label="Liquid formulation"></FilterOption><FilterOption id="596" count="2949" label="Injectable formulation"></FilterOption><FilterOption id="805" count="2786" label="Daily dosing"></FilterOption><FilterOption id="66" count="2639" label="Antibiotic"></FilterOption><FilterOption id="127" count="2530" label="Cell culture"></FilterOption><FilterOption id="743" count="2380" label="Granule"></FilterOption><FilterOption id="348" count="2199" label="PEGylated formulation"></FilterOption><FilterOption id="84" count="2166" label="Protein fusion"></FilterOption><FilterOption id="102" count="2086" label="Nucleotide and derivatives"></FilterOption><FilterOption id="641" count="1976" label="Controlled release formulation"></FilterOption><FilterOption id="599" count="1888" label="Nanoparticle formulation injectable"></FilterOption><FilterOption id="680" count="1804" label="Buccal formulation systemic"></FilterOption><FilterOption id="611" count="1790" label="Dermatological formulation"></FilterOption><FilterOption id="207" count="1704" label="Protein conjugated"></FilterOption><FilterOption id="90" count="1690" label="Steroid"></FilterOption><FilterOption id="731" count="1627" label="Imaging"></FilterOption><FilterOption id="649" count="1626" label="Intraperitoneal formulation"></FilterOption><FilterOption id="630" count="1612" label="Stereochemistry"></FilterOption><FilterOption id="852" count="1594" label="Intravesical formulation"></FilterOption><FilterOption id="112" count="1448" label="DNA technology"></FilterOption><FilterOption id="590" count="1433" label="Enteric coated formulation"></FilterOption><FilterOption id="616" count="1430" label="Inhalant formulation"></FilterOption><FilterOption id="558" count="1374" label="Transdermal formulation"></FilterOption><FilterOption id="180" count="1371" label="Antibody fragment"></FilterOption><FilterOption id="724" count="1303" label="Radiolabeling"></FilterOption><FilterOption id="660" count="1301" label="Oral sustained release formulation"></FilterOption><FilterOption id="167" count="1300" label="Monoclonal antibody murine"></FilterOption><FilterOption id="62" count="1264" label="Virus recombinant"></FilterOption><FilterOption id="723" count="1229" label="Drug coating"></FilterOption><FilterOption id="598" count="1180" label="Liposome formulation injectable"></FilterOption><FilterOption id="171" count="1114" label="Monoclonal antibody conjugated"></FilterOption><FilterOption id="347" count="1079" label="Intratumoral formulation"></FilterOption><FilterOption id="74" count="1055" label="Glycoprotein"></FilterOption><FilterOption id="756" count="1031" label="Pharmaceutical carrier"></FilterOption><FilterOption id="570" count="917" label="Cell therapy"></FilterOption><FilterOption id="236" count="883" label="Macrolide"></FilterOption><FilterOption id="851" count="808" label="Intradermal formulation"></FilterOption><FilterOption id="776" count="803" label="Oral gel formulation"></FilterOption><FilterOption id="615" count="777" label="Aerosol formulation dermatological"></FilterOption><FilterOption id="753" count="775" label="Microparticle formulation"></FilterOption><FilterOption id="135" count="775" label="T-lymphocyte"></FilterOption><FilterOption id="559" count="756" label="Oral controlled release formulation"></FilterOption><FilterOption id="617" count="747" label="Aerosol formulation inhalant"></FilterOption><FilterOption id="618" count="660" label="Powder formulation inhalant"></FilterOption><FilterOption id="51" count="646" label="Monoclonal antibody"></FilterOption><FilterOption id="667" count="596" label="Peptidomimetic"></FilterOption><FilterOption id="128" count="590" label="Cell culture technique"></FilterOption><FilterOption id="612" count="585" label="Emulsion dermatological"></FilterOption><FilterOption id="1646" count="582" label="Injectable controlled release formulation"></FilterOption><FilterOption id="654" count="561" label="Intrathecal formulation"></FilterOption><FilterOption id="742" count="542" label="Pellet"></FilterOption><FilterOption id="701" count="541" label="Nucleoside synthesis"></FilterOption><FilterOption id="582" count="539" label="Antibody polyclonal"></FilterOption><FilterOption id="159" count="523" label="Oligosaccharide"></FilterOption><FilterOption id="661" count="509" label="Oral quick release formulation"></FilterOption><FilterOption id="345" count="494" label="Receptor chimeric"></FilterOption><FilterOption id="962" count="483" label="Biosimilar product"></FilterOption><FilterOption id="1247" count="475" label="Chimeric antigen receptor T cell therapy"></FilterOption><FilterOption id="620" count="474" label="Ophthalmic formulation"></FilterOption><FilterOption id="142" count="442" label="Liposome formulation"></FilterOption><FilterOption id="597" count="437" label="Injectable emulsion"></FilterOption><FilterOption id="652" count="436" label="Intra-articular formulation"></FilterOption><FilterOption id="67" count="429" label="Antigen"></FilterOption><FilterOption id="658" count="426" label="Subcutaneous drug implant"></FilterOption><FilterOption id="1164" count="424" label="Antibody drug conjugate"></FilterOption><FilterOption id="103" count="408" label="Oligonucleotide"></FilterOption><FilterOption id="93" count="404" label="Toxin"></FilterOption><FilterOption id="349" count="400" label="Lipid"></FilterOption><FilterOption id="600" count="399" label="Patch formulation"></FilterOption><FilterOption id="1669" count="387" label="Emulsion formulation"></FilterOption></Filter><Filter label="Indications" name="indications" total="100"><FilterOption id="49" count="5515" label="Breast tumor"></FilterOption><FilterOption id="3665" count="4112" label="Metastatic non small cell lung cancer"></FilterOption><FilterOption id="3657" count="3639" label="Metastatic breast cancer"></FilterOption><FilterOption id="1262" count="3330" label="Non-small-cell lung cancer"></FilterOption><FilterOption id="3713" count="3223" label="Advanced solid tumor"></FilterOption><FilterOption id="1069" count="3191" label="Metastasis"></FilterOption><FilterOption id="837" count="2870" label="Non-insulin dependent diabetes"></FilterOption><FilterOption id="1731" count="2742" label="Acute myelogenous leukemia"></FilterOption><FilterOption id="3658" count="2721" label="Metastatic colorectal cancer"></FilterOption><FilterOption id="276" count="2609" label="Prostate tumor"></FilterOption><FilterOption id="2399" count="2501" label="Adenocarcinoma"></FilterOption><FilterOption id="725" count="2421" label="Solid tumor"></FilterOption><FilterOption id="1767" count="2401" label="Hepatocellular carcinoma"></FilterOption><FilterOption id="1828" count="2390" label="Multiple myeloma"></FilterOption><FilterOption id="20" count="2364" label="Pain"></FilterOption><FilterOption id="307" count="2345" label="Squamous cell carcinoma"></FilterOption><FilterOption id="319" count="2230" label="Non-Hodgkin lymphoma"></FilterOption><FilterOption id="799" count="2029" label="Ovary tumor"></FilterOption><FilterOption id="989" count="1931" label="Colorectal tumor"></FilterOption><FilterOption id="651" count="1916" label="Cancer"></FilterOption><FilterOption id="3246" count="1748" label="Hormone refractory prostate cancer"></FilterOption><FilterOption id="3257" count="1730" label="Stage IV melanoma"></FilterOption><FilterOption id="249" count="1653" label="Pancreas tumor"></FilterOption><FilterOption id="1272" count="1580" label="Myelodysplastic syndrome"></FilterOption><FilterOption id="2454" count="1547" label="Glioblastoma"></FilterOption><FilterOption id="623" count="1543" label="Head and neck tumor"></FilterOption><FilterOption id="3666" count="1516" label="Metastatic stomach cancer"></FilterOption><FilterOption id="158" count="1437" label="HIV infection"></FilterOption><FilterOption id="127" count="1419" label="Stomach tumor"></FilterOption><FilterOption id="3669" count="1412" label="Metastatic pancreas cancer"></FilterOption><FilterOption id="203" count="1392" label="Lymphoma"></FilterOption><FilterOption id="1734" count="1363" label="Chronic lymphocytic leukemia"></FilterOption><FilterOption id="4250" count="1313" label="Metastatic renal cell carcinoma"></FilterOption><FilterOption id="1011" count="1287" label="Esophagus tumor"></FilterOption><FilterOption id="427" count="1279" label="Uterine cervix tumor"></FilterOption><FilterOption id="1108" count="1239" label="Glioma"></FilterOption><FilterOption id="1728" count="1232" label="Acute lymphoblastic leukemia"></FilterOption><FilterOption id="1735" count="1212" label="Chronic myelocytic leukemia"></FilterOption><FilterOption id="1185" count="1179" label="Chronic obstructive pulmonary disease"></FilterOption><FilterOption id="1749" count="1177" label="Diffuse large B-cell lymphoma"></FilterOption><FilterOption id="3083" count="1151" label="Peritoneal tumor"></FilterOption><FilterOption id="238" count="1141" label="Obesity"></FilterOption><FilterOption id="755" count="1065" label="Lung tumor"></FilterOption><FilterOption id="291" count="1051" label="Rheumatoid arthritis"></FilterOption><FilterOption id="205" count="1039" label="Melanoma"></FilterOption><FilterOption id="161" count="989" label="Hodgkins disease"></FilterOption><FilterOption id="1261" count="985" label="Small-cell lung cancer"></FilterOption><FilterOption id="178" count="935" label="Hypertension"></FilterOption><FilterOption id="3664" count="934" label="Metastatic prostate cancer"></FilterOption><FilterOption id="3673" count="929" label="Metastatic head and neck cancer"></FilterOption><FilterOption id="760" count="897" label="Brain tumor"></FilterOption><FilterOption id="2380" count="886" label="Bladder cancer"></FilterOption><FilterOption id="3866" count="882" label="Metastatic ovary cancer"></FilterOption><FilterOption id="31" count="880" label="Asthma"></FilterOption><FilterOption id="2243" count="877" label="Fallopian tube cancer"></FilterOption><FilterOption id="1745" count="834" label="Follicle center lymphoma"></FilterOption><FilterOption id="80" count="827" label="Coronary artery disease"></FilterOption><FilterOption id="3667" count="810" label="Metastatic esophageal cancer"></FilterOption><FilterOption id="245" count="806" label="Osteoarthritis"></FilterOption><FilterOption id="1705" count="789" label="Endometrioid carcinoma"></FilterOption><FilterOption id="316" count="760" label="B-cell lymphoma"></FilterOption><FilterOption id="1771" count="736" label="Transitional cell carcinoma"></FilterOption><FilterOption id="2054" count="735" label="Hematological neoplasm"></FilterOption><FilterOption id="55" count="732" label="Cardiac failure"></FilterOption><FilterOption id="153" count="724" label="Hepatitis C virus infection"></FilterOption><FilterOption id="17" count="714" label="Anemia"></FilterOption><FilterOption id="152" count="698" label="Hepatitis B virus infection"></FilterOption><FilterOption id="281" count="696" label="Psoriasis"></FilterOption><FilterOption id="3251" count="680" label="End stage renal disease"></FilterOption><FilterOption id="836" count="674" label="Insulin dependent diabetes"></FilterOption><FilterOption id="191" count="665" label="Influenza virus infection"></FilterOption><FilterOption id="1744" count="661" label="Mantle cell lymphoma"></FilterOption><FilterOption id="14" count="650" label="Alzheimers disease"></FilterOption><FilterOption id="3378" count="615" label="Soft tissue sarcoma"></FilterOption><FilterOption id="159" count="606" label="HIV-1 infection"></FilterOption><FilterOption id="1766" count="604" label="Renal cell carcinoma"></FilterOption><FilterOption id="1768" count="590" label="Nasopharyngeal carcinoma"></FilterOption><FilterOption id="1055" count="588" label="Rectal tumor"></FilterOption><FilterOption id="616" count="581" label="Graft versus host disease"></FilterOption><FilterOption id="202" count="573" label="Liver tumor"></FilterOption><FilterOption id="1128" count="567" label="Neuroendocrine tumor"></FilterOption><FilterOption id="194" count="563" label="Sarcoma"></FilterOption><FilterOption id="199" count="560" label="Leukemia"></FilterOption><FilterOption id="57" count="541" label="Cardiovascular disease"></FilterOption><FilterOption id="1765" count="537" label="Cholangiocarcinoma"></FilterOption><FilterOption id="224" count="532" label="Myocardial infarction"></FilterOption><FilterOption id="759" count="512" label="Central nervous system tumor"></FilterOption><FilterOption id="255" count="499" label="Parkinsons disease"></FilterOption><FilterOption id="2726" count="496" label="Neuroblastoma"></FilterOption><FilterOption id="3256" count="493" label="Stage III melanoma"></FilterOption><FilterOption id="767" count="466" label="Colon tumor"></FilterOption><FilterOption id="3668" count="465" label="Metastatic lung cancer"></FilterOption><FilterOption id="97" count="464" label="Diabetes mellitus"></FilterOption><FilterOption id="84" count="462" label="Crohns disease"></FilterOption><FilterOption id="1240" count="457" label="Mesothelioma"></FilterOption><FilterOption id="3211" count="444" label="Cancer pain"></FilterOption><FilterOption id="3676" count="443" label="Ischemic stroke"></FilterOption><FilterOption id="1829" count="442" label="Bone metastases"></FilterOption><FilterOption id="793" count="431" label="Mouth tumor"></FilterOption><FilterOption id="1134" count="428" label="Thyroid tumor"></FilterOption></Filter><Filter label="Endpoint Index" name="trialEndpointIndex" total="100"><FilterOption id="8639" count="4398" label="Lung tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="8481" count="3721" label="Lung tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="8489" count="3633" label="Lung tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="15312" count="3594" label="Solid tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="7679" count="2774" label="Lymphoma - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="8996" count="2745" label="Breast tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="15285" count="2740" label="Solid tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="8998" count="2737" label="Breast tumor - Assessment of adverse events"></FilterOption><FilterOption id="8077" count="2673" label="Leukemia - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="7879" count="2500" label="Leukemia - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="15287" count="2472" label="Solid tumor - Assessment of adverse events"></FilterOption><FilterOption id="8712" count="2438" label="Breast tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="7538" count="2307" label="Lymphoma - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="8078" count="2215" label="Leukemia - Assessment of adverse events"></FilterOption><FilterOption id="8430" count="2140" label="Colorectal tumor - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"></FilterOption><FilterOption id="7547" count="2098" label="Lymphoma - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="8663" count="2029" label="Lung tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="7680" count="2009" label="Lymphoma - Assessment of adverse events"></FilterOption><FilterOption id="8640" count="1981" label="Lung tumor - Assessment of Safety and Tolerability - Adverse events as graded by CTCAE/CTC"></FilterOption><FilterOption id="8719" count="1942" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"></FilterOption><FilterOption id="19282" count="1938" label="Cancer supportive care - Patient Reported Outcomes/Quality of Life Assessments"></FilterOption><FilterOption id="8713" count="1862" label="Breast tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="8151" count="1842" label="Colorectal tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="19374" count="1836" label="Cancer supportive care - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="8505" count="1821" label="Lung tumor - Assessment of Objective Response - Assessment of objective response rate(ORR)"></FilterOption><FilterOption id="9122" count="1806" label="Breast tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="15293" count="1798" label="Solid tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"></FilterOption><FilterOption id="7189" count="1757" label="Prostate tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="7563" count="1744" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Complete Response"></FilterOption><FilterOption id="7908" count="1706" label="Leukemia - Assessment of Response Rates (RR) - Assessment of Complete Response"></FilterOption><FilterOption id="8163" count="1640" label="Colorectal tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="7569" count="1632" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"></FilterOption><FilterOption id="8429" count="1607" label="Colorectal tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="12048" count="1590" label="Hepatobiliary system tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="19412" count="1552" label="Cancer supportive care - Protocol Specified Other Endpoints - Assessment of Other Treatment or Procedure Related Outcomes"></FilterOption><FilterOption id="8508" count="1534" label="Lung tumor - Assessment of Overall Response"></FilterOption><FilterOption id="8187" count="1532" label="Colorectal tumor - Assessment of Response Rates (RR) - Assessment of Objective/Overall Response Rate (ORR)"></FilterOption><FilterOption id="8451" count="1460" label="Colorectal tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="7311" count="1449" label="Head and neck tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="8140" count="1421" label="Leukemia - Protocol Specified Other Endpoints - Assessment of Clinical Efficacy"></FilterOption><FilterOption id="13344" count="1416" label="Pancreas tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="26033" count="1408" label="Pain - Assessment of adverse events"></FilterOption><FilterOption id="8513" count="1360" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"></FilterOption><FilterOption id="8721" count="1359" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"></FilterOption><FilterOption id="9153" count="1358" label="Lung tumor - Imaging/Radiological Assessments - Assessment by Response Evaluation Criteria in Solid Tumors (RECIST) Criteria"></FilterOption><FilterOption id="19407" count="1341" label="Cancer supportive care - Assessment of Laboratory/Diagnostic Measures"></FilterOption><FilterOption id="25874" count="1339" label="Pain - Assessment of Intensity of Pain - Based on Visual analog scale[VAS]"></FilterOption><FilterOption id="7564" count="1327" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"></FilterOption><FilterOption id="26044" count="1326" label="Pain - Assessment of Therapy Related Outcomes - Assessment of analgesic use/rescue medication"></FilterOption><FilterOption id="7244" count="1319" label="Head and neck tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="7190" count="1317" label="Prostate tumor - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"></FilterOption><FilterOption id="15212" count="1300" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of objective response rate (ORR)"></FilterOption><FilterOption id="7981" count="1295" label="Leukemia - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="7611" count="1275" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of tumor response rate (Duration of response)"></FilterOption><FilterOption id="7312" count="1269" label="Head and neck tumor - Assessment of adverse events"></FilterOption><FilterOption id="8523" count="1267" label="Lung tumor - Assessment of Disease Progression"></FilterOption><FilterOption id="7906" count="1256" label="Leukemia - Assessment of Response Rates (RR)"></FilterOption><FilterOption id="8514" count="1244" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"></FilterOption><FilterOption id="7868" count="1233" label="Lymphoma - Protocol Specified Other Endpoints - Assessment of Efficacy"></FilterOption><FilterOption id="13433" count="1193" label="Pancreas tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="10900" count="1190" label="Ovary tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="17405" count="1180" label="Stem cell transplantation - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="12148" count="1166" label="Stomach tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="1" count="1165" label="Hypertension - Assessment of Blood Pressure (BP)"></FilterOption><FilterOption id="26032" count="1161" label="Pain - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="8563" count="1155" label="Lung tumor - Patient Reported Outcomes/Quality of Life Assessments"></FilterOption><FilterOption id="8720" count="1139" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"></FilterOption><FilterOption id="9152" count="1139" label="Lung tumor - Assessment of Other/Unspecified Efficacy Parameters"></FilterOption><FilterOption id="8726" count="1123" label="Breast tumor - Assessment of Response Rates (RR)"></FilterOption><FilterOption id="1345" count="1114" label="Non-insulin dependent diabetes - Glycemic Control Analysis - Assessment of fasting blood glucose"></FilterOption><FilterOption id="37159" count="1113" label="Breast tumor - Assessment of Laboratory/Diagnostic Measures"></FilterOption><FilterOption id="8759" count="1096" label="Breast tumor - Patient Reported Outcomes/Quality of Life Assessments"></FilterOption><FilterOption id="1358" count="1094" label="Non-insulin dependent diabetes - Assessment of Hemoglobin A1c (HbA1c) Levels"></FilterOption><FilterOption id="12118" count="1088" label="Hepatobiliary system tumor - Assessment of adverse events"></FilterOption><FilterOption id="6940" count="1081" label="Melanoma - Assessment of Response Rates (RR) - Assessment of overall/objective response rate"></FilterOption><FilterOption id="8670" count="1069" label="Lung tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters - Assessment of maximum tolerated dose (MTD)"></FilterOption><FilterOption id="12117" count="1065" label="Hepatobiliary system tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="7217" count="1060" label="Prostate tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="8999" count="1059" label="Breast tumor - Assessment of Safety and Tolerability - Assessment of safety as measured by NCI CTCAE/NCI-CTC criteria"></FilterOption><FilterOption id="15207" count="1054" label="Solid tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="9218" count="1051" label="HIV infection - Assessment of Immune Response"></FilterOption><FilterOption id="7354" count="1050" label="Multiple myeloma - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="9147" count="1049" label="Colorectal tumor - Assessment of Safety and Tolerability - Assessment of toxicities"></FilterOption><FilterOption id="8651" count="1048" label="Lung tumor - Assessment of Laboratory/Diagnostic Measures"></FilterOption><FilterOption id="19376" count="1047" label="Cancer supportive care - Assessment of adverse events"></FilterOption><FilterOption id="12051" count="1035" label="Hepatobiliary system tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="7988" count="1035" label="Leukemia - Assessment of Laboratory/Diagnostic Measures"></FilterOption><FilterOption id="1624" count="1034" label="Non-insulin dependent diabetes - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="7891" count="1024" label="Leukemia - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="15318" count="1017" label="Solid tumor - Protocol Specified Other Endpoints - Assessment of Anti-tumor Activity"></FilterOption><FilterOption id="8522" count="1000" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of duration of response"></FilterOption><FilterOption id="7987" count="999" label="Leukemia - Assessment of Pharmacokinetic/Pharmacodynamic Parameters - Assessment of maximum tolerated dose (MTD)"></FilterOption><FilterOption id="7256" count="995" label="Head and neck tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="13352" count="993" label="Pancreas tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="13435" count="988" label="Pancreas tumor - Assessment of adverse events"></FilterOption><FilterOption id="9133" count="975" label="Lymphoma - Assessment of Pharmacokinetic/Pharmacodynamic Parameters - Assessment of maximum tolerated dose (MTD)"></FilterOption><FilterOption id="12209" count="971" label="Stomach tumor - Assessment of adverse events"></FilterOption><FilterOption id="7909" count="969" label="Leukemia - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"></FilterOption><FilterOption id="12207" count="946" label="Stomach tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="7921" count="943" label="Leukemia - Assessment of Disease Relapse/Recurrence"></FilterOption></Filter><Filter label="Trial Drug Phase Highest" name="trialDrugPhaseHighest" total="12"><FilterOption id="L" count="72016" label="Launched"></FilterOption><FilterOption id="C2" count="8248" label="Phase 2 Clinical"></FilterOption><FilterOption id="DX" count="6234" label="Discontinued"></FilterOption><FilterOption id="C3" count="4935" label="Phase 3 Clinical"></FilterOption><FilterOption id="NDR" count="4252" label="No Development Reported"></FilterOption><FilterOption id="C1" count="2585" label="Phase 1 Clinical"></FilterOption><FilterOption id="DR" count="1062" label="Discovery"></FilterOption><FilterOption id="PR" count="899" label="Pre-registration"></FilterOption><FilterOption id="R" count="692" label="Registered"></FilterOption><FilterOption id="W" count="407" label="Withdrawn"></FilterOption><FilterOption id="CU" count="163" label="Clinical"></FilterOption><FilterOption id="S" count="150" label="Suspended"></FilterOption></Filter><Filter label="Trial Company Sponsor" name="trialCompaniesSponsor" total="100"><FilterOption id="20519" count="2681" label="National Cancer Institute"></FilterOption><FilterOption id="23382" count="1729" label="MD Anderson Cancer Center"></FilterOption><FilterOption id="23137" count="1622" label="Novartis AG"></FilterOption><FilterOption id="28355" count="1359" label="GlaxoSmithKline plc"></FilterOption><FilterOption id="18767" count="1267" label="Pfizer Inc"></FilterOption><FilterOption id="20520" count="1180" label="National Institute of Allergy and Infectious Diseases"></FilterOption><FilterOption id="19446" count="1140" label="Roche Holding AG"></FilterOption><FilterOption id="22122" count="1098" label="Memorial Sloan-Kettering Cancer Center"></FilterOption><FilterOption id="17810" count="1046" label="Eli Lilly &amp; Co"></FilterOption><FilterOption id="14190" count="1037" label="AstraZeneca plc"></FilterOption><FilterOption id="15065" count="915" label="Bristol-Myers Squibb Co"></FilterOption><FilterOption id="1009547" count="896" label="Sanofi SA"></FilterOption><FilterOption id="1059823" count="836" label="Merck Sharp &amp; Dohme Corp"></FilterOption><FilterOption id="21569" count="814" label="Massachusetts General Hospital"></FilterOption><FilterOption id="21111" count="770" label="Mayo Clinic Foundation"></FilterOption><FilterOption id="15615" count="624" label="Dana-Farber Cancer Institute Inc"></FilterOption><FilterOption id="1004360" count="620" label="Sun Yat-Sen University"></FilterOption><FilterOption id="14881" count="565" label="Boehringer Ingelheim International GmbH"></FilterOption><FilterOption id="14109" count="559" label="Amgen Inc"></FilterOption><FilterOption id="14455" count="551" label="Bayer AG"></FilterOption><FilterOption id="26113" count="440" label="Washington University in St Louis"></FilterOption><FilterOption id="15331" count="435" label="Celgene Corp"></FilterOption><FilterOption id="20679" count="431" label="Stanford University"></FilterOption><FilterOption id="19453" count="426" label="Genentech Inc"></FilterOption><FilterOption id="20567" count="418" label="Duke University"></FilterOption><FilterOption id="1042135" count="415" label="Sidney Kimmel Comprehensive Cancer Center"></FilterOption><FilterOption id="24773" count="389" label="University of California San Francisco"></FilterOption><FilterOption id="1040381" count="387" label="Cancer and Leukemia Group B"></FilterOption><FilterOption id="DOL1000375" count="382" label="Fudan University"></FilterOption><FilterOption id="26013" count="373" label="University of Chicago"></FilterOption><FilterOption id="20645" count="351" label="Northwestern University"></FilterOption><FilterOption id="20659" count="351" label="University of Pittsburgh"></FilterOption><FilterOption id="16218" count="343" label="Fred Hutchinson Cancer Research Center"></FilterOption><FilterOption id="1004334" count="342" label="Samsung Medical Center (SMC)"></FilterOption><FilterOption id="16450" count="338" label="Gilead Sciences Inc"></FilterOption><FilterOption id="28443" count="336" label="The University Health Network"></FilterOption><FilterOption id="20300" count="332" label="Takeda Pharmaceutical Co Ltd"></FilterOption><FilterOption id="20658" count="328" label="University of Pennsylvania"></FilterOption><FilterOption id="20534" count="326" label="Baylor College of Medicine"></FilterOption><FilterOption id="1003017" count="319" label="Seoul National University Hospital"></FilterOption><FilterOption id="29603" count="318" label="H Lee Moffitt Cancer Center and Research Institute"></FilterOption><FilterOption id="18077" count="315" label="Merck &amp; Co Inc"></FilterOption><FilterOption id="1039242" count="306" label="Case Comprehensive Cancer Center"></FilterOption><FilterOption id="25760" count="300" label="University of Texas Southwestern Medical Center"></FilterOption><FilterOption id="23948" count="299" label="Assistance Publique Hopitaux de Paris"></FilterOption><FilterOption id="20573" count="298" label="Emory University"></FilterOption><FilterOption id="1038961" count="298" label="National Taiwan University Hospital"></FilterOption><FilterOption id="1013295" count="293" label="Astellas Pharma Inc"></FilterOption><FilterOption id="1041378" count="290" label="Children's Oncology Group"></FilterOption><FilterOption id="1028858" count="289" label="Southwest Oncology Group"></FilterOption><FilterOption id="20518" count="285" label="National Institutes of Health"></FilterOption><FilterOption id="1051922" count="282" label="City of Hope Medical Center"></FilterOption><FilterOption id="23119" count="281" label="European Organisation for Research and Treatment of Cancer (EORTC)"></FilterOption><FilterOption id="1060642" count="280" label="National Cancer Center Hospital"></FilterOption><FilterOption id="DOL1000742" count="278" label="University of Wisconsin-Madison"></FilterOption><FilterOption id="20524" count="277" label="University of Alabama at Birmingham"></FilterOption><FilterOption id="20701" count="274" label="University of Washington"></FilterOption><FilterOption id="1072507" count="268" label="AbbVie Inc"></FilterOption><FilterOption id="21099" count="268" label="Roswell Park Comprehensive Cancer Center"></FilterOption><FilterOption id="13601" count="257" label="Abbott Laboratories"></FilterOption><FilterOption id="20623" count="257" label="University of Michigan"></FilterOption><FilterOption id="1036320" count="252" label="Asan Medical Center"></FilterOption><FilterOption id="25184" count="249" label="Yonsei University"></FilterOption><FilterOption id="20631" count="248" label="Mount Sinai School of Medicine"></FilterOption><FilterOption id="20653" count="247" label="Osaka University"></FilterOption><FilterOption id="20559" count="241" label="Columbia University"></FilterOption><FilterOption id="26178" count="239" label="F Hoffmann-La Roche AG"></FilterOption><FilterOption id="20634" count="236" label="University of North Carolina"></FilterOption><FilterOption id="26109" count="235" label="Jonsson Comprehensive Cancer Center"></FilterOption><FilterOption id="1067538" count="232" label="Janssen Research &amp; Development LLC"></FilterOption><FilterOption id="1039740" count="230" label="National Natural Science Foundation of China"></FilterOption><FilterOption id="18101" count="219" label="Merck KGaA"></FilterOption><FilterOption id="1043016" count="219" label="Tehran University of Medical Sciences"></FilterOption><FilterOption id="20703" count="216" label="Yale University"></FilterOption><FilterOption id="1007827" count="213" label="University Medical Center Groningen"></FilterOption><FilterOption id="20673" count="213" label="University of Southern California"></FilterOption><FilterOption id="24771" count="203" label="Eastern Cooperative Oncology Group"></FilterOption><FilterOption id="1041702" count="202" label="Gynecologic Oncology Group"></FilterOption><FilterOption id="21189" count="201" label="Chinese Academy of Medical Sciences"></FilterOption><FilterOption id="22487" count="198" label="The University of Hong Kong"></FilterOption><FilterOption id="20669" count="198" label="University of Rochester"></FilterOption><FilterOption id="1039932" count="197" label="Peking Union Medical College Hospital"></FilterOption><FilterOption id="1053899" count="196" label="Abramson Cancer Center of the University of Pennsylvania"></FilterOption><FilterOption id="1042263" count="195" label="Ohio State University Comprehensive Cancer Center"></FilterOption><FilterOption id="1040998" count="194" label="Masonic Cancer Center"></FilterOption><FilterOption id="30810" count="194" label="VU University Medical Center"></FilterOption><FilterOption id="1015721" count="192" label="Medical University of Vienna"></FilterOption><FilterOption id="18614" count="192" label="Novo Nordisk A/S"></FilterOption><FilterOption id="1003379" count="192" label="Sichuan University"></FilterOption><FilterOption id="1021685" count="190" label="Chinese PLA General Hospital"></FilterOption><FilterOption id="21991" count="189" label="Takeda Oncology"></FilterOption><FilterOption id="1018611" count="188" label="Erasmus University Medical Center Rotterdam"></FilterOption><FilterOption id="22182" count="188" label="University of Oxford"></FilterOption><FilterOption id="29469" count="187" label="Cancer Research UK"></FilterOption><FilterOption id="18720" count="187" label="Taiho Pharmaceutical Co Ltd"></FilterOption><FilterOption id="29481" count="186" label="Johnson &amp; Johnson Pharmaceutical Research &amp; Development LLC"></FilterOption><FilterOption id="30065" count="185" label="Charite Universitaetsmedizin Berlin"></FilterOption><FilterOption id="26334" count="185" label="National Institute of Diabetes, Digestive and Kidney Diseases"></FilterOption><FilterOption id="26112" count="181" label="All India Institute of Medical Sciences"></FilterOption><FilterOption id="1025024" count="181" label="Assiut University"></FilterOption></Filter><Filter label="Trial Recruitment Status" name="trialRecruitmentStatus" total="8"><FilterOption id="4" count="50413" label="Completed"></FilterOption><FilterOption id="2" count="34506" label="Recruiting"></FilterOption><FilterOption id="12" count="14354" label="Status not specified"></FilterOption><FilterOption id="3" count="12979" label="No longer recruiting"></FilterOption><FilterOption id="6" count="11625" label="Terminated"></FilterOption><FilterOption id="1" count="10260" label="Not yet recruiting"></FilterOption><FilterOption id="15" count="730" label="Planned"></FilterOption><FilterOption id="5" count="607" label="Suspended"></FilterOption></Filter><Filter label="Trial Commercially Significant" name="trialIsCommerciallySignificant" total="2"><FilterOption id="NO" count="97782" label="No"></FilterOption><FilterOption id="YES" count="37692" label="Yes"></FilterOption></Filter><Filter label="Trial Indications Pioneer" name="trialIndicationsPioneer" total="100"><FilterOption id="3713" count="1497" label="Advanced solid tumor"></FilterOption><FilterOption id="725" count="939" label="Solid tumor"></FilterOption><FilterOption id="3665" count="841" label="Metastatic non small cell lung cancer"></FilterOption><FilterOption id="1069" count="832" label="Metastasis"></FilterOption><FilterOption id="3657" count="798" label="Metastatic breast cancer"></FilterOption><FilterOption id="49" count="747" label="Breast tumor"></FilterOption><FilterOption id="651" count="701" label="Cancer"></FilterOption><FilterOption id="3658" count="613" label="Metastatic colorectal cancer"></FilterOption><FilterOption id="2399" count="567" label="Adenocarcinoma"></FilterOption><FilterOption id="1262" count="560" label="Non-small-cell lung cancer"></FilterOption><FilterOption id="319" count="559" label="Non-Hodgkin lymphoma"></FilterOption><FilterOption id="1731" count="539" label="Acute myelogenous leukemia"></FilterOption><FilterOption id="3257" count="522" label="Stage IV melanoma"></FilterOption><FilterOption id="799" count="519" label="Ovary tumor"></FilterOption><FilterOption id="307" count="507" label="Squamous cell carcinoma"></FilterOption><FilterOption id="203" count="501" label="Lymphoma"></FilterOption><FilterOption id="1828" count="498" label="Multiple myeloma"></FilterOption><FilterOption id="3669" count="489" label="Metastatic pancreas cancer"></FilterOption><FilterOption id="3246" count="488" label="Hormone refractory prostate cancer"></FilterOption><FilterOption id="1767" count="426" label="Hepatocellular carcinoma"></FilterOption><FilterOption id="276" count="420" label="Prostate tumor"></FilterOption><FilterOption id="989" count="419" label="Colorectal tumor"></FilterOption><FilterOption id="2454" count="403" label="Glioblastoma"></FilterOption><FilterOption id="3866" count="393" label="Metastatic ovary cancer"></FilterOption><FilterOption id="205" count="379" label="Melanoma"></FilterOption><FilterOption id="249" count="374" label="Pancreas tumor"></FilterOption><FilterOption id="1734" count="367" label="Chronic lymphocytic leukemia"></FilterOption><FilterOption id="3666" count="367" label="Metastatic stomach cancer"></FilterOption><FilterOption id="1272" count="361" label="Myelodysplastic syndrome"></FilterOption><FilterOption id="4250" count="358" label="Metastatic renal cell carcinoma"></FilterOption><FilterOption id="623" count="349" label="Head and neck tumor"></FilterOption><FilterOption id="3673" count="340" label="Metastatic head and neck cancer"></FilterOption><FilterOption id="3083" count="340" label="Peritoneal tumor"></FilterOption><FilterOption id="1108" count="335" label="Glioma"></FilterOption><FilterOption id="1749" count="331" label="Diffuse large B-cell lymphoma"></FilterOption><FilterOption id="158" count="308" label="HIV infection"></FilterOption><FilterOption id="1261" count="300" label="Small-cell lung cancer"></FilterOption><FilterOption id="427" count="289" label="Uterine cervix tumor"></FilterOption><FilterOption id="2243" count="285" label="Fallopian tube cancer"></FilterOption><FilterOption id="1728" count="284" label="Acute lymphoblastic leukemia"></FilterOption><FilterOption id="316" count="276" label="B-cell lymphoma"></FilterOption><FilterOption id="2054" count="269" label="Hematological neoplasm"></FilterOption><FilterOption id="3667" count="265" label="Metastatic esophageal cancer"></FilterOption><FilterOption id="194" count="265" label="Sarcoma"></FilterOption><FilterOption id="1771" count="256" label="Transitional cell carcinoma"></FilterOption><FilterOption id="127" count="255" label="Stomach tumor"></FilterOption><FilterOption id="1745" count="254" label="Follicle center lymphoma"></FilterOption><FilterOption id="1705" count="251" label="Endometrioid carcinoma"></FilterOption><FilterOption id="3664" count="251" label="Metastatic prostate cancer"></FilterOption><FilterOption id="760" count="250" label="Brain tumor"></FilterOption><FilterOption id="755" count="246" label="Lung tumor"></FilterOption><FilterOption id="1735" count="234" label="Chronic myelocytic leukemia"></FilterOption><FilterOption id="161" count="229" label="Hodgkins disease"></FilterOption><FilterOption id="199" count="219" label="Leukemia"></FilterOption><FilterOption id="1744" count="217" label="Mantle cell lymphoma"></FilterOption><FilterOption id="1011" count="214" label="Esophagus tumor"></FilterOption><FilterOption id="837" count="208" label="Non-insulin dependent diabetes"></FilterOption><FilterOption id="2380" count="207" label="Bladder cancer"></FilterOption><FilterOption id="1766" count="206" label="Renal cell carcinoma"></FilterOption><FilterOption id="759" count="205" label="Central nervous system tumor"></FilterOption><FilterOption id="291" count="204" label="Rheumatoid arthritis"></FilterOption><FilterOption id="1240" count="193" label="Mesothelioma"></FilterOption><FilterOption id="3378" count="191" label="Soft tissue sarcoma"></FilterOption><FilterOption id="2726" count="179" label="Neuroblastoma"></FilterOption><FilterOption id="3256" count="174" label="Stage III melanoma"></FilterOption><FilterOption id="1765" count="171" label="Cholangiocarcinoma"></FilterOption><FilterOption id="20" count="165" label="Pain"></FilterOption><FilterOption id="1128" count="161" label="Neuroendocrine tumor"></FilterOption><FilterOption id="3466" count="158" label="Metastatic bladder cancer"></FilterOption><FilterOption id="202" count="155" label="Liver tumor"></FilterOption><FilterOption id="159" count="153" label="HIV-1 infection"></FilterOption><FilterOption id="230" count="147" label="Neoplasm"></FilterOption><FilterOption id="281" count="143" label="Psoriasis"></FilterOption><FilterOption id="3668" count="142" label="Metastatic lung cancer"></FilterOption><FilterOption id="191" count="137" label="Influenza virus infection"></FilterOption><FilterOption id="767" count="134" label="Colon tumor"></FilterOption><FilterOption id="14" count="124" label="Alzheimers disease"></FilterOption><FilterOption id="999" count="121" label="Renal tumor"></FilterOption><FilterOption id="616" count="119" label="Graft versus host disease"></FilterOption><FilterOption id="1746" count="115" label="Marginal zone B-cell lymphoma"></FilterOption><FilterOption id="1772" count="114" label="Osteosarcoma"></FilterOption><FilterOption id="311" count="114" label="T-cell lymphoma"></FilterOption><FilterOption id="2567" count="112" label="Anaplastic astrocytoma"></FilterOption><FilterOption id="3462" count="112" label="Metastatic liver cancer"></FilterOption><FilterOption id="1134" count="112" label="Thyroid tumor"></FilterOption><FilterOption id="2975" count="111" label="Ewing sarcoma"></FilterOption><FilterOption id="793" count="110" label="Mouth tumor"></FilterOption><FilterOption id="1185" count="108" label="Chronic obstructive pulmonary disease"></FilterOption><FilterOption id="836" count="107" label="Insulin dependent diabetes"></FilterOption><FilterOption id="3251" count="106" label="End stage renal disease"></FilterOption><FilterOption id="54" count="105" label="Carcinoma"></FilterOption><FilterOption id="2436" count="105" label="Myelofibrosis"></FilterOption><FilterOption id="1516" count="104" label="Biliary cancer"></FilterOption><FilterOption id="131" count="104" label="Gastrointestinal tumor"></FilterOption><FilterOption id="1754" count="102" label="Cutaneous T-cell lymphoma"></FilterOption><FilterOption id="153" count="102" label="Hepatitis C virus infection"></FilterOption><FilterOption id="1768" count="102" label="Nasopharyngeal carcinoma"></FilterOption><FilterOption id="31" count="100" label="Asthma"></FilterOption><FilterOption id="2727" count="99" label="Gliosarcoma"></FilterOption><FilterOption id="152" count="99" label="Hepatitis B virus infection"></FilterOption></Filter><Filter label="Registry Id" name="trialRegistries" total="37"><FilterOption id="1000" count="90631" label="CT.gov"></FilterOption><FilterOption id="1001" count="17327" label="EudraCT"></FilterOption><FilterOption id="1003" count="8853" label="UMIN"></FilterOption><FilterOption id="1007" count="5578" label="ChiCTR"></FilterOption><FilterOption id="1012" count="2584" label="CTRI"></FilterOption><FilterOption id="1002" count="2571" label="ISRCTN"></FilterOption><FilterOption id="1006" count="2122" label="JapicCTI"></FilterOption><FilterOption id="1030" count="1779" label="RSRM CTR"></FilterOption><FilterOption id="1004" count="1766" label="WHO ICTRP"></FilterOption><FilterOption id="1019" count="1609" label="DRKS"></FilterOption><FilterOption id="1039" count="1540" label="CDE"></FilterOption><FilterOption id="1011" count="1516" label="ANZCTR"></FilterOption><FilterOption id="1023" count="1356" label="UKCRN"></FilterOption><FilterOption id="1014" count="1205" label="IRCT"></FilterOption><FilterOption id="1015" count="946" label="NTR"></FilterOption><FilterOption id="1010" count="825" label="CRiS"></FilterOption><FilterOption id="1035" count="563" label="Singapore HSA CTR"></FilterOption><FilterOption id="1009" count="501" label="HKClinicalTrials.com"></FilterOption><FilterOption id="1021" count="440" label="NMRR"></FilterOption><FilterOption id="1033" count="326" label="Mexico CTR"></FilterOption><FilterOption id="1037" count="295" label="TCTR"></FilterOption><FilterOption id="1020" count="234" label="ReBec"></FilterOption><FilterOption id="1038" count="218" label="PHRR"></FilterOption><FilterOption id="1013" count="164" label="RPCEC"></FilterOption><FilterOption id="1005" count="79" label="JMACCT CTR"></FilterOption><FilterOption id="1040" count="44" label="REec"></FilterOption><FilterOption id="1008" count="42" label="Hong Kong CCTCTR"></FilterOption><FilterOption id="1018" count="34" label="SLCTR"></FilterOption><FilterOption id="1016" count="31" label="PACTR"></FilterOption><FilterOption id="1017" count="10" label="CTR Freiburg"></FilterOption><FilterOption id="1031" count="5" label="Estonia CTR"></FilterOption><FilterOption id="1036" count="5" label="JAZMP CTR"></FilterOption><FilterOption id="1026" count="3" label="SANCTR"></FilterOption><FilterOption id="1024" count="3" label="TzCTR"></FilterOption><FilterOption id="1034" count="2" label="INFARMA CTR"></FilterOption><FilterOption id="1027" count="2" label="SUKL CTR"></FilterOption><FilterOption id="1032" count="1" label="Chile CTR"></FilterOption></Filter><Filter label="Trial Reason for Discontinuation" name="trialReasonForDiscontinuation" total="8"><FilterOption id="2" count="3374" label="Not Reported"></FilterOption><FilterOption id="5" count="3288" label="Patient Enrollment Issues"></FilterOption><FilterOption id="4" count="1800" label="Other"></FilterOption><FilterOption id="3" count="1331" label="Operational Issues"></FilterOption><FilterOption id="8" count="865" label="Sponsor/Business Decision"></FilterOption><FilterOption id="1" count="710" label="Lack of Efficacy"></FilterOption><FilterOption id="7" count="466" label="Safety Issues"></FilterOption><FilterOption id="6" count="290" label="Planned, not Initiated"></FilterOption></Filter><Filter label="Active Controls" name="trialActiveControls" total="100"><FilterOption id="3803" count="577" label="paclitaxel"></FilterOption><FilterOption id="2953" count="529" label="docetaxel"></FilterOption><FilterOption id="44383" count="525" label="carboplatin"></FilterOption><FilterOption id="3199" count="514" label="gemcitabine"></FilterOption><FilterOption id="12205" count="322" label="capecitabine"></FilterOption><FilterOption id="3792" count="322" label="oxaliplatin"></FilterOption><FilterOption id="8047" count="221" label="bevacizumab"></FilterOption><FilterOption id="6050" count="207" label="metformin hydrochloride"></FilterOption><FilterOption id="6736" count="206" label="rituximab"></FilterOption><FilterOption id="3536" count="195" label="pemetrexed disodium"></FilterOption><FilterOption id="2871" count="192" label="irinotecan"></FilterOption><FilterOption id="3072" count="160" label="etoposide phosphate"></FilterOption><FilterOption id="13022" count="151" label="epirubicin"></FilterOption><FilterOption id="6386" count="151" label="trastuzumab"></FilterOption><FilterOption id="4510" count="138" label="tacrolimus"></FilterOption><FilterOption id="10252" count="120" label="insulin glargine"></FilterOption><FilterOption id="6408" count="113" label="vinorelbine"></FilterOption><FilterOption id="29016" count="110" label="paclitaxel (albumin-bound nanoparticle, intravenous), Celgene"></FilterOption><FilterOption id="3669" count="102" label="mycophenolate mofetil"></FilterOption><FilterOption id="4529" count="101" label="temozolomide"></FilterOption><FilterOption id="29831" count="94" label="sorafenib"></FilterOption><FilterOption id="11961" count="89" label="erlotinib"></FilterOption><FilterOption id="2836" count="88" label="clopidogrel"></FilterOption><FilterOption id="2807" count="84" label="atorvastatin"></FilterOption><FilterOption id="44314" count="81" label="tamoxifen"></FilterOption><FilterOption id="10084" count="80" label="tegafur + gimeracil + oteracil potassium"></FilterOption><FilterOption id="10388" count="79" label="cetuximab"></FilterOption><FilterOption id="7934" count="79" label="doxorubicin (liposomal, STEALTH), Alza"></FilterOption><FilterOption id="2784" count="74" label="letrozole"></FilterOption><FilterOption id="3750" count="74" label="ondansetron"></FilterOption><FilterOption id="14163" count="71" label="adalimumab"></FilterOption><FilterOption id="6156" count="71" label="fludarabine"></FilterOption><FilterOption id="48945" count="68" label="bupivacaine, AstraZeneca"></FilterOption><FilterOption id="7286" count="67" label="goserelin acetate"></FilterOption><FilterOption id="8165" count="67" label="tiotropium bromide"></FilterOption><FilterOption id="27572" count="66" label="lenalidomide"></FilterOption><FilterOption id="5267" count="66" label="leuprorelin acetate"></FilterOption><FilterOption id="3130" count="65" label="filgrastim"></FilterOption><FilterOption id="11460" count="64" label="imatinib"></FilterOption><FilterOption id="21374" count="64" label="pegfilgrastim"></FilterOption><FilterOption id="15954" count="60" label="bortezomib"></FilterOption><FilterOption id="70667" count="60" label="pembrolizumab"></FilterOption><FilterOption id="8832" count="59" label="glimepiride"></FilterOption><FilterOption id="44305" count="58" label="omeprazole"></FilterOption><FilterOption id="3321" count="57" label="anastrozole"></FilterOption><FilterOption id="44375" count="57" label="warfarin"></FilterOption><FilterOption id="44279" count="56" label="amoxicillin"></FilterOption><FilterOption id="44403" count="56" label="lidocaine"></FilterOption><FilterOption id="3313" count="54" label="fulvestrant"></FilterOption><FilterOption id="11603" count="54" label="gefitinib"></FilterOption><FilterOption id="54804" count="53" label="nivolumab"></FilterOption><FilterOption id="13486" count="51" label="entecavir"></FilterOption><FilterOption id="44308" count="51" label="propofol, AstraZeneca/Fresenius"></FilterOption><FilterOption id="3081" count="50" label="exemestane"></FilterOption><FilterOption id="14493" count="49" label="tenofovir disoproxil fumarate"></FilterOption><FilterOption id="4577" count="49" label="topotecan"></FilterOption><FilterOption id="2829" count="48" label="clarithromycin"></FilterOption><FilterOption id="3353" count="48" label="insulin lispro"></FilterOption><FilterOption id="44499" count="47" label="sitagliptin"></FilterOption><FilterOption id="2500" count="46" label="amlodipine"></FilterOption><FilterOption id="12978" count="46" label="moxifloxacin"></FilterOption><FilterOption id="44303" count="45" label="midazolam hydrochloride"></FilterOption><FilterOption id="12973" count="45" label="sunitinib"></FilterOption><FilterOption id="12135" count="44" label="celecoxib"></FilterOption><FilterOption id="14336" count="43" label="fluticasone propionate + salmeterol (asthma and COPD), GlaxoSmithKline"></FilterOption><FilterOption id="37370" count="42" label="azacitidine"></FilterOption><FilterOption id="16026" count="42" label="esomeprazole"></FilterOption><FilterOption id="4271" count="42" label="ropivacaine"></FilterOption><FilterOption id="4513" count="42" label="tamsulosin hydrochloride"></FilterOption><FilterOption id="47000" count="41" label="bendamustine"></FilterOption><FilterOption id="6140" count="41" label="formoterol"></FilterOption><FilterOption id="11519" count="40" label="mitoxantrone"></FilterOption><FilterOption id="10411" count="39" label="insulin aspart"></FilterOption><FilterOption id="23625" count="39" label="peginterferon alfa-2a"></FilterOption><FilterOption id="12150" count="39" label="vincristine sulfate (liposomal injection), Spectrum Pharmaceuticals"></FilterOption><FilterOption id="44409" count="38" label="Fluzone"></FilterOption><FilterOption id="3474" count="38" label="lamivudine"></FilterOption><FilterOption id="5999" count="37" label="ciclosporin, Novartis"></FilterOption><FilterOption id="13928" count="37" label="enoxaparin sodium"></FilterOption><FilterOption id="3311" count="36" label="bicalutamide"></FilterOption><FilterOption id="3492" count="36" label="levofloxacin"></FilterOption><FilterOption id="44312" count="36" label="salmeterol"></FilterOption><FilterOption id="44401" count="36" label="vancomycin"></FilterOption><FilterOption id="36630" count="35" label="ipilimumab"></FilterOption><FilterOption id="44313" count="35" label="simvastatin"></FilterOption><FilterOption id="10309" count="34" label="abiraterone"></FilterOption><FilterOption id="13340" count="33" label="everolimus"></FilterOption><FilterOption id="5148" count="33" label="liraglutide"></FilterOption><FilterOption id="4126" count="33" label="pioglitazone"></FilterOption><FilterOption id="49219" count="33" label="tenofovir disoproxil fumarate + emtricitabine (fixed dose), Gilead Sciences"></FilterOption><FilterOption id="2765" count="33" label="zoledronic acid"></FilterOption><FilterOption id="10172" count="32" label="efavirenz"></FilterOption><FilterOption id="6104" count="32" label="lansoprazole"></FilterOption><FilterOption id="12420" count="32" label="rosuvastatin"></FilterOption><FilterOption id="3159" count="31" label="fluticasone propionate"></FilterOption><FilterOption id="4567" count="30" label="etanercept"></FilterOption><FilterOption id="5369" count="30" label="ribavirin"></FilterOption><FilterOption id="5356" count="30" label="sevoflurane"></FilterOption><FilterOption id="7310" count="29" label="ritonavir"></FilterOption><FilterOption id="7413" count="27" label="darbepoetin alfa"></FilterOption></Filter><Filter label="Exclusion Criteria Index" name="trialExclusionCriteriaIndex" total="100"><FilterOption id="10704" count="5132" label="Solid tumor - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="4702" count="4846" label="Lymphoma - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="6554" count="4822" label="Leukemia - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="5132" count="4716" label="Lung tumor - Subjects co-morbid with cardiovascular diseases/disorders"></FilterOption><FilterOption id="5365" count="4416" label="Lung tumor - Protocol Specified Other Exclusion Criteria - Protocol specified exclusion criteria for females"></FilterOption><FilterOption id="5193" count="4355" label="Lung tumor - Subjects with History of/Active Malignancy/Cancer"></FilterOption><FilterOption id="6258" count="4349" label="Breast tumor - Subjects co-morbid with cardiovascular diseases/disorders"></FilterOption><FilterOption id="20282" count="4142" label="Lung tumor - Subjects co-morbid with inflammatory disorders"></FilterOption><FilterOption id="10881" count="3969" label="Cancer supportive care - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="6294" count="3761" label="Breast tumor - Subjects with History of/Active Malignancy/Cancer"></FilterOption><FilterOption id="5125" count="3591" label="Lung tumor - Subjects with Evidence of Metastasis - Subjects with central nervous system metastases"></FilterOption><FilterOption id="6272" count="3551" label="Breast tumor - Subjects co-morbid with inflammatory disorders"></FilterOption><FilterOption id="925" count="3429" label="Non-insulin dependent diabetes - Subjects with History of/Active Malignancy/Cancer"></FilterOption><FilterOption id="6252" count="3344" label="Breast tumor - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="5291" count="3313" label="Lung tumor - Subjects with History of/Scheduled for Other Treatments"></FilterOption><FilterOption id="6393" count="3180" label="Breast tumor - Subjects with History of/Scheduled to Receive Therapy"></FilterOption><FilterOption id="5282" count="3169" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for radiation therapy"></FilterOption><FilterOption id="5270" count="3167" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"></FilterOption><FilterOption id="5349" count="3141" label="Lung tumor - Subjects with Protocol Specified Compliance Status - Subjects unable/unwilling to comply with protocol requirements"></FilterOption><FilterOption id="6253" count="3138" label="Breast tumor - Subjects with Co-morbid Conditions - Subjects with central nervous system diseases"></FilterOption><FilterOption id="20281" count="3120" label="Lung tumor - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="5139" count="3104" label="Lung tumor - Subjects co-morbid with Respiratory Diseases/Disorders - Subjects co-morbid with pulmonary diseases/disorders"></FilterOption><FilterOption id="6328" count="3086" label="Breast tumor - Subjects with History of/Scheduled for Anti-neoplastic Therapy"></FilterOption><FilterOption id="20124" count="3070" label="Pain - Immunocompromised Subjects - Subjects immunocompromised with cancer/malignancy"></FilterOption><FilterOption id="6377" count="2938" label="Breast tumor - Subjects with history of/planned radiotherapy"></FilterOption><FilterOption id="5128" count="2922" label="Lung tumor - Subjects with Co-morbid Conditions - Subjects with central nervous system diseases/disorders"></FilterOption><FilterOption id="5744" count="2751" label="Head and neck tumor - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="20114" count="2731" label="Pain - Subjects with Co-morbid Conditions - Subjects co-morbid with CNS disorders/diseases"></FilterOption><FilterOption id="5841" count="2687" label="Colorectal tumor - Subjects with History of/Active Malignancy/Cancer"></FilterOption><FilterOption id="6247" count="2672" label="Breast tumor - Subjects by disease severity - Subjects with Brain/Leptomeningeal metastases"></FilterOption><FilterOption id="4692" count="2643" label="Lymphoma - Subjects with History of/Active Malignancy/Cancer"></FilterOption><FilterOption id="5856" count="2599" label="Colorectal tumor - Subjects co-morbid with inflammatory disorders"></FilterOption><FilterOption id="5864" count="2593" label="Colorectal tumor - Subjects co-morbid with cardiovascular diseases/disorders"></FilterOption><FilterOption id="15723" count="2572" label="Stem cell transplantation - Subjects with Co-morbid Conditions - Subjects with history of infections"></FilterOption><FilterOption id="5879" count="2527" label="Colorectal tumor - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="5962" count="2519" label="Colorectal tumor - Subjects with history of/scheduled to receive therapy for other indication"></FilterOption><FilterOption id="4769" count="2487" label="Lymphoma - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"></FilterOption><FilterOption id="9412" count="2479" label="Hepatobiliary system tumor - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="10761" count="2467" label="Solid tumor - Subjects with Evidence of Metastasis - Subjects with brain/CNS metastasis"></FilterOption><FilterOption id="10739" count="2339" label="Solid tumor - Subjects with History of Other Non Anti-cancer Drugs/Agents"></FilterOption><FilterOption id="6331" count="2307" label="Breast tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"></FilterOption><FilterOption id="10378" count="2306" label="Pancreas tumor - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="6756" count="2305" label="Lung tumor - Subjects with History of/Scheduled for Other Cancer Therapies"></FilterOption><FilterOption id="5149" count="2299" label="Lung tumor - Subjects co-morbid with gastrointestinal diseases/disorders"></FilterOption><FilterOption id="10916" count="2291" label="Cancer supportive care - Subjects with History of Treatment with Non-chemotherapeutic Drugs"></FilterOption><FilterOption id="5345" count="2284" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled to receive an investigational drug"></FilterOption><FilterOption id="6534" count="2276" label="Leukemia - Subjects with History of/Active Malignancy/Cancer"></FilterOption><FilterOption id="4918" count="2271" label="Prostate tumor - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="6065" count="2249" label="Multiple myeloma - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="4864" count="2203" label="Prostate tumor - Subjects co-morbid with cardiovascular diseases/disorders"></FilterOption><FilterOption id="5236" count="2199" label="Lung tumor - Subjects with Hypersensitivity/Contraindications to Drugs/Excipients"></FilterOption><FilterOption id="4909" count="2173" label="Prostate tumor - Subjects with History of/Active Malignancy/Cancer"></FilterOption><FilterOption id="10736" count="2169" label="Solid tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of radiotherapy"></FilterOption><FilterOption id="9484" count="2137" label="Stomach tumor - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="10732" count="2135" label="Solid tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"></FilterOption><FilterOption id="17533" count="2127" label="End stage renal disease - Subjects with History of/Active Malignancy/Cancer"></FilterOption><FilterOption id="5344" count="2093" label="Lung tumor - Protocol Specified Other Exclusion Criteria"></FilterOption><FilterOption id="9810" count="2082" label="Ovary tumor - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="20115" count="2048" label="Pain - Subjects co-morbid with cardiovascular diseases/disorders"></FilterOption><FilterOption id="5826" count="2046" label="Colorectal tumor - Subjects with Metastatic Colorectal Cancer - Subjects with brain metastases or leptomeningeal carcinomatosis"></FilterOption><FilterOption id="20290" count="1986" label="Breast tumor - Subjects with History of/Scheduled for Intervention/Surgery - Subjects with history of/scheduled for surgery"></FilterOption><FilterOption id="5949" count="1973" label="Colorectal tumor - Subjects with history of/scheduled to receive radiation therapy"></FilterOption><FilterOption id="4810" count="1961" label="Lymphoma - Subjects with History of Treatment with Non-chemotherapeutic Drugs"></FilterOption><FilterOption id="10738" count="1957" label="Solid tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled to receive an investigational drug"></FilterOption><FilterOption id="5163" count="1951" label="Lung tumor - Subjects with Co-morbid Conditions - Subjects co-morbid with hepatobiliary diseases/disorders"></FilterOption><FilterOption id="5848" count="1947" label="Colorectal tumor - Subjects co-morbid with gastrointestinal diseases/disorders"></FilterOption><FilterOption id="6302" count="1945" label="Breast tumor - Subjects with Hypersensitivity/Contraindications to Drugs/Excipients - Subjects with hypersensitivity/contraindication to any investigational agents"></FilterOption><FilterOption id="20112" count="1938" label="Pain - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="6261" count="1932" label="Breast tumor - Subjects with Co-morbid Conditions - Subjects co-morbid with hepatobiliary diseases/disorders"></FilterOption><FilterOption id="6474" count="1916" label="Breast tumor - Protocol Specified Other Exclusion Criteria - Protocol specified exclusion criteria for females"></FilterOption><FilterOption id="4762" count="1902" label="Lymphoma - Subjects with History of/Scheduled to Receive Therapy - Subject with history of radiotherapy"></FilterOption><FilterOption id="4968" count="1897" label="Prostate tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects on prior/concurrent radiotherapy"></FilterOption><FilterOption id="20123" count="1885" label="Pain - Subjects with Co-morbid Conditions - Subjects with infectious disorders/disease"></FilterOption><FilterOption id="837" count="1880" label="Non-insulin dependent diabetes - Subjects co-morbid with renal disease/disorder"></FilterOption><FilterOption id="5751" count="1875" label="Head and neck tumor - Subjects with History of/Active Malignancy/Cancer"></FilterOption><FilterOption id="10717" count="1827" label="Solid tumor - Subjects with Abnormal Organ Function - Subjects with abnormal/unacceptable cardiac function"></FilterOption><FilterOption id="5934" count="1826" label="Colorectal tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"></FilterOption><FilterOption id="20182" count="1825" label="Pain - Protocol Specified Other Exclusion Criteria"></FilterOption><FilterOption id="5176" count="1792" label="Lung tumor - Subjects with Co-morbid Conditions - Subjects co-morbid with hematological disease/disorders"></FilterOption><FilterOption id="4967" count="1788" label="Prostate tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"></FilterOption><FilterOption id="6660" count="1765" label="Leukemia - Subjects with History of Treatment with Non-chemotherapeutic Drugs"></FilterOption><FilterOption id="6260" count="1743" label="Breast tumor - Subjects co-morbid with gastrointestinal diseases/disorders"></FilterOption><FilterOption id="6767" count="1738" label="Lymphoma - Lymphoma Subjects with Advanced Disease - Subjects with central nervous system involvement of lymphoma"></FilterOption><FilterOption id="12316" count="1732" label="Solid tumor - Subjects with History of/Active Malignancy/Cancer"></FilterOption><FilterOption id="4783" count="1726" label="Lymphoma - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled to receive an investigational drug"></FilterOption><FilterOption id="4975" count="1699" label="Prostate tumor - Subjects with history of/scheduled to receive therapy for other indication"></FilterOption><FilterOption id="10900" count="1689" label="Cancer supportive care - Subjects with Hypersensitivity/Contraindications to Drugs/Excipients"></FilterOption><FilterOption id="10641" count="1681" label="Central nervous system tumor - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="5168" count="1681" label="Lung tumor - Subjects co-morbid with endocrine/metabolic diseases/disorders"></FilterOption><FilterOption id="6618" count="1653" label="Leukemia - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for chemotherapy"></FilterOption><FilterOption id="17531" count="1604" label="End stage renal disease - Subjects co-morbid with infections"></FilterOption><FilterOption id="5470" count="1600" label="Melanoma - Subjects co-morbid with inflammatory disorders"></FilterOption><FilterOption id="5277" count="1597" label="Lung tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of/scheduled for biological therapy"></FilterOption><FilterOption id="6259" count="1588" label="Breast tumor - Subjects co-morbid with Respiratory Diseases/Disorders - Subjects co-morbid with pulmonary diseases/disorders"></FilterOption><FilterOption id="5589" count="1560" label="Coronary artery disease - Immunocompromised Subjects - Subjects immunocompromised with cancer/malignancy"></FilterOption><FilterOption id="5285" count="1552" label="Lung tumor - Subjects with History of/Scheduled for Intervention/Surgery - Subjects with history of/scheduled for surgery"></FilterOption><FilterOption id="911" count="1547" label="Non-insulin dependent diabetes - Subjects co-morbid with hepatobiliary disorders/diseases"></FilterOption><FilterOption id="5781" count="1539" label="Head and neck tumor - Subjects with History of/Scheduled to Receive Therapy - Subjects with history of radiotherapy"></FilterOption><FilterOption id="9161" count="1528" label="Myelodysplastic syndrome - Subjects with Co-morbid Conditions"></FilterOption><FilterOption id="6301" count="1520" label="Breast tumor - Subjects with Hypersensitivity/Contraindications to Drugs/Excipients"></FilterOption></Filter><Filter label="Trial Date Enrollment End By Month" name="trialDateEnrollmentEndByMonth" total="100"><FilterOption count="322" label="201905"></FilterOption><FilterOption count="311" label="201703"></FilterOption><FilterOption count="304" label="201904"></FilterOption><FilterOption count="302" label="201902"></FilterOption><FilterOption count="301" label="201708"></FilterOption><FilterOption count="297" label="201609"></FilterOption><FilterOption count="290" label="201601"></FilterOption><FilterOption count="289" label="201603"></FilterOption><FilterOption count="289" label="201801"></FilterOption><FilterOption count="287" label="201901"></FilterOption><FilterOption count="286" label="201701"></FilterOption><FilterOption count="285" label="201802"></FilterOption><FilterOption count="284" label="201705"></FilterOption><FilterOption count="283" label="201604"></FilterOption><FilterOption count="283" label="201803"></FilterOption><FilterOption count="277" label="201702"></FilterOption><FilterOption count="276" label="201903"></FilterOption><FilterOption count="274" label="201710"></FilterOption><FilterOption count="274" label="201805"></FilterOption><FilterOption count="269" label="201503"></FilterOption><FilterOption count="268" label="201610"></FilterOption><FilterOption count="267" label="201608"></FilterOption><FilterOption count="267" label="201706"></FilterOption><FilterOption count="267" label="201804"></FilterOption><FilterOption count="263" label="201605"></FilterOption><FilterOption count="262" label="201602"></FilterOption><FilterOption count="258" label="201106"></FilterOption><FilterOption count="257" label="201403"></FilterOption><FilterOption count="257" label="201510"></FilterOption><FilterOption count="257" label="201512"></FilterOption><FilterOption count="257" label="201612"></FilterOption><FilterOption count="256" label="201711"></FilterOption><FilterOption count="253" label="201807"></FilterOption><FilterOption count="252" label="201404"></FilterOption><FilterOption count="252" label="201509"></FilterOption><FilterOption count="247" label="201806"></FilterOption><FilterOption count="247" label="201812"></FilterOption><FilterOption count="243" label="201506"></FilterOption><FilterOption count="242" label="201504"></FilterOption><FilterOption count="242" label="201712"></FilterOption><FilterOption count="241" label="201412"></FilterOption><FilterOption count="240" label="200710"></FilterOption><FilterOption count="240" label="201401"></FilterOption><FilterOption count="240" label="201507"></FilterOption><FilterOption count="239" label="201607"></FilterOption><FilterOption count="239" label="201704"></FilterOption><FilterOption count="239" label="201808"></FilterOption><FilterOption count="238" label="201810"></FilterOption><FilterOption count="235" label="201303"></FilterOption><FilterOption count="232" label="201305"></FilterOption><FilterOption count="232" label="201707"></FilterOption><FilterOption count="231" label="201505"></FilterOption><FilterOption count="229" label="201301"></FilterOption><FilterOption count="223" label="201207"></FilterOption><FilterOption count="223" label="201410"></FilterOption><FilterOption count="223" label="201606"></FilterOption><FilterOption count="223" label="201811"></FilterOption><FilterOption count="221" label="201502"></FilterOption><FilterOption count="220" label="201809"></FilterOption><FilterOption count="219" label="201208"></FilterOption><FilterOption count="219" label="201405"></FilterOption><FilterOption count="219" label="201501"></FilterOption><FilterOption count="219" label="201709"></FilterOption><FilterOption count="219" label="201906"></FilterOption><FilterOption count="217" label="201210"></FilterOption><FilterOption count="217" label="201211"></FilterOption><FilterOption count="216" label="201201"></FilterOption><FilterOption count="215" label="201407"></FilterOption><FilterOption count="213" label="201109"></FilterOption><FilterOption count="213" label="201611"></FilterOption><FilterOption count="209" label="201508"></FilterOption><FilterOption count="209" label="201511"></FilterOption><FilterOption count="208" label="201304"></FilterOption><FilterOption count="208" label="201409"></FilterOption><FilterOption count="203" label="201202"></FilterOption><FilterOption count="203" label="201302"></FilterOption><FilterOption count="203" label="201402"></FilterOption><FilterOption count="203" label="201408"></FilterOption><FilterOption count="202" label="201108"></FilterOption><FilterOption count="202" label="201312"></FilterOption><FilterOption count="201" label="201310"></FilterOption><FilterOption count="200" label="201406"></FilterOption><FilterOption count="199" label="201212"></FilterOption><FilterOption count="199" label="201309"></FilterOption><FilterOption count="197" label="200901"></FilterOption><FilterOption count="197" label="201103"></FilterOption><FilterOption count="197" label="201206"></FilterOption><FilterOption count="195" label="201307"></FilterOption><FilterOption count="194" label="201204"></FilterOption><FilterOption count="193" label="201102"></FilterOption><FilterOption count="193" label="201203"></FilterOption><FilterOption count="192" label="200902"></FilterOption><FilterOption count="192" label="201411"></FilterOption><FilterOption count="190" label="200909"></FilterOption><FilterOption count="190" label="201205"></FilterOption><FilterOption count="189" label="201005"></FilterOption><FilterOption count="188" label="201306"></FilterOption><FilterOption count="187" label="201001"></FilterOption><FilterOption count="187" label="201007"></FilterOption><FilterOption count="185" label="201311"></FilterOption></Filter><Filter label="Funder Type" name="trialFunderType" total="5"><FilterOption id="CMP" count="70443" label="Company"></FilterOption><FilterOption id="ACA" count="66205" label="Academic"></FilterOption><FilterOption id="GOV" count="18598" label="Government"></FilterOption><FilterOption id="OTH" count="5437" label="Others"></FilterOption><FilterOption id="NGO" count="3999" label="Non-Government"></FilterOption></Filter><Filter label="Trial Region" name="trialRegions" total="11"><FilterOption id="USCA" count="53150" label="US &amp; Canada"></FilterOption><FilterOption id="EAPO" count="32861" label="East Asia &amp; Pacific Ocean"></FilterOption><FilterOption id="NSWE" count="32244" label="Northern, Southern &amp; Western Europe"></FilterOption><FilterOption id="EEUR" count="7512" label="Eastern Europe"></FilterOption><FilterOption id="MENA" count="5691" label="Middle East &amp; North Africa"></FilterOption><FilterOption id="AUNZ" count="5640" label="Australia &amp; New Zealand"></FilterOption><FilterOption id="SOAM" count="3795" label="South America"></FilterOption><FilterOption id="SOCA" count="3770" label="Southern &amp; Central Asia"></FilterOption><FilterOption id="CAAC" count="3417" label="Central America &amp; Caribbean"></FilterOption><FilterOption id="CSAF" count="1762" label="Central &amp; Southern Africa"></FilterOption><FilterOption id="INDO" count="8" label="Indian Ocean"></FilterOption></Filter><Filter label="Patient Segment Index" name="trialPatientSegmentIndex" total="100"><FilterOption id="3617" count="5433" label="Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC)"></FilterOption><FilterOption id="3634" count="4841" label="Lung tumor - Subjects with Advanced Stage Lung Cancer - Subjects with metastatic/stage IV lung cancer"></FilterOption><FilterOption id="7961" count="4257" label="Solid tumor - Subjects with Advanced/Metastatic Solid Tumors"></FilterOption><FilterOption id="3954" count="4232" label="Breast tumor - Subjects with Advanced/Metastatic Breast Cancer/Stage IV Breast Cancer"></FilterOption><FilterOption id="10295" count="3571" label="Lung tumor - Subjects with Advanced Stage Lung Cancer - Subjects with locally advanced/stage III lung cancer"></FilterOption><FilterOption id="3824" count="3457" label="Colorectal tumor - Subjects with TNM stage IV/Metastatic/Advanced Colorectal Cancer"></FilterOption><FilterOption id="7967" count="3321" label="Solid tumor - Subjects with Treatment Resistant Disease"></FilterOption><FilterOption id="3623" count="3075" label="Lung tumor - Subjects with Advanced Stage Lung Cancer"></FilterOption><FilterOption id="3977" count="2763" label="Leukemia - Subjects with Acute Myeloid Leukemia (AML)"></FilterOption><FilterOption id="3530" count="2718" label="Lymphoma - Subjects with Treatment Resistant Disease"></FilterOption><FilterOption id="3525" count="2573" label="Lymphoma - Subjects with Relapse/Recurrent Lymphoma"></FilterOption><FilterOption id="9010" count="2475" label="Cancer supportive care - Solid tumor subjects for supportive care"></FilterOption><FilterOption id="3489" count="2441" label="Lymphoma - Subjects with B Cell Non Hodgkin's Lymphoma"></FilterOption><FilterOption id="3564" count="2380" label="Prostate tumor - Subjects with Advanced/Metastatic Prostate Cancer"></FilterOption><FilterOption id="11487" count="2197" label="Stem cell transplantation - Subjects with H/O Hematological Malignancies Indicated for SCT"></FilterOption><FilterOption id="3814" count="2168" label="Colorectal tumor - Subjects with Colon Cancer"></FilterOption><FilterOption id="3952" count="2066" label="Breast tumor - Subjects with Locally Advanced Breast Cancer"></FilterOption><FilterOption id="3813" count="2057" label="Colorectal tumor - Subjects with Rectal Cancer"></FilterOption><FilterOption id="3975" count="1938" label="Leukemia - Subjects with Acute Leukemia Unspecified Type"></FilterOption><FilterOption id="12053" count="1938" label="Lung tumor - Treatment Naive Subjects"></FilterOption><FilterOption id="3965" count="1922" label="Breast tumor - Subjects with Treatment Resistant Disease"></FilterOption><FilterOption id="3565" count="1891" label="Prostate tumor - Subjects with Stage IV Prostate Cancer"></FilterOption><FilterOption id="4003" count="1871" label="Leukemia - Subjects with Relapsed/Recurrent Leukemia"></FilterOption><FilterOption id="3650" count="1843" label="Lung tumor - Subjects with Recurrent/Relapsed Lung Cancer"></FilterOption><FilterOption id="10714" count="1835" label="Stem cell transplantation - Subjects with History of/Indicated for Hematopoietic Stem Cell Transplantation(HSCT)"></FilterOption><FilterOption id="3667" count="1811" label="Melanoma - Subjects with Advanced/Metastatic Cancer"></FilterOption><FilterOption id="3647" count="1810" label="Lung tumor - Subjects with Treatment Resistant Disease"></FilterOption><FilterOption id="10713" count="1801" label="Stem cell transplantation - Subjects with History of/Indicated for Allogenic Stem Cell Transplantation(SCT)"></FilterOption><FilterOption id="3490" count="1745" label="Lymphoma - Subjects with T Cell Non Hodgkin's Lymphoma"></FilterOption><FilterOption id="12018" count="1718" label="Prostate tumor - Subjects with adenocarcinoma of prostate"></FilterOption><FilterOption id="3999" count="1689" label="Leukemia - Subjects with Treatment Resistant Disease"></FilterOption><FilterOption id="3944" count="1682" label="Breast tumor - Subjects with Stage II Breast Cancer"></FilterOption><FilterOption id="3979" count="1662" label="Leukemia - Subjects with Acute Lymphocytic Leukemia (ALL)"></FilterOption><FilterOption id="3778" count="1650" label="Head and neck tumor - Subjects with Specific Histological Sub-type of HNC - Subjects with squamous cell carcinoma"></FilterOption><FilterOption id="145" count="1591" label="Non-insulin dependent diabetes - Subjects with Moderate Glycemic Control"></FilterOption><FilterOption id="3680" count="1552" label="Melanoma - Subjects with Stage IV Melanoma"></FilterOption><FilterOption id="3937" count="1551" label="Breast tumor - Subjects with HER-2 Negative Breast Cancer"></FilterOption><FilterOption id="8073" count="1545" label="Pancreas tumor - Subjects with Advanced/Metastatic Pancreatic Cancer"></FilterOption><FilterOption id="7126" count="1535" label="HIV infection - Subjects with HIV Infection - Subjects with HIV-1 Infection"></FilterOption><FilterOption id="3586" count="1510" label="Prostate tumor - Subjects with Treatment Resistant Disease"></FilterOption><FilterOption id="3502" count="1498" label="Lymphoma - Subjects with Specific Grade of Lymphoma - Subjects with Aggressive (high grade) Lymphoma"></FilterOption><FilterOption id="3950" count="1464" label="Breast tumor - Subjects with Early Stage Breast Cancer"></FilterOption><FilterOption id="3936" count="1452" label="Breast tumor - Subjects with HER-2 Positive Breast Cancer"></FilterOption><FilterOption id="3774" count="1439" label="Head and neck tumor - Subjects with Advanced/Metastatic Head and Neck Cancer"></FilterOption><FilterOption id="3931" count="1428" label="Breast tumor - Subjects with Hormone Receptor Positive Breast Cancer - Estrogen receptor positive (ER+) breast cancer"></FilterOption><FilterOption id="3980" count="1424" label="Leukemia - Subjects with Chronic Lymphocytic Leukemia (CLL)"></FilterOption><FilterOption id="10712" count="1415" label="Stem cell transplantation - Subjects with History of/Indicated for Autologous Stem Cell Transplantation(SCT)"></FilterOption><FilterOption id="8010" count="1410" label="Stomach tumor - Subjects with Advanced/Metastatic Gastric Cancer"></FilterOption><FilterOption id="3500" count="1389" label="Lymphoma - Subjects with Specific Grade of Lymphoma - Subjects with Indolent (slow-growing, low grade) Lymphoma"></FilterOption><FilterOption id="3976" count="1388" label="Leukemia - Subjects with Chronic Leukemia Unspecified Type"></FilterOption><FilterOption id="3945" count="1373" label="Breast tumor - Subjects with Stage III Breast Cancer"></FilterOption><FilterOption id="3583" count="1347" label="Prostate tumor - Subjects with Castrate Resistant Prostate Cancer"></FilterOption><FilterOption id="9624" count="1340" label="Central nervous system tumor - Subjects with Brain Tumors"></FilterOption><FilterOption id="103" count="1313" label="Non-insulin dependent diabetes - Subjects with Poor/Inadequate Glycemic Control"></FilterOption><FilterOption id="3978" count="1293" label="Leukemia - Subjects with Chronic Myeloid Leukemia (CML)"></FilterOption><FilterOption id="3966" count="1282" label="Breast tumor - Subjects with Relapsed/Recurrent Breast cancer"></FilterOption><FilterOption id="3637" count="1258" label="Lung tumor - Subjects with Unresectable/In-operable Lung Cancer"></FilterOption><FilterOption id="3472" count="1223" label="Lymphoma - Subjects with B Cell Non Hodgkin's Lymphoma - Subjects with diffuse large B cell lymphoma"></FilterOption><FilterOption id="9632" count="1212" label="Central nervous system tumor - Subjects with Gliomas"></FilterOption><FilterOption id="7415" count="1192" label="Renal cell carcinoma - Subjects with Metastatic Renal Cell Carcinoma"></FilterOption><FilterOption id="3775" count="1164" label="Head and neck tumor - Subjects with Locally Advanced Head and Neck Cancer"></FilterOption><FilterOption id="8754" count="1155" label="Myeloproliferative disorder - Subjects with Chronic Myelogenous Leukemia"></FilterOption><FilterOption id="11424" count="1155" label="Pancreas tumor - Subjects with Adenocarcinoma of Pancreas"></FilterOption><FilterOption id="3943" count="1151" label="Breast tumor - Subjects with Stage I Breast Cancer"></FilterOption><FilterOption id="3926" count="1144" label="Multiple myeloma - Subjects with Relapsed/Recurrent Multiple Myeloma"></FilterOption><FilterOption id="3681" count="1138" label="Melanoma - Subjects with Evidence of Metastasis"></FilterOption><FilterOption id="3467" count="1130" label="Lymphoma - Subjects with Hodgkin's Lymphoma"></FilterOption><FilterOption id="10289" count="1108" label="Head and neck tumor - Subjects with TNM Stage III Head and Neck Cancer"></FilterOption><FilterOption id="3923" count="1105" label="Multiple myeloma - Subjects with Treatment Resistant Disease"></FilterOption><FilterOption id="8062" count="1098" label="Hepatobiliary system tumor - Subjects with Unresectable Hepato-biliary Cancer"></FilterOption><FilterOption id="7877" count="1094" label="Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC) - Subjects with non-squamous cell lung cancer"></FilterOption><FilterOption id="3860" count="1074" label="Colorectal tumor - Subjects with Treatment Resistant Disease"></FilterOption><FilterOption id="7411" count="1059" label="Renal cell carcinoma - Subjects with TNM Stage IV Renal Cell Carcinoma"></FilterOption><FilterOption id="8426" count="1041" label="Pain - Subjects with Cancer Related Pain"></FilterOption><FilterOption id="7879" count="1040" label="Ovary tumor - Subjects with Ovarian Epithelial Tumor"></FilterOption><FilterOption id="7966" count="1026" label="Solid tumor - Subjects with Relapsed/Recurrent Solid Tumors"></FilterOption><FilterOption id="7894" count="1020" label="Ovary tumor - Subjects with Recurrent or Persistent Ovarian Cancer"></FilterOption><FilterOption id="3473" count="1018" label="Lymphoma - Subjects with B Cell Non Hodgkin's Lymphoma - Subjects with follicular lymphoma"></FilterOption><FilterOption id="102" count="1007" label="Non-insulin dependent diabetes - Subjects with Good Glycemic Control"></FilterOption><FilterOption id="3501" count="998" label="Lymphoma - Subjects with Specific Grade of Lymphoma - Subjects with Moderately Aggressive (intermediate grade) Lymphoma"></FilterOption><FilterOption id="3955" count="983" label="Breast tumor - Subjects with Resectable/Operable Breast Cancer"></FilterOption><FilterOption id="8424" count="964" label="Pain - Subjects with Post-Operative Pain"></FilterOption><FilterOption id="3638" count="953" label="Lung tumor - Subjects with Resectable/Operable Lung Cancer"></FilterOption><FilterOption id="11612" count="949" label="Menopause - Subjects with Protocol Specified Menstrual Status - Postmenopausal Subjects"></FilterOption><FilterOption id="3498" count="946" label="Lymphoma - Subjects with specific Ann Arbor stage - Subjects with Ann Arbor Stage IV Lymphoma"></FilterOption><FilterOption id="12009" count="942" label="Prostate tumor - Subjects With Prostate Cancer"></FilterOption><FilterOption id="7895" count="938" label="Ovary tumor - Platinum-Resistant/Refractory Ovarian Cancer Subjects"></FilterOption><FilterOption id="10129" count="936" label="Lung tumor - Subjects with EGFR Positive Lung Cancer"></FilterOption><FilterOption id="16345" count="922" label="Hepatobiliary system tumor - Subjects with specific disease - Subjects with hepatocellular carcinoma"></FilterOption><FilterOption id="8075" count="915" label="Pancreas tumor - Subjects with Unresectable Pancreatic Cancer"></FilterOption><FilterOption id="8059" count="908" label="Hepatobiliary system tumor - Subjects with Advanced/Metastatic Primary Liver Cancer"></FilterOption><FilterOption id="7918" count="891" label="Ovary tumor - Advanced Ovarian Cancer Subjects - Stage IV or metastatic ovarian cancer subjects"></FilterOption><FilterOption id="7962" count="891" label="Solid tumor - Subjects with Unresectable Solid Tumors"></FilterOption><FilterOption id="3973" count="886" label="Leukemia - Subjects at risk of developing disease"></FilterOption><FilterOption id="3823" count="885" label="Colorectal tumor - Subjects with TNM stage III/Dukes C Colorectal Cancer"></FilterOption><FilterOption id="3932" count="877" label="Breast tumor - Subjects with Hormone Receptor Positive Breast Cancer - Progesterone receptor positive (PR+) breast cancer"></FilterOption><FilterOption id="8387" count="875" label="Pain - Subjects with Chronic Pain"></FilterOption><FilterOption id="8998" count="869" label="Cancer supportive care - Other Chemotherapy Induced Adverse Events"></FilterOption><FilterOption id="3559" count="868" label="Prostate tumor - Subjects with Early Stage/Localized Prostate Cancer"></FilterOption><FilterOption id="7988" count="861" label="Glioblastoma - Subjects with Relapse/Recurrent Glioblastoma Multiforme"></FilterOption></Filter><Filter label="Primary Completion Filter by Month" name="trialPrimaryCompletionDateByMonth" total="100"><FilterOption count="2134" label="201912"></FilterOption><FilterOption count="1355" label="201812"></FilterOption><FilterOption count="1233" label="202012"></FilterOption><FilterOption count="1143" label="201712"></FilterOption><FilterOption count="1116" label="201906"></FilterOption><FilterOption count="904" label="201612"></FilterOption><FilterOption count="826" label="201909"></FilterOption><FilterOption count="796" label="202006"></FilterOption><FilterOption count="781" label="201907"></FilterOption><FilterOption count="745" label="202001"></FilterOption><FilterOption count="737" label="201512"></FilterOption><FilterOption count="720" label="201908"></FilterOption><FilterOption count="716" label="201910"></FilterOption><FilterOption count="673" label="201412"></FilterOption><FilterOption count="658" label="202003"></FilterOption><FilterOption count="645" label="201706"></FilterOption><FilterOption count="622" label="201312"></FilterOption><FilterOption count="620" label="201806"></FilterOption><FilterOption count="599" label="201903"></FilterOption><FilterOption count="596" label="201212"></FilterOption><FilterOption count="595" label="201807"></FilterOption><FilterOption count="585" label="202112"></FilterOption><FilterOption count="574" label="201809"></FilterOption><FilterOption count="574" label="201911"></FilterOption><FilterOption count="572" label="201904"></FilterOption><FilterOption count="570" label="201905"></FilterOption><FilterOption count="558" label="202004"></FilterOption><FilterOption count="553" label="201901"></FilterOption><FilterOption count="539" label="201808"></FilterOption><FilterOption count="538" label="201805"></FilterOption><FilterOption count="536" label="202002"></FilterOption><FilterOption count="533" label="202007"></FilterOption><FilterOption count="529" label="201801"></FilterOption><FilterOption count="528" label="201606"></FilterOption><FilterOption count="528" label="202009"></FilterOption><FilterOption count="525" label="201810"></FilterOption><FilterOption count="524" label="201803"></FilterOption><FilterOption count="520" label="201112"></FilterOption><FilterOption count="514" label="202005"></FilterOption><FilterOption count="512" label="201709"></FilterOption><FilterOption count="509" label="201701"></FilterOption><FilterOption count="504" label="201707"></FilterOption><FilterOption count="498" label="201811"></FilterOption><FilterOption count="486" label="201703"></FilterOption><FilterOption count="484" label="201012"></FilterOption><FilterOption count="477" label="201506"></FilterOption><FilterOption count="466" label="201804"></FilterOption><FilterOption count="460" label="201710"></FilterOption><FilterOption count="456" label="200912"></FilterOption><FilterOption count="454" label="201603"></FilterOption><FilterOption count="448" label="202008"></FilterOption><FilterOption count="447" label="201708"></FilterOption><FilterOption count="445" label="202106"></FilterOption><FilterOption count="444" label="201705"></FilterOption><FilterOption count="439" label="201704"></FilterOption><FilterOption count="431" label="201605"></FilterOption><FilterOption count="429" label="201601"></FilterOption><FilterOption count="427" label="201607"></FilterOption><FilterOption count="427" label="201711"></FilterOption><FilterOption count="426" label="201608"></FilterOption><FilterOption count="422" label="201609"></FilterOption><FilterOption count="419" label="201306"></FilterOption><FilterOption count="414" label="201610"></FilterOption><FilterOption count="410" label="201406"></FilterOption><FilterOption count="410" label="201902"></FilterOption><FilterOption count="409" label="201501"></FilterOption><FilterOption count="408" label="200812"></FilterOption><FilterOption count="407" label="201802"></FilterOption><FilterOption count="407" label="202010"></FilterOption><FilterOption count="404" label="201604"></FilterOption><FilterOption count="404" label="201611"></FilterOption><FilterOption count="401" label="201206"></FilterOption><FilterOption count="399" label="201507"></FilterOption><FilterOption count="389" label="201508"></FilterOption><FilterOption count="389" label="201702"></FilterOption><FilterOption count="387" label="201509"></FilterOption><FilterOption count="379" label="201301"></FilterOption><FilterOption count="379" label="201410"></FilterOption><FilterOption count="377" label="201404"></FilterOption><FilterOption count="376" label="201503"></FilterOption><FilterOption count="375" label="201510"></FilterOption><FilterOption count="374" label="202101"></FilterOption><FilterOption count="370" label="201303"></FilterOption><FilterOption count="370" label="201505"></FilterOption><FilterOption count="368" label="201409"></FilterOption><FilterOption count="367" label="201305"></FilterOption><FilterOption count="366" label="202103"></FilterOption><FilterOption count="362" label="201006"></FilterOption><FilterOption count="362" label="202011"></FilterOption><FilterOption count="361" label="201407"></FilterOption><FilterOption count="359" label="201109"></FilterOption><FilterOption count="358" label="201209"></FilterOption><FilterOption count="358" label="201210"></FilterOption><FilterOption count="356" label="201405"></FilterOption><FilterOption count="354" label="201207"></FilterOption><FilterOption count="353" label="201307"></FilterOption><FilterOption count="353" label="201511"></FilterOption><FilterOption count="353" label="201602"></FilterOption><FilterOption count="352" label="201408"></FilterOption><FilterOption count="350" label="201105"></FilterOption></Filter><Filter label="Trial Country" name="trialCountries" total="100"><FilterOption id="US" count="50459" label="US"></FilterOption><FilterOption id="CN" count="13453" label="China"></FilterOption><FilterOption id="JP" count="12308" label="Japan"></FilterOption><FilterOption id="DE" count="9939" label="Germany"></FilterOption><FilterOption id="GB" count="9547" label="UK"></FilterOption><FilterOption id="CA" count="8607" label="Canada"></FilterOption><FilterOption id="FR" count="8600" label="France"></FilterOption><FilterOption id="IT" count="7615" label="Italy"></FilterOption><FilterOption id="ES" count="7152" label="Spain"></FilterOption><FilterOption id="NL" count="5548" label="Netherlands"></FilterOption><FilterOption id="AU" count="5338" label="Australia"></FilterOption><FilterOption id="KR" count="5182" label="South Korea"></FilterOption><FilterOption id="BE" count="4833" label="Belgium"></FilterOption><FilterOption id="PL" count="3876" label="Poland"></FilterOption><FilterOption id="IN" count="3558" label="India"></FilterOption><FilterOption id="RU" count="3271" label="Russian Federation"></FilterOption><FilterOption id="DK" count="3039" label="Denmark"></FilterOption><FilterOption id="AT" count="2947" label="Austria"></FilterOption><FilterOption id="HU" count="2828" label="Hungary"></FilterOption><FilterOption id="SE" count="2740" label="Sweden"></FilterOption><FilterOption id="TW" count="2729" label="Taiwan"></FilterOption><FilterOption id="CZ" count="2728" label="Czech Republic"></FilterOption><FilterOption id="BR" count="2553" label="Brazil"></FilterOption><FilterOption id="IL" count="2537" label="Israel"></FilterOption><FilterOption id="CH" count="2452" label="Switzerland"></FilterOption><FilterOption id="MX" count="2029" label="Mexico"></FilterOption><FilterOption id="AR" count="1694" label="Argentina"></FilterOption><FilterOption id="GR" count="1631" label="Greece"></FilterOption><FilterOption id="RO" count="1538" label="Romania"></FilterOption><FilterOption id="ZA" count="1503" label="South Africa"></FilterOption><FilterOption id="FI" count="1470" label="Finland"></FilterOption><FilterOption id="HK" count="1428" label="Hong Kong"></FilterOption><FilterOption id="IR" count="1402" label="Iran"></FilterOption><FilterOption id="TR" count="1388" label="Turkey"></FilterOption><FilterOption id="NO" count="1379" label="Norway"></FilterOption><FilterOption id="NZ" count="1376" label="New Zealand"></FilterOption><FilterOption id="PR" count="1305" label="Puerto Rico"></FilterOption><FilterOption id="BG" count="1296" label="Bulgaria"></FilterOption><FilterOption id="SG" count="1268" label="Singapore"></FilterOption><FilterOption id="TH" count="1257" label="Thailand"></FilterOption><FilterOption id="UA" count="1249" label="Ukraine"></FilterOption><FilterOption id="PT" count="1218" label="Portugal"></FilterOption><FilterOption id="SK" count="1171" label="Slovakia"></FilterOption><FilterOption id="IE" count="1091" label="Ireland"></FilterOption><FilterOption id="CL" count="865" label="Chile"></FilterOption><FilterOption id="X5" count="809" label="Europe"></FilterOption><FilterOption id="PE" count="728" label="Peru"></FilterOption><FilterOption id="LT" count="707" label="Lithuania"></FilterOption><FilterOption id="CO" count="697" label="Colombia"></FilterOption><FilterOption id="MY" count="685" label="Malaysia"></FilterOption><FilterOption id="RS" count="672" label="Serbia"></FilterOption><FilterOption id="EG" count="663" label="Egypt"></FilterOption><FilterOption id="EE" count="596" label="Estonia"></FilterOption><FilterOption id="LV" count="596" label="Latvia"></FilterOption><FilterOption id="HR" count="595" label="Croatia"></FilterOption><FilterOption id="PH" count="546" label="Philippines"></FilterOption><FilterOption id="SI" count="383" label="Slovenia"></FilterOption><FilterOption id="XD" count="254" label="North America"></FilterOption><FilterOption id="GE" count="229" label="Georgia"></FilterOption><FilterOption id="SA" count="228" label="Saudi Arabia"></FilterOption><FilterOption id="X2" count="208" label="Asia"></FilterOption><FilterOption id="CU" count="190" label="Cuba"></FilterOption><FilterOption id="VN" count="183" label="Vietnam"></FilterOption><FilterOption id="LB" count="181" label="Lebanon"></FilterOption><FilterOption id="BY" count="180" label="Belarus"></FilterOption><FilterOption id="GT" count="164" label="Guatemala"></FilterOption><FilterOption id="BA" count="147" label="Bosnia and Herzegovina"></FilterOption><FilterOption id="PA" count="133" label="Panama"></FilterOption><FilterOption id="ID" count="123" label="Indonesia"></FilterOption><FilterOption id="PK" count="110" label="Pakistan"></FilterOption><FilterOption id="TN" count="100" label="Tunisia"></FilterOption><FilterOption id="CR" count="99" label="Costa Rica"></FilterOption><FilterOption id="UG" count="96" label="Uganda"></FilterOption><FilterOption id="MD" count="94" label="Moldova, Republic of"></FilterOption><FilterOption id="EU" count="93" label="EU"></FilterOption><FilterOption id="IS" count="92" label="Iceland"></FilterOption><FilterOption id="VE" count="87" label="Venezuela"></FilterOption><FilterOption id="JO" count="81" label="Jordan"></FilterOption><FilterOption id="KP" count="73" label="North Korea"></FilterOption><FilterOption id="XE" count="73" label="South America"></FilterOption><FilterOption id="DO" count="72" label="Dominican Republic"></FilterOption><FilterOption id="LU" count="72" label="Luxembourg"></FilterOption><FilterOption id="AE" count="72" label="United Arab Emirates"></FilterOption><FilterOption id="TZ" count="66" label="Tanzania"></FilterOption><FilterOption id="BD" count="64" label="Bangladesh"></FilterOption><FilterOption id="KE" count="62" label="Kenya"></FilterOption><FilterOption id="MK" count="62" label="Macedonia, The Former Yugoslav Republic of"></FilterOption><FilterOption id="EC" count="58" label="Ecuador"></FilterOption><FilterOption id="MA" count="55" label="Morocco"></FilterOption><FilterOption id="DZ" count="48" label="Algeria"></FilterOption><FilterOption id="LK" count="47" label="Sri Lanka"></FilterOption><FilterOption id="KZ" count="44" label="Kazakhstan"></FilterOption><FilterOption id="UY" count="38" label="Uruguay"></FilterOption><FilterOption id="CY" count="36" label="Cyprus"></FilterOption><FilterOption id="ZW" count="35" label="Zimbabwe"></FilterOption><FilterOption id="MW" count="34" label="Malawi"></FilterOption><FilterOption id="KW" count="31" label="Kuwait"></FilterOption><FilterOption id="ME" count="31" label="Montenegro"></FilterOption><FilterOption id="QA" count="31" label="Qatar"></FilterOption><FilterOption id="XW" count="25" label="Western Europe"></FilterOption></Filter><Filter label="Trial Patient Selection" name="trialTermsPatientSelection" total="19"><FilterOption id="EAMAA" count="107533" label="Middle-aged Adults (45-64 yrs)"></FilterOption><FilterOption id="EAYAD" count="107476" label="Young Adults (18-44 yrs)"></FilterOption><FilterOption id="EAAAD" count="99865" label="Aged Adults (65-79 yrs)"></FilterOption><FilterOption id="EAELD" count="74963" label="Elderly Adults (80 and over)"></FilterOption><FilterOption id="EGFEM" count="13578" label="Female"></FilterOption><FilterOption id="EVHVA" count="10669" label="Healthy volunteers accepted"></FilterOption><FilterOption id="EAADL" count="10545" label="Adolescents (13-17 yrs)"></FilterOption><FilterOption id="EACHI" count="7959" label="Children (6-12 yrs)"></FilterOption><FilterOption id="EGMAL" count="7139" label="Male"></FilterOption><FilterOption id="EAPRE" count="5918" label="Preschool Children (2-5 yrs)"></FilterOption><FilterOption id="EAINF" count="4209" label="Infants (6-23 months)"></FilterOption><FilterOption id="EANEW" count="2865" label="Newborn Infants (up to 5 months)"></FilterOption><FilterOption id="EVHVO" count="2219" label="Healthy volunteers only"></FilterOption><FilterOption id="ECASI" count="2173" label="Asian Ancestry"></FilterOption><FilterOption id="ECJAP" count="1712" label="Japanese Ancestry"></FilterOption><FilterOption id="ECEUR" count="554" label="European Ancestry"></FilterOption><FilterOption id="ECAFR" count="303" label="African Ancestry"></FilterOption><FilterOption id="ECNAM" count="42" label="Native American Ancestry"></FilterOption><FilterOption id="ECOCE" count="10" label="Oceanic Ancestry"></FilterOption></Filter><Filter label="Trial Terms Design" name="trialTermsDesign" total="29"><FilterOption id="SSTINV" count="117736" label="Interventional"></FilterOption><FilterOption id="SIPTRE" count="105227" label="Treatment"></FilterOption><FilterOption id="SIMOPN" count="68422" label="Open Label"></FilterOption><FilterOption id="SIARND" count="57308" label="Randomized"></FilterOption><FilterOption id="SISPRL" count="49123" label="Parallel Assignment"></FilterOption><FilterOption id="SISSNG" count="38906" label="Single Group Assignment"></FilterOption><FilterOption id="SIMMBD" count="26297" label="Multiple Blind"></FilterOption><FilterOption id="SIANON" count="23751" label="Non-Randomized"></FilterOption><FilterOption id="SICPLC" count="23190" label="Placebo Control"></FilterOption><FilterOption id="SICACT" count="18244" label="Active Control"></FilterOption><FilterOption id="SSTOBS" count="14340" label="Observational"></FilterOption><FilterOption id="SICNOC" count="10107" label="No Control"></FilterOption><FilterOption id="SOTPRO" count="8025" label="Prospective"></FilterOption><FilterOption id="SIPPRE" count="7811" label="Prevention"></FilterOption><FilterOption id="SOSCOH" count="6447" label="Cohort"></FilterOption><FilterOption id="SISXOV" count="5259" label="Crossover Assignment"></FilterOption><FilterOption id="SIMSBD" count="4982" label="Single Blind"></FilterOption><FilterOption id="SOTRET" count="4403" label="Retrospective"></FilterOption><FilterOption id="SIPDIA" count="3685" label="Diagnosis"></FilterOption><FilterOption id="SOSCSC" count="2041" label="Case Control"></FilterOption><FilterOption id="SICHST" count="1583" label="Historical Control"></FilterOption><FilterOption id="SODXSC" count="1073" label="Cross-sectional"></FilterOption><FilterOption id="SISFCT" count="926" label="Factorial Assignment"></FilterOption><FilterOption id="SICDSC" count="871" label="Dose Comparison"></FilterOption><FilterOption id="SODLNG" count="488" label="Longitudinal"></FilterOption><FilterOption id="SOSDEF" count="130" label="Defined Population"></FilterOption><FilterOption id="SISEAA" count="71" label="Expanded Access Assignment"></FilterOption><FilterOption id="SOSRND" count="9" label="Random Sample"></FilterOption><FilterOption id="SOSCON" count="8" label="Convenience Sample"></FilterOption></Filter><Filter label="Trial Source" name="trialSources" total="3"><FilterOption id="CTGOV" count="58703" label="ClinicalTrials.gov only"></FilterOption><FilterOption id="CTGOVOTHERS" count="31682" label="ClinicalTrials.gov and others"></FilterOption><FilterOption id="OTHERS" count="28433" label="Others only"></FilterOption></Filter><Filter label="Trial Actions Secondary Interventions Primary" name="trialActionsSecondaryInterventionsPrimary" total="100"><FilterOption id="1545" count="52604" label="Anticancer"></FilterOption><FilterOption id="62255" count="17250" label="Anticancer protein kinase inhibitor"></FilterOption><FilterOption id="2953" count="17192" label="Anti-inflammatory"></FilterOption><FilterOption id="55685" count="15633" label="Anticancer monoclonal antibody"></FilterOption><FilterOption id="767" count="13890" label="Cell cycle inhibitor"></FilterOption><FilterOption id="140" count="11215" label="DNA synthesis inhibitor"></FilterOption><FilterOption id="61" count="11199" label="Angiogenesis inhibitor"></FilterOption><FilterOption id="1589" count="10503" label="Apoptosis stimulator"></FilterOption><FilterOption id="991" count="10452" label="Antiviral"></FilterOption><FilterOption id="50" count="10318" label="Anticancer alkylating agent"></FilterOption><FilterOption id="1569" count="10291" label="Anticancer antimetabolite"></FilterOption><FilterOption id="393" count="6942" label="Immunostimulant"></FilterOption><FilterOption id="7293" count="6382" label="Synergist"></FilterOption><FilterOption id="7761" count="5700" label="T-lymphocyte stimulator"></FilterOption><FilterOption id="2575" count="5296" label="Microtubule inhibitor"></FilterOption><FilterOption id="2946" count="4991" label="Analgesic"></FilterOption><FilterOption id="2576" count="4734" label="Microtubule stabilizer"></FilterOption><FilterOption id="2660" count="3726" label="Vasoprotectant"></FilterOption><FilterOption id="396" count="3651" label="Immunosuppressant"></FilterOption><FilterOption id="399" count="3559" label="Hypoglycemic agent"></FilterOption><FilterOption id="59620" count="3394" label="Unspecified drug target"></FilterOption><FilterOption id="1596" count="3300" label="Immunomodulator"></FilterOption><FilterOption id="12379" count="2668" label="Therapeutic vaccine"></FilterOption><FilterOption id="1594" count="2497" label="Antibacterial"></FilterOption><FilterOption id="750" count="2305" label="DNA intercalator"></FilterOption><FilterOption id="2657" count="2257" label="Antihypertensive"></FilterOption><FilterOption id="15184" count="2246" label="Systemic antipsoriatic product"></FilterOption><FilterOption id="12378" count="2020" label="Prophylactic vaccine"></FilterOption><FilterOption id="1615" count="1922" label="Neuroprotectant"></FilterOption><FilterOption id="610" count="1801" label="Hematopoietic stimulator"></FilterOption><FilterOption id="70" count="1709" label="Anticonvulsant agent"></FilterOption><FilterOption id="2947" count="1613" label="Antiparkinsonian"></FilterOption><FilterOption id="382" count="1495" label="TNF alpha synthesis inhibitor"></FilterOption><FilterOption id="7220" count="1475" label="Neoplasm diagnostic agent"></FilterOption><FilterOption id="2941" count="1433" label="Antidepressant"></FilterOption><FilterOption id="695" count="1356" label="Metastasis inhibitor"></FilterOption><FilterOption id="664" count="1234" label="Fibrosuppressant"></FilterOption><FilterOption id="2942" count="1169" label="Anxiolytic"></FilterOption><FilterOption id="62254" count="1160" label="Anticancer hormone antagonist"></FilterOption><FilterOption id="805" count="1128" label="Folate modulator"></FilterOption><FilterOption id="7760" count="1128" label="T-lymphocyte inhibitor"></FilterOption><FilterOption id="2970" count="1089" label="Anti-emetic"></FilterOption><FilterOption id="71" count="1057" label="Antihypercholesterolemic agent"></FilterOption><FilterOption id="2667" count="1051" label="Antiarteriosclerotic"></FilterOption><FilterOption id="89" count="991" label="Bone resorption inhibitor"></FilterOption><FilterOption id="72" count="971" label="Antihyperlipidemic agent"></FilterOption><FilterOption id="12372" count="963" label="Protein subunit vaccine"></FilterOption><FilterOption id="646" count="948" label="Bronchodilator"></FilterOption><FilterOption id="1669" count="925" label="Local anesthetic"></FilterOption><FilterOption id="2659" count="895" label="Cardioprotectant"></FilterOption><FilterOption id="38206" count="888" label="Biguanide antidiabetic product"></FilterOption><FilterOption id="2955" count="859" label="Non-steroidal anti-inflammatory"></FilterOption><FilterOption id="388" count="859" label="Vasodilator"></FilterOption><FilterOption id="5720" count="836" label="Radiodiagnostic"></FilterOption><FilterOption id="1748" count="805" label="Fungicide"></FilterOption><FilterOption id="15187" count="793" label="Systemic dermatological antibacterial product"></FilterOption><FilterOption id="539" count="784" label="Immunotoxin"></FilterOption><FilterOption id="38200" count="757" label="Acid pump inhibitor antiulcerant product"></FilterOption><FilterOption id="747" count="731" label="HIV replication inhibitor"></FilterOption><FilterOption id="312" count="728" label="Platelet aggregation inhibitor"></FilterOption><FilterOption id="3272" count="719" label="Growth hormone release inhibitor"></FilterOption><FilterOption id="4155" count="719" label="Imaging agent"></FilterOption><FilterOption id="12596" count="702" label="Osteoclast inhibitor"></FilterOption><FilterOption id="4790" count="700" label="Genetically engineered autologous cell therapy"></FilterOption><FilterOption id="7212" count="695" label="Endocrine diagnostic agent"></FilterOption><FilterOption id="659" count="689" label="Coagulation inhibitor"></FilterOption><FilterOption id="449" count="684" label="Antiarrhythmic agent"></FilterOption><FilterOption id="2943" count="662" label="Antipsychotic"></FilterOption><FilterOption id="284" count="651" label="Nootropic agent"></FilterOption><FilterOption id="1332" count="648" label="Gastrointestinal system agent"></FilterOption><FilterOption id="5555" count="635" label="PET contrast agent"></FilterOption><FilterOption id="1532" count="633" label="Viral replication inhibitor"></FilterOption><FilterOption id="339" count="627" label="Protein synthesis inhibitor"></FilterOption><FilterOption id="12370" count="626" label="Recombinant viral vector vaccine"></FilterOption><FilterOption id="182" count="624" label="Gastric secretion inhibitor"></FilterOption><FilterOption id="3189" count="574" label="Corticosteroid agonist"></FilterOption><FilterOption id="2954" count="566" label="Steroidal anti-inflammatory"></FilterOption><FilterOption id="1538" count="553" label="Bacterial protein synthesis inhibitor"></FilterOption><FilterOption id="7213" count="552" label="Gastrointestinal diagnostic agent"></FilterOption><FilterOption id="3" count="531" label="5-HT uptake inhibitor"></FilterOption><FilterOption id="439" count="530" label="RNA synthesis inhibitor"></FilterOption><FilterOption id="104" count="523" label="Bacterial cell wall synthesis inhibitor"></FilterOption><FilterOption id="12367" count="509" label="Inactivated viral vaccine"></FilterOption><FilterOption id="1552" count="502" label="Radioimmunotherapeutic"></FilterOption><FilterOption id="1668" count="499" label="General anesthetic"></FilterOption><FilterOption id="7210" count="489" label="Cardiovascular diagnostic agent"></FilterOption><FilterOption id="38439" count="478" label="DPP IV inhibitor antidiabetic product"></FilterOption><FilterOption id="7018" count="463" label="Antihypertriglyceridemic agent"></FilterOption><FilterOption id="524" count="459" label="Adjuvant"></FilterOption><FilterOption id="2638" count="459" label="Antiparasitic"></FilterOption><FilterOption id="285" count="451" label="Norepinephrine uptake inhibitor"></FilterOption><FilterOption id="463" count="444" label="Ribosome binding agent"></FilterOption><FilterOption id="55686" count="441" label="Anticancer polyclonal antibody"></FilterOption><FilterOption id="55684" count="434" label="Anticancer antibody"></FilterOption><FilterOption id="15128" count="402" label="Ophthalmological agent"></FilterOption><FilterOption id="1586" count="385" label="Anticancer chemosensitizer"></FilterOption><FilterOption id="1540" count="385" label="Macrolide antibiotic"></FilterOption><FilterOption id="7757" count="381" label="Natural killer cell stimulator"></FilterOption><FilterOption id="1470" count="380" label="Respiratory system agent"></FilterOption><FilterOption id="7211" count="376" label="CNS diagnostic agent"></FilterOption></Filter><Filter label="Trial Endpoint Achieved" name="trialEndpointsAchieved" total="3"><FilterOption id="UNSPECIFIED" count="35938" label="Unspecified"></FilterOption><FilterOption id="YES" count="7053" label="Yes"></FilterOption><FilterOption id="NO" count="2658" label="No"></FilterOption></Filter><Filter label="Endpoint Index Secondary" name="trialEndpointIndexSecondary" total="100"><FilterOption id="8481" count="2836" label="Lung tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="8639" count="2368" label="Lung tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="15312" count="2292" label="Solid tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="8489" count="2284" label="Lung tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="8712" count="1957" label="Breast tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="7538" count="1799" label="Lymphoma - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="7879" count="1776" label="Leukemia - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="8998" count="1587" label="Breast tumor - Assessment of adverse events"></FilterOption><FilterOption id="8151" count="1472" label="Colorectal tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="7547" count="1453" label="Lymphoma - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="8663" count="1321" label="Lung tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="8996" count="1311" label="Breast tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="19282" count="1276" label="Cancer supportive care - Patient Reported Outcomes/Quality of Life Assessments"></FilterOption><FilterOption id="8430" count="1229" label="Colorectal tumor - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"></FilterOption><FilterOption id="8719" count="1180" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"></FilterOption><FilterOption id="8713" count="1124" label="Breast tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="8640" count="1123" label="Lung tumor - Assessment of Safety and Tolerability - Adverse events as graded by CTCAE/CTC"></FilterOption><FilterOption id="8505" count="1108" label="Lung tumor - Assessment of Objective Response - Assessment of objective response rate(ORR)"></FilterOption><FilterOption id="7679" count="1106" label="Lymphoma - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="8163" count="1070" label="Colorectal tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="12048" count="1065" label="Hepatobiliary system tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="7680" count="1016" label="Lymphoma - Assessment of adverse events"></FilterOption><FilterOption id="8078" count="1004" label="Leukemia - Assessment of adverse events"></FilterOption><FilterOption id="15287" count="999" label="Solid tumor - Assessment of adverse events"></FilterOption><FilterOption id="7244" count="972" label="Head and neck tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="7611" count="963" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of tumor response rate (Duration of response)"></FilterOption><FilterOption id="19374" count="959" label="Cancer supportive care - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="15212" count="956" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of objective response rate (ORR)"></FilterOption><FilterOption id="26044" count="953" label="Pain - Assessment of Therapy Related Outcomes - Assessment of analgesic use/rescue medication"></FilterOption><FilterOption id="26033" count="950" label="Pain - Assessment of adverse events"></FilterOption><FilterOption id="8077" count="944" label="Leukemia - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="9153" count="942" label="Lung tumor - Imaging/Radiological Assessments - Assessment by Response Evaluation Criteria in Solid Tumors (RECIST) Criteria"></FilterOption><FilterOption id="9122" count="923" label="Breast tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="8187" count="915" label="Colorectal tumor - Assessment of Response Rates (RR) - Assessment of Objective/Overall Response Rate (ORR)"></FilterOption><FilterOption id="13344" count="907" label="Pancreas tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="7563" count="905" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Complete Response"></FilterOption><FilterOption id="15207" count="905" label="Solid tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="8522" count="903" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of duration of response"></FilterOption><FilterOption id="15285" count="895" label="Solid tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="7569" count="858" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"></FilterOption><FilterOption id="19407" count="855" label="Cancer supportive care - Assessment of Laboratory/Diagnostic Measures"></FilterOption><FilterOption id="7908" count="853" label="Leukemia - Assessment of Response Rates (RR) - Assessment of Complete Response"></FilterOption><FilterOption id="12148" count="846" label="Stomach tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="7354" count="844" label="Multiple myeloma - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="8563" count="840" label="Lung tumor - Patient Reported Outcomes/Quality of Life Assessments"></FilterOption><FilterOption id="19412" count="837" label="Cancer supportive care - Protocol Specified Other Endpoints - Assessment of Other Treatment or Procedure Related Outcomes"></FilterOption><FilterOption id="1345" count="824" label="Non-insulin dependent diabetes - Glycemic Control Analysis - Assessment of fasting blood glucose"></FilterOption><FilterOption id="8451" count="811" label="Colorectal tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="8508" count="801" label="Lung tumor - Assessment of Overall Response"></FilterOption><FilterOption id="17405" count="801" label="Stem cell transplantation - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="8514" count="783" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"></FilterOption><FilterOption id="8513" count="777" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"></FilterOption><FilterOption id="7891" count="755" label="Leukemia - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="7981" count="738" label="Leukemia - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="8429" count="737" label="Colorectal tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="8721" count="732" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"></FilterOption><FilterOption id="8759" count="732" label="Breast tumor - Patient Reported Outcomes/Quality of Life Assessments"></FilterOption><FilterOption id="1503" count="728" label="Non-insulin dependent diabetes - Anthropometric Assessments - Assessment of body weight"></FilterOption><FilterOption id="13352" count="721" label="Pancreas tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="7190" count="721" label="Prostate tumor - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"></FilterOption><FilterOption id="15199" count="718" label="Solid tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="7189" count="713" label="Prostate tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="12051" count="704" label="Hepatobiliary system tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="7311" count="695" label="Head and neck tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="19376" count="694" label="Cancer supportive care - Assessment of adverse events"></FilterOption><FilterOption id="8523" count="694" label="Lung tumor - Assessment of Disease Progression"></FilterOption><FilterOption id="8999" count="692" label="Breast tumor - Assessment of Safety and Tolerability - Assessment of safety as measured by NCI CTCAE/NCI-CTC criteria"></FilterOption><FilterOption id="8738" count="680" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of duration of tumor response"></FilterOption><FilterOption id="7312" count="679" label="Head and neck tumor - Assessment of adverse events"></FilterOption><FilterOption id="1" count="674" label="Hypertension - Assessment of Blood Pressure (BP)"></FilterOption><FilterOption id="7256" count="672" label="Head and neck tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="25874" count="671" label="Pain - Assessment of Intensity of Pain - Based on Visual analog scale[VAS]"></FilterOption><FilterOption id="7045" count="670" label="Prostate tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="7360" count="669" label="Multiple myeloma - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="15318" count="668" label="Solid tumor - Protocol Specified Other Endpoints - Assessment of Anti-tumor Activity"></FilterOption><FilterOption id="8726" count="659" label="Breast tumor - Assessment of Response Rates (RR)"></FilterOption><FilterOption id="26827" count="658" label="Solid tumor - Imaging/Radiological Assessments - Assessment by Response Evaluation Criteria in Solid Tumors (RECIST) Criteria"></FilterOption><FilterOption id="6919" count="641" label="Melanoma - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="7564" count="635" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"></FilterOption><FilterOption id="7906" count="634" label="Leukemia - Assessment of Response Rates (RR)"></FilterOption><FilterOption id="37159" count="628" label="Breast tumor - Assessment of Laboratory/Diagnostic Measures"></FilterOption><FilterOption id="12118" count="624" label="Hepatobiliary system tumor - Assessment of adverse events"></FilterOption><FilterOption id="7921" count="622" label="Leukemia - Assessment of Disease Relapse/Recurrence"></FilterOption><FilterOption id="7217" count="620" label="Prostate tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="2" count="618" label="Hypertension - Assessment of Blood Pressure (BP) - BP control rate"></FilterOption><FilterOption id="10828" count="618" label="Ovary tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="6940" count="612" label="Melanoma - Assessment of Response Rates (RR) - Assessment of overall/objective response rate"></FilterOption><FilterOption id="8720" count="607" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"></FilterOption><FilterOption id="12151" count="607" label="Stomach tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="25959" count="606" label="Pain - Assessment of Functional Disability/Physical Function"></FilterOption><FilterOption id="12209" count="606" label="Stomach tumor - Assessment of adverse events"></FilterOption><FilterOption id="9147" count="592" label="Colorectal tumor - Assessment of Safety and Tolerability - Assessment of toxicities"></FilterOption><FilterOption id="8519" count="589" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Tumor Growth Control Rate (TGCR)"></FilterOption><FilterOption id="11950" count="588" label="Esophagus tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="10830" count="586" label="Ovary tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="8651" count="584" label="Lung tumor - Assessment of Laboratory/Diagnostic Measures"></FilterOption><FilterOption id="6924" count="574" label="Melanoma - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="8524" count="573" label="Lung tumor - Assessment of Disease Progression - Assessment of time to disease progression (TTP)"></FilterOption><FilterOption id="7988" count="563" label="Leukemia - Assessment of Laboratory/Diagnostic Measures"></FilterOption><FilterOption id="1358" count="555" label="Non-insulin dependent diabetes - Assessment of Hemoglobin A1c (HbA1c) Levels"></FilterOption></Filter><Filter label="Biomarker" name="trialBiomarkerNames" total="100"><FilterOption id="1735" count="5305" label="Glucose"></FilterOption><FilterOption id="12058" count="5169" label="Total body mass"></FilterOption><FilterOption id="2586" count="4527" label="Blood pressure"></FilterOption><FilterOption id="46" count="4424" label="C-reactive protein"></FilterOption><FilterOption id="1211" count="3908" label="Alanine transaminase"></FilterOption><FilterOption id="3" count="3896" label="HER2"></FilterOption><FilterOption id="213" count="3760" label="Creatinine"></FilterOption><FilterOption id="1904" count="3597" label="Heart rate"></FilterOption><FilterOption id="2527" count="3344" label="Aspartate aminotransferase"></FilterOption><FilterOption id="289" count="3215" label="Hemoglobin A, glycosylated"></FilterOption><FilterOption id="2054" count="3211" label="Blood platelets"></FilterOption><FilterOption id="1236" count="3166" label="Hemoglobin"></FilterOption><FilterOption id="8" count="2892" label="Epidermal growth factor receptor"></FilterOption><FilterOption id="1925" count="2874" label="Neutrophils"></FilterOption><FilterOption id="38" count="2815" label="Prostate-specific antigen"></FilterOption><FilterOption id="176" count="2676" label="Interleukin-6"></FilterOption><FilterOption id="133" count="2544" label="Total cholesterol"></FilterOption><FilterOption id="36136" count="2511" label="Cytokines"></FilterOption><FilterOption id="217" count="2451" label="Triglycerides"></FilterOption><FilterOption id="113" count="2446" label="Body Mass Index"></FilterOption><FilterOption id="153" count="2321" label="High-density lipoprotein cholesterol"></FilterOption><FilterOption id="125" count="2307" label="Leukocyte count"></FilterOption><FilterOption id="152" count="2299" label="Low-density lipoprotein cholesterol"></FilterOption><FilterOption id="808" count="2234" label="Insulin"></FilterOption><FilterOption id="1857" count="2189" label="T-cell surface glycoprotein CD4"></FilterOption><FilterOption id="46506" count="2186" label="T-Lymphocytes"></FilterOption><FilterOption id="2387" count="2141" label="Bilirubin"></FilterOption><FilterOption id="330" count="2131" label="Systolic blood pressure"></FilterOption><FilterOption id="274" count="2069" label="Tumor necrosis factor"></FilterOption><FilterOption id="1289" count="2026" label="Tumor mass"></FilterOption><FilterOption id="118" count="1987" label="Albumin"></FilterOption><FilterOption id="5" count="1931" label="Estrogen receptor"></FilterOption><FilterOption id="14767" count="1899" label="Lipids"></FilterOption><FilterOption id="3447" count="1813" label="T-cell surface glycoprotein CD8 alpha chain"></FilterOption><FilterOption id="332" count="1772" label="Diastolic blood pressure"></FilterOption><FilterOption id="28899" count="1698" label="Alkaline phosphatase"></FilterOption><FilterOption id="4806" count="1664" label="Lymphocytes"></FilterOption><FilterOption id="44216" count="1626" label="Body temperature"></FilterOption><FilterOption id="1880" count="1572" label="T-Helper Lymphocytes"></FilterOption><FilterOption id="7895" count="1534" label="Estimated glomerular filtration rate"></FilterOption><FilterOption id="46505" count="1512" label="Cytotoxic T-Lymphocytes"></FilterOption><FilterOption id="2713" count="1483" label="Forced expiratory volume"></FilterOption><FilterOption id="824" count="1393" label="Programmed cell death 1 ligand 1"></FilterOption><FilterOption id="19714" count="1370" label="Muscle strength"></FilterOption><FilterOption id="6" count="1315" label="Progesterone receptor"></FilterOption><FilterOption id="147" count="1314" label="Six-minute walk distance"></FilterOption><FilterOption id="10684" count="1270" label="Blood cells"></FilterOption><FilterOption id="7" count="1258" label="Antigen KI-67"></FilterOption><FilterOption id="52" count="1246" label="GTPase KRas"></FilterOption><FilterOption id="252" count="1242" label="Interferon gamma"></FilterOption><FilterOption id="6663" count="1238" label="B-lymphocytes"></FilterOption><FilterOption id="418" count="1227" label="Waist circumference"></FilterOption><FilterOption id="2417" count="1222" label="Calcium"></FilterOption><FilterOption id="17697" count="1164" label="Body height"></FilterOption><FilterOption id="64" count="1060" label="Circulating Tumor Cells"></FilterOption><FilterOption id="82" count="1033" label="B-Raf proto-oncogene serine/threonine-protein kinase"></FilterOption><FilterOption id="3374" count="1002" label="Bone mineral density"></FilterOption><FilterOption id="2098" count="970" label="Potassium"></FilterOption><FilterOption id="175" count="942" label="Interleukin-10"></FilterOption><FilterOption id="46731" count="940" label="Standardized uptake value"></FilterOption><FilterOption id="2662" count="934" label="Sodium"></FilterOption><FilterOption id="3451" count="919" label="Immunoglobulin G"></FilterOption><FilterOption id="2358" count="909" label="Urea nitrogen"></FilterOption><FilterOption id="9" count="904" label="Cellular tumor antigen p53"></FilterOption><FilterOption id="1387" count="878" label="Testosterone"></FilterOption><FilterOption id="10260" count="873" label="Respiratory frequency"></FilterOption><FilterOption id="1912" count="870" label="Forced Vital Capacity"></FilterOption><FilterOption id="1945" count="864" label="Left ventricular ejection fraction"></FilterOption><FilterOption id="2706" count="860" label="Natural killer cells"></FilterOption><FilterOption id="4522" count="859" label="Erythrocytes"></FilterOption><FilterOption id="5022" count="857" label="Regulatory T-Lymphocytes"></FilterOption><FilterOption id="8458" count="848" label="gamma-Glutamyltransferase"></FilterOption><FilterOption id="554" count="843" label="Interleukin-8"></FilterOption><FilterOption id="126" count="841" label="BCR-ABL1 fusion protein"></FilterOption><FilterOption id="1221" count="819" label="Hematocrit"></FilterOption><FilterOption id="148" count="801" label="QT interval"></FilterOption><FilterOption id="1566" count="785" label="HLA class I histocompatibility antigen, A alpha chain"></FilterOption><FilterOption id="71" count="770" label="CA-125 antigen"></FilterOption><FilterOption id="11359" count="767" label="Vascular endothelial growth factors"></FilterOption><FilterOption id="154" count="755" label="Lactate dehydrogenase"></FilterOption><FilterOption id="5700" count="748" label="ALK receptor"></FilterOption><FilterOption id="288" count="745" label="Uric acid"></FilterOption><FilterOption id="1731" count="727" label="B-lymphocyte antigen CD20"></FilterOption><FilterOption id="8097" count="697" label="Monocytes"></FilterOption><FilterOption id="425" count="690" label="C-peptide"></FilterOption><FilterOption id="8024" count="658" label="Creatine kinase"></FilterOption><FilterOption id="248" count="639" label="Eosinophils"></FilterOption><FilterOption id="172" count="628" label="Adiponectin"></FilterOption><FilterOption id="46244" count="625" label="Circulating tumor DNA"></FilterOption><FilterOption id="22" count="620" label="Breast cancer type 1 susceptibility protein"></FilterOption><FilterOption id="1175" count="608" label="B-lymphocyte antigen CD19"></FilterOption><FilterOption id="5326" count="606" label="Estradiol"></FilterOption><FilterOption id="70" count="600" label="CA19-9 antigen"></FilterOption><FilterOption id="3614" count="599" label="RAC-alpha serine/threonine-protein kinase"></FilterOption><FilterOption id="2534" count="596" label="Hydrocortisone"></FilterOption><FilterOption id="1855" count="590" label="CD3 Antigens"></FilterOption><FilterOption id="781" count="580" label="Erythrocyte sedimentation rate"></FilterOption><FilterOption id="106" count="562" label="N-terminal Pro Brain Natriuretic Peptide"></FilterOption><FilterOption id="1688" count="555" label="Follicle-stimulating hormone"></FilterOption><FilterOption id="10" count="548" label="Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN"></FilterOption></Filter><Filter label="Trial Terms Endpoint" name="trialTermsEndpoint" total="6"><FilterOption id="SIEEFC" count="110313" label="Efficacy"></FilterOption><FilterOption id="SIESFT" count="93638" label="Safety"></FilterOption><FilterOption id="SIEPCK" count="22691" label="Pharmacokinetics"></FilterOption><FilterOption id="SIEPCD" count="10202" label="Pharmacodynamics"></FilterOption><FilterOption id="SIEBAV" count="1079" label="Bioavailability"></FilterOption><FilterOption id="SIEBEQ" count="965" label="Bioequivalence"></FilterOption></Filter><Filter label="Trial Interventions Primary In Regimen Name Display" name="trialInterventionsPrimaryInRegimenNameDisplay" total="100"><FilterOption id="44383" count="3250" label="carboplatin"></FilterOption><FilterOption id="3803" count="3082" label="paclitaxel"></FilterOption><FilterOption id="3199" count="3075" label="gemcitabine"></FilterOption><FilterOption id="2953" count="2842" label="docetaxel"></FilterOption><FilterOption id="3792" count="2673" label="oxaliplatin"></FilterOption><FilterOption id="8047" count="2087" label="bevacizumab"></FilterOption><FilterOption id="12205" count="1956" label="capecitabine"></FilterOption><FilterOption id="2871" count="1955" label="irinotecan"></FilterOption><FilterOption id="3072" count="1869" label="etoposide phosphate"></FilterOption><FilterOption id="6736" count="1717" label="rituximab"></FilterOption><FilterOption id="6156" count="1428" label="fludarabine"></FilterOption><FilterOption id="10084" count="981" label="tegafur + gimeracil + oteracil potassium"></FilterOption><FilterOption id="3130" count="927" label="filgrastim"></FilterOption><FilterOption id="3536" count="925" label="pemetrexed disodium"></FilterOption><FilterOption id="10388" count="877" label="cetuximab"></FilterOption><FilterOption id="6386" count="872" label="trastuzumab"></FilterOption><FilterOption id="54804" count="841" label="nivolumab"></FilterOption><FilterOption id="13022" count="799" label="epirubicin"></FilterOption><FilterOption id="70667" count="790" label="pembrolizumab"></FilterOption><FilterOption id="15954" count="789" label="bortezomib"></FilterOption><FilterOption id="29016" count="789" label="paclitaxel (albumin-bound nanoparticle, intravenous), Celgene"></FilterOption><FilterOption id="27572" count="733" label="lenalidomide"></FilterOption><FilterOption id="4529" count="696" label="temozolomide"></FilterOption><FilterOption id="11961" count="651" label="erlotinib"></FilterOption><FilterOption id="6408" count="615" label="vinorelbine"></FilterOption><FilterOption id="4510" count="594" label="tacrolimus"></FilterOption><FilterOption id="3669" count="574" label="mycophenolate mofetil"></FilterOption><FilterOption id="6050" count="507" label="metformin hydrochloride"></FilterOption><FilterOption id="36630" count="495" label="ipilimumab"></FilterOption><FilterOption id="29831" count="490" label="sorafenib"></FilterOption><FilterOption id="13340" count="487" label="everolimus"></FilterOption><FilterOption id="11519" count="366" label="mitoxantrone"></FilterOption><FilterOption id="7934" count="351" label="doxorubicin (liposomal, STEALTH), Alza"></FilterOption><FilterOption id="6306" count="335" label="aldesleukin"></FilterOption><FilterOption id="9298" count="329" label="Thymoglobulin"></FilterOption><FilterOption id="47000" count="327" label="bendamustine"></FilterOption><FilterOption id="4577" count="320" label="topotecan"></FilterOption><FilterOption id="7121" count="311" label="sargramostim"></FilterOption><FilterOption id="81193" count="306" label="durvalumab"></FilterOption><FilterOption id="2784" count="304" label="letrozole"></FilterOption><FilterOption id="37370" count="296" label="azacitidine"></FilterOption><FilterOption id="5369" count="293" label="ribavirin"></FilterOption><FilterOption id="4200" count="289" label="sirolimus"></FilterOption><FilterOption id="21374" count="283" label="pegfilgrastim"></FilterOption><FilterOption id="11603" count="277" label="gefitinib"></FilterOption><FilterOption id="72699" count="271" label="atezolizumab"></FilterOption><FilterOption id="11460" count="271" label="imatinib"></FilterOption><FilterOption id="12135" count="268" label="celecoxib"></FilterOption><FilterOption id="12150" count="266" label="vincristine sulfate (liposomal injection), Spectrum Pharmaceuticals"></FilterOption><FilterOption id="54452" count="264" label="rivoceranib mesylate"></FilterOption><FilterOption id="44314" count="263" label="tamoxifen"></FilterOption><FilterOption id="33591" count="251" label="lapatinib"></FilterOption><FilterOption id="12646" count="239" label="panitumumab"></FilterOption><FilterOption id="24142" count="236" label="mesna"></FilterOption><FilterOption id="2716" count="233" label="alemtuzumab"></FilterOption><FilterOption id="8050" count="227" label="thalidomide, Celgene"></FilterOption><FilterOption id="55237" count="219" label="ibrutinib"></FilterOption><FilterOption id="44279" count="214" label="amoxicillin"></FilterOption><FilterOption id="10309" count="213" label="abiraterone"></FilterOption><FilterOption id="7286" count="207" label="goserelin acetate"></FilterOption><FilterOption id="3081" count="204" label="exemestane"></FilterOption><FilterOption id="5999" count="202" label="ciclosporin, Novartis"></FilterOption><FilterOption id="2829" count="202" label="clarithromycin"></FilterOption><FilterOption id="3313" count="201" label="fulvestrant"></FilterOption><FilterOption id="3321" count="198" label="anastrozole"></FilterOption><FilterOption id="12973" count="197" label="sunitinib"></FilterOption><FilterOption id="13239" count="193" label="decitabine"></FilterOption><FilterOption id="48945" count="188" label="bupivacaine, AstraZeneca"></FilterOption><FilterOption id="28532" count="188" label="pertuzumab"></FilterOption><FilterOption id="54601" count="182" label="carfilzomib"></FilterOption><FilterOption id="23625" count="181" label="peginterferon alfa-2a"></FilterOption><FilterOption id="7310" count="180" label="ritonavir"></FilterOption><FilterOption id="17625" count="180" label="vorinostat (oral), Merck &amp; Co"></FilterOption><FilterOption id="2836" count="173" label="clopidogrel"></FilterOption><FilterOption id="55288" count="164" label="trametinib"></FilterOption><FilterOption id="48946" count="163" label="dasatinib"></FilterOption><FilterOption id="44403" count="162" label="lidocaine"></FilterOption><FilterOption id="3474" count="161" label="lamivudine"></FilterOption><FilterOption id="70895" count="161" label="venetoclax"></FilterOption><FilterOption id="44303" count="159" label="midazolam hydrochloride"></FilterOption><FilterOption id="22965" count="152" label="temsirolimus"></FilterOption><FilterOption id="44305" count="151" label="omeprazole"></FilterOption><FilterOption id="44308" count="151" label="propofol, AstraZeneca/Fresenius"></FilterOption><FilterOption id="44316" count="151" label="zidovudine"></FilterOption><FilterOption id="16063" count="150" label="olaparib"></FilterOption><FilterOption id="5267" count="149" label="leuprorelin acetate"></FilterOption><FilterOption id="3311" count="148" label="bicalutamide"></FilterOption><FilterOption id="10271" count="146" label="palbociclib"></FilterOption><FilterOption id="2765" count="146" label="zoledronic acid"></FilterOption><FilterOption id="45562" count="145" label="tremelimumab"></FilterOption><FilterOption id="16748" count="144" label="aprepitant"></FilterOption><FilterOption id="9049" count="143" label="cytarabine (sustained release, DepoFoam), Pacira/Sigma-Tau/Pfizer/Napp Pharmaceutical"></FilterOption><FilterOption id="2807" count="142" label="atorvastatin"></FilterOption><FilterOption id="3688" count="141" label="nedaplatin"></FilterOption><FilterOption id="23624" count="139" label="clofarabine"></FilterOption><FilterOption id="2573" count="139" label="pegaspargase"></FilterOption><FilterOption id="83065" count="138" label="avelumab"></FilterOption><FilterOption id="53981" count="138" label="enzalutamide"></FilterOption><FilterOption id="3750" count="137" label="ondansetron"></FilterOption><FilterOption id="27696" count="133" label="pomalidomide"></FilterOption></Filter><Filter label="Trial Document Source" name="trialDocumentSource" total="5"><FilterOption id="SERIAL" count="33244" label="Serial Publications"></FilterOption><FilterOption id="OTHER" count="17933" label="Other Publications"></FilterOption><FilterOption id="PR" count="15904" label="Press Releases"></FilterOption><FilterOption id="CONFERENCE" count="3305" label="Conference Reports"></FilterOption><FilterOption id="CORPORATE" count="2342" label="Corporate Publications"></FilterOption></Filter><Filter label="Trial Interventions Primary Alone Name Display" name="trialInterventionsPrimaryAloneNameDisplay" total="100"><FilterOption id="54804" count="619" label="nivolumab"></FilterOption><FilterOption id="29831" count="591" label="sorafenib"></FilterOption><FilterOption id="8047" count="558" label="bevacizumab"></FilterOption><FilterOption id="2953" count="548" label="docetaxel"></FilterOption><FilterOption id="3199" count="546" label="gemcitabine"></FilterOption><FilterOption id="11961" count="496" label="erlotinib"></FilterOption><FilterOption id="6736" count="487" label="rituximab"></FilterOption><FilterOption id="70667" count="485" label="pembrolizumab"></FilterOption><FilterOption id="12973" count="480" label="sunitinib"></FilterOption><FilterOption id="4529" count="470" label="temozolomide"></FilterOption><FilterOption id="11460" count="440" label="imatinib"></FilterOption><FilterOption id="12205" count="423" label="capecitabine"></FilterOption><FilterOption id="3803" count="412" label="paclitaxel"></FilterOption><FilterOption id="6050" count="408" label="metformin hydrochloride"></FilterOption><FilterOption id="11603" count="351" label="gefitinib"></FilterOption><FilterOption id="44314" count="344" label="tamoxifen"></FilterOption><FilterOption id="10084" count="344" label="tegafur + gimeracil + oteracil potassium"></FilterOption><FilterOption id="6386" count="324" label="trastuzumab"></FilterOption><FilterOption id="13340" count="315" label="everolimus"></FilterOption><FilterOption id="10388" count="279" label="cetuximab"></FilterOption><FilterOption id="2765" count="270" label="zoledronic acid"></FilterOption><FilterOption id="27572" count="268" label="lenalidomide"></FilterOption><FilterOption id="54452" count="248" label="rivoceranib mesylate"></FilterOption><FilterOption id="2871" count="247" label="irinotecan"></FilterOption><FilterOption id="48946" count="240" label="dasatinib"></FilterOption><FilterOption id="43738" count="236" label="pazopanib"></FilterOption><FilterOption id="3536" count="235" label="pemetrexed disodium"></FilterOption><FilterOption id="3130" count="229" label="filgrastim"></FilterOption><FilterOption id="14163" count="227" label="adalimumab"></FilterOption><FilterOption id="44383" count="227" label="carboplatin"></FilterOption><FilterOption id="36630" count="226" label="ipilimumab"></FilterOption><FilterOption id="15954" count="209" label="bortezomib"></FilterOption><FilterOption id="2784" count="206" label="letrozole"></FilterOption><FilterOption id="2807" count="202" label="atorvastatin"></FilterOption><FilterOption id="51388" count="187" label="nilotinib"></FilterOption><FilterOption id="3792" count="187" label="oxaliplatin"></FilterOption><FilterOption id="29016" count="184" label="paclitaxel (albumin-bound nanoparticle, intravenous), Celgene"></FilterOption><FilterOption id="53981" count="182" label="enzalutamide"></FilterOption><FilterOption id="44403" count="182" label="lidocaine"></FilterOption><FilterOption id="4126" count="179" label="pioglitazone"></FilterOption><FilterOption id="12135" count="170" label="celecoxib"></FilterOption><FilterOption id="54449" count="169" label="afatinib"></FilterOption><FilterOption id="4567" count="165" label="etanercept"></FilterOption><FilterOption id="3321" count="161" label="anastrozole"></FilterOption><FilterOption id="5148" count="161" label="liraglutide"></FilterOption><FilterOption id="6850" count="156" label="infliximab"></FilterOption><FilterOption id="37370" count="155" label="azacitidine"></FilterOption><FilterOption id="4200" count="154" label="sirolimus"></FilterOption><FilterOption id="4510" count="152" label="tacrolimus"></FilterOption><FilterOption id="81193" count="150" label="durvalumab"></FilterOption><FilterOption id="6156" count="147" label="fludarabine"></FilterOption><FilterOption id="8783" count="144" label="dexmedetomidine"></FilterOption><FilterOption id="54624" count="144" label="regorafenib"></FilterOption><FilterOption id="12420" count="144" label="rosuvastatin"></FilterOption><FilterOption id="49721" count="141" label="denosumab"></FilterOption><FilterOption id="6306" count="139" label="aldesleukin"></FilterOption><FilterOption id="3081" count="136" label="exemestane"></FilterOption><FilterOption id="2836" count="135" label="clopidogrel"></FilterOption><FilterOption id="4577" count="135" label="topotecan"></FilterOption><FilterOption id="3669" count="132" label="mycophenolate mofetil"></FilterOption><FilterOption id="16063" count="131" label="olaparib"></FilterOption><FilterOption id="3072" count="130" label="etoposide phosphate"></FilterOption><FilterOption id="72699" count="129" label="atezolizumab"></FilterOption><FilterOption id="6408" count="128" label="vinorelbine"></FilterOption><FilterOption id="55237" count="127" label="ibrutinib"></FilterOption><FilterOption id="33591" count="127" label="lapatinib"></FilterOption><FilterOption id="83873" count="127" label="osimertinib"></FilterOption><FilterOption id="28773" count="124" label="eribulin mesylate"></FilterOption><FilterOption id="10309" count="123" label="abiraterone"></FilterOption><FilterOption id="4271" count="122" label="ropivacaine"></FilterOption><FilterOption id="39209" count="119" label="axitinib"></FilterOption><FilterOption id="7413" count="117" label="darbepoetin alfa"></FilterOption><FilterOption id="44499" count="115" label="sitagliptin"></FilterOption><FilterOption id="7934" count="114" label="doxorubicin (liposomal, STEALTH), Alza"></FilterOption><FilterOption id="3313" count="113" label="fulvestrant"></FilterOption><FilterOption id="48945" count="112" label="bupivacaine, AstraZeneca"></FilterOption><FilterOption id="21374" count="112" label="pegfilgrastim"></FilterOption><FilterOption id="8050" count="112" label="thalidomide, Celgene"></FilterOption><FilterOption id="17814" count="111" label="pregabalin"></FilterOption><FilterOption id="2716" count="110" label="alemtuzumab"></FilterOption><FilterOption id="16026" count="110" label="esomeprazole"></FilterOption><FilterOption id="44313" count="110" label="simvastatin"></FilterOption><FilterOption id="67892" count="109" label="epoetin alfa (Procrit/Eprex), Johnson &amp; Johnson"></FilterOption><FilterOption id="23625" count="108" label="peginterferon alfa-2a"></FilterOption><FilterOption id="55798" count="107" label="crizotinib"></FilterOption><FilterOption id="7121" count="107" label="sargramostim"></FilterOption><FilterOption id="9000" count="106" label="onabotulinumtoxinA"></FilterOption><FilterOption id="32677" count="106" label="rivaroxaban"></FilterOption><FilterOption id="51160" count="105" label="nintedanib"></FilterOption><FilterOption id="22965" count="104" label="temsirolimus"></FilterOption><FilterOption id="2888" count="100" label="abatacept"></FilterOption><FilterOption id="5267" count="100" label="leuprorelin acetate"></FilterOption><FilterOption id="44375" count="100" label="warfarin"></FilterOption><FilterOption id="4119" count="99" label="tadalafil"></FilterOption><FilterOption id="8165" count="99" label="tiotropium bromide"></FilterOption><FilterOption id="44316" count="96" label="zidovudine"></FilterOption><FilterOption id="13486" count="95" label="entecavir"></FilterOption><FilterOption id="50935" count="94" label="cabozantinib S-malate"></FilterOption><FilterOption id="52192" count="92" label="dapagliflozin propanediol"></FilterOption><FilterOption id="44308" count="92" label="propofol, AstraZeneca/Fresenius"></FilterOption></Filter><Filter label="Trial Interventions Control In Regimen Name Display" name="trialInterventionsControlInRegimenNameDisplay" total="100"><FilterOption id="44383" count="506" label="carboplatin"></FilterOption><FilterOption id="3803" count="427" label="paclitaxel"></FilterOption><FilterOption id="3199" count="341" label="gemcitabine"></FilterOption><FilterOption id="3792" count="315" label="oxaliplatin"></FilterOption><FilterOption id="2953" count="305" label="docetaxel"></FilterOption><FilterOption id="12205" count="190" label="capecitabine"></FilterOption><FilterOption id="8047" count="158" label="bevacizumab"></FilterOption><FilterOption id="3072" count="152" label="etoposide phosphate"></FilterOption><FilterOption id="2871" count="148" label="irinotecan"></FilterOption><FilterOption id="3536" count="148" label="pemetrexed disodium"></FilterOption><FilterOption id="13022" count="145" label="epirubicin"></FilterOption><FilterOption id="6736" count="144" label="rituximab"></FilterOption><FilterOption id="6386" count="116" label="trastuzumab"></FilterOption><FilterOption id="6050" count="113" label="metformin hydrochloride"></FilterOption><FilterOption id="4510" count="85" label="tacrolimus"></FilterOption><FilterOption id="29016" count="83" label="paclitaxel (albumin-bound nanoparticle, intravenous), Celgene"></FilterOption><FilterOption id="3669" count="81" label="mycophenolate mofetil"></FilterOption><FilterOption id="6408" count="74" label="vinorelbine"></FilterOption><FilterOption id="10252" count="67" label="insulin glargine"></FilterOption><FilterOption id="6156" count="61" label="fludarabine"></FilterOption><FilterOption id="44279" count="52" label="amoxicillin"></FilterOption><FilterOption id="10084" count="49" label="tegafur + gimeracil + oteracil potassium"></FilterOption><FilterOption id="10388" count="48" label="cetuximab"></FilterOption><FilterOption id="2836" count="48" label="clopidogrel"></FilterOption><FilterOption id="15954" count="47" label="bortezomib"></FilterOption><FilterOption id="3750" count="45" label="ondansetron"></FilterOption><FilterOption id="2829" count="41" label="clarithromycin"></FilterOption><FilterOption id="27572" count="41" label="lenalidomide"></FilterOption><FilterOption id="12150" count="39" label="vincristine sulfate (liposomal injection), Spectrum Pharmaceuticals"></FilterOption><FilterOption id="7286" count="37" label="goserelin acetate"></FilterOption><FilterOption id="7934" count="36" label="doxorubicin (liposomal, STEALTH), Alza"></FilterOption><FilterOption id="47000" count="34" label="bendamustine"></FilterOption><FilterOption id="11519" count="34" label="mitoxantrone"></FilterOption><FilterOption id="8832" count="31" label="glimepiride"></FilterOption><FilterOption id="11961" count="29" label="erlotinib"></FilterOption><FilterOption id="5999" count="28" label="ciclosporin, Novartis"></FilterOption><FilterOption id="3353" count="28" label="insulin lispro"></FilterOption><FilterOption id="44403" count="28" label="lidocaine"></FilterOption><FilterOption id="44308" count="28" label="propofol, AstraZeneca/Fresenius"></FilterOption><FilterOption id="5369" count="28" label="ribavirin"></FilterOption><FilterOption id="2784" count="27" label="letrozole"></FilterOption><FilterOption id="44305" count="27" label="omeprazole"></FilterOption><FilterOption id="49219" count="27" label="tenofovir disoproxil fumarate + emtricitabine (fixed dose), Gilead Sciences"></FilterOption><FilterOption id="10309" count="26" label="abiraterone"></FilterOption><FilterOption id="10172" count="26" label="efavirenz"></FilterOption><FilterOption id="3130" count="26" label="filgrastim"></FilterOption><FilterOption id="7310" count="26" label="ritonavir"></FilterOption><FilterOption id="3474" count="24" label="lamivudine"></FilterOption><FilterOption id="44314" count="23" label="tamoxifen"></FilterOption><FilterOption id="48945" count="22" label="bupivacaine, AstraZeneca"></FilterOption><FilterOption id="44303" count="22" label="midazolam hydrochloride"></FilterOption><FilterOption id="2807" count="21" label="atorvastatin"></FilterOption><FilterOption id="23625" count="21" label="peginterferon alfa-2a"></FilterOption><FilterOption id="28532" count="21" label="pertuzumab"></FilterOption><FilterOption id="25880" count="20" label="enteric-coated mycophenolate sodium, Novartis"></FilterOption><FilterOption id="3081" count="20" label="exemestane"></FilterOption><FilterOption id="10411" count="20" label="insulin aspart"></FilterOption><FilterOption id="5267" count="20" label="leuprorelin acetate"></FilterOption><FilterOption id="54804" count="20" label="nivolumab"></FilterOption><FilterOption id="4529" count="20" label="temozolomide"></FilterOption><FilterOption id="3321" count="19" label="anastrozole"></FilterOption><FilterOption id="36630" count="19" label="ipilimumab"></FilterOption><FilterOption id="33591" count="19" label="lapatinib"></FilterOption><FilterOption id="21374" count="19" label="pegfilgrastim"></FilterOption><FilterOption id="5356" count="19" label="sevoflurane"></FilterOption><FilterOption id="44499" count="19" label="sitagliptin"></FilterOption><FilterOption id="15254" count="18" label="atazanavir"></FilterOption><FilterOption id="8050" count="18" label="thalidomide, Celgene"></FilterOption><FilterOption id="9298" count="18" label="Thymoglobulin"></FilterOption><FilterOption id="44375" count="18" label="warfarin"></FilterOption><FilterOption id="14163" count="17" label="adalimumab"></FilterOption><FilterOption id="16026" count="17" label="esomeprazole"></FilterOption><FilterOption id="9754" count="17" label="palanosetron hydrochloride"></FilterOption><FilterOption id="14493" count="17" label="tenofovir disoproxil fumarate"></FilterOption><FilterOption id="13486" count="16" label="entecavir"></FilterOption><FilterOption id="3311" count="15" label="bicalutamide"></FilterOption><FilterOption id="16915" count="15" label="calcium levofolinate"></FilterOption><FilterOption id="32981" count="15" label="darunavir"></FilterOption><FilterOption id="3492" count="15" label="levofloxacin"></FilterOption><FilterOption id="12420" count="15" label="rosuvastatin"></FilterOption><FilterOption id="16748" count="14" label="aprepitant"></FilterOption><FilterOption id="4271" count="14" label="ropivacaine"></FilterOption><FilterOption id="37370" count="13" label="azacitidine"></FilterOption><FilterOption id="11603" count="13" label="gefitinib"></FilterOption><FilterOption id="6104" count="13" label="lansoprazole"></FilterOption><FilterOption id="70667" count="13" label="pembrolizumab"></FilterOption><FilterOption id="27696" count="13" label="pomalidomide"></FilterOption><FilterOption id="34281" count="13" label="Prevnar 13"></FilterOption><FilterOption id="4577" count="13" label="topotecan"></FilterOption><FilterOption id="11141" count="12" label="basiliximab"></FilterOption><FilterOption id="48181" count="12" label="lamivudine + abacavir, GlaxoSmithKline"></FilterOption><FilterOption id="44316" count="12" label="zidovudine"></FilterOption><FilterOption id="2500" count="11" label="amlodipine"></FilterOption><FilterOption id="13239" count="11" label="decitabine"></FilterOption><FilterOption id="2997" count="11" label="rabeprazole"></FilterOption><FilterOption id="29831" count="11" label="sorafenib"></FilterOption><FilterOption id="13340" count="10" label="everolimus"></FilterOption><FilterOption id="3159" count="10" label="fluticasone propionate"></FilterOption><FilterOption id="3313" count="10" label="fulvestrant"></FilterOption><FilterOption id="5148" count="10" label="liraglutide"></FilterOption></Filter><Filter label="Trial Category" name="trialCategory" total="18"><FilterOption id="4" count="84835" label="Small molecule"></FilterOption><FilterOption id="3" count="33271" label="Biological"></FilterOption><FilterOption id="9" count="10174" label="Medical procedure"></FilterOption><FilterOption id="15" count="9651" label="Radiation therapy"></FilterOption><FilterOption id="8" count="7519" label="Medical device"></FilterOption><FilterOption id="5" count="5954" label="Vaccine"></FilterOption><FilterOption id="11" count="5709" label="Dietary supplement"></FilterOption><FilterOption id="16" count="5072" label="Behavioral intervention"></FilterOption><FilterOption id="6" count="4976" label="Cell therapy"></FilterOption><FilterOption id="14" count="2909" label="Diagnostic"></FilterOption><FilterOption id="7" count="2504" label="Gene therapy"></FilterOption><FilterOption id="18" count="2487" label="Pathophysiology"></FilterOption><FilterOption id="17" count="1911" label="Biomarker identification"></FilterOption><FilterOption id="12" count="564" label="Herbal preparation"></FilterOption><FilterOption id="10" count="424" label="Borderline product"></FilterOption><FilterOption id="19" count="205" label="Surgical procedure"></FilterOption><FilterOption id="2" count="83" label="Drug"></FilterOption><FilterOption id="13" count="79" label="Hospital solutions"></FilterOption></Filter><Filter label="Trial Outcome Available" name="trialOutcomesAvailable" total="2"><FilterOption id="NO" count="89864" label="No"></FilterOption><FilterOption id="YES" count="45610" label="Yes"></FilterOption></Filter><Filter label="Trial Actions Primary Interventions Primary" name="trialActionsPrimaryInterventionsPrimary" total="100"><FilterOption id="3848" count="4351" label="VEGF-2 receptor antagonist"></FilterOption><FilterOption id="3808" count="4112" label="Kit tyrosine kinase inhibitor"></FilterOption><FilterOption id="740" count="3871" label="Epidermal growth factor receptor antagonist"></FilterOption><FilterOption id="142" count="3744" label="Topoisomerase II inhibitor"></FilterOption><FilterOption id="372" count="3669" label="Thymidylate synthase inhibitor"></FilterOption><FilterOption id="3846" count="3330" label="VEGF-1 receptor antagonist"></FilterOption><FilterOption id="3850" count="3211" label="VEGF-3 receptor antagonist"></FilterOption><FilterOption id="141" count="3129" label="Topoisomerase I inhibitor"></FilterOption><FilterOption id="67136" count="2888" label="Programmed cell death protein 1 inhibitor"></FilterOption><FilterOption id="12521" count="2640" label="VEGF ligand inhibitor"></FilterOption><FilterOption id="948" count="2623" label="PDGF receptor antagonist"></FilterOption><FilterOption id="48492" count="2529" label="PDGF receptor beta antagonist"></FilterOption><FilterOption id="5085" count="2512" label="B-lymphocyte antigen CD20 inhibitor"></FilterOption><FilterOption id="3806" count="2449" label="Flt3 tyrosine kinase inhibitor"></FilterOption><FilterOption id="3754" count="2330" label="EGFR family tyrosine kinase receptor inhibitor"></FilterOption><FilterOption id="3756" count="2172" label="Erbb2 tyrosine kinase receptor inhibitor"></FilterOption><FilterOption id="1722" count="2161" label="VEGF receptor antagonist"></FilterOption><FilterOption id="3816" count="2109" label="RET tyrosine kinase receptor family inhibitor"></FilterOption><FilterOption id="138" count="1842" label="DNA polymerase inhibitor"></FilterOption><FilterOption id="346" count="1774" label="Ribonucleotide reductase inhibitor"></FilterOption><FilterOption id="10240" count="1675" label="mTOR inhibitor"></FilterOption><FilterOption id="3151" count="1608" label="GCSF receptor agonist"></FilterOption><FilterOption id="4548" count="1575" label="Raf B protein kinase inhibitor"></FilterOption><FilterOption id="6830" count="1572" label="DNA primase inhibitor"></FilterOption><FilterOption id="51708" count="1565" label="DNA polymerase alpha inhibitor"></FilterOption><FilterOption id="48489" count="1505" label="PDGF receptor alpha antagonist"></FilterOption><FilterOption id="13571" count="1427" label="Bcr protein inhibitor"></FilterOption><FilterOption id="782" count="1321" label="Dihydropyrimidine dehydrogenase inhibitor"></FilterOption><FilterOption id="4917" count="1314" label="Proteasome inhibitor"></FilterOption><FilterOption id="3524" count="1309" label="Abl tyrosine kinase inhibitor"></FilterOption><FilterOption id="6661" count="1291" label="Orotate phosphoribosyltransferase inhibitor"></FilterOption><FilterOption id="135" count="1278" label="DHFR inhibitor"></FilterOption><FilterOption id="3154" count="1266" label="CSF-1 antagonist"></FilterOption><FilterOption id="4550" count="1254" label="Raf 1 protein kinase inhibitor"></FilterOption><FilterOption id="374" count="1163" label="Transferase inhibitor"></FilterOption><FilterOption id="181" count="1121" label="GAR transformylase inhibitor"></FilterOption><FilterOption id="4010" count="1101" label="Calcineurin inhibitor"></FilterOption><FilterOption id="4542" count="1096" label="Raf protein kinase inhibitor"></FilterOption><FilterOption id="14007" count="1077" label="Programmed cell death ligand 1 inhibitor"></FilterOption><FilterOption id="3688" count="1053" label="FGF3 receptor antagonist"></FilterOption><FilterOption id="3682" count="1047" label="FGF1 receptor antagonist"></FilterOption><FilterOption id="385" count="979" label="Protein tyrosine kinase inhibitor"></FilterOption><FilterOption id="76469" count="975" label="26S proteasome complex inhibitor"></FilterOption><FilterOption id="498" count="972" label="Sodium channel inhibitor"></FilterOption><FilterOption id="76" count="947" label="Aromatase inhibitor"></FilterOption><FilterOption id="76090" count="932" label="mTOR complex 1 inhibitor"></FilterOption><FilterOption id="3576" count="929" label="Src tyrosine kinase inhibitor"></FilterOption><FilterOption id="8805" count="917" label="AMP activated protein kinase stimulator"></FilterOption><FilterOption id="3584" count="916" label="Lck tyrosine kinase inhibitor"></FilterOption><FilterOption id="5482" count="914" label="Cytotoxic T-lymphocyte protein-4 inhibitor"></FilterOption><FilterOption id="286" count="890" label="Estrogen receptor antagonist"></FilterOption><FilterOption id="82444" count="867" label="DNA helicase inhibitor"></FilterOption><FilterOption id="205" count="834" label="HMG CoA reductase inhibitor"></FilterOption><FilterOption id="629" count="823" label="Inosine monophosphate dehydrogenase inhibitor"></FilterOption><FilterOption id="2574" count="789" label="Histone deacetylase inhibitor"></FilterOption><FilterOption id="208" count="788" label="H+ K+ ATPase inhibitor"></FilterOption><FilterOption id="721" count="777" label="TNF binding agent"></FilterOption><FilterOption id="1832" count="757" label="Nucleoside reverse transcriptase inhibitor"></FilterOption><FilterOption id="168" count="745" label="FGF receptor antagonist"></FilterOption><FilterOption id="60" count="701" label="Androgen receptor antagonist"></FilterOption><FilterOption id="11778" count="701" label="PurH purine biosynthesis protein inhibitor"></FilterOption><FilterOption id="7025" count="697" label="Signal transduction inhibitor"></FilterOption><FilterOption id="381" count="683" label="TNF alpha ligand inhibitor"></FilterOption><FilterOption id="1016" count="665" label="HIV-1 reverse transcriptase inhibitor"></FilterOption><FilterOption id="3685" count="657" label="FGF2 receptor antagonist"></FilterOption><FilterOption id="1120" count="648" label="Somatostatin receptor agonist"></FilterOption><FilterOption id="2585" count="621" label="Glucagon-like peptide 1 receptor agonist"></FilterOption><FilterOption id="12481" count="618" label="Interleukin-2 ligand"></FilterOption><FilterOption id="38283" count="614" label="Poly ADP ribose polymerase 1 inhibitor"></FilterOption><FilterOption id="3834" count="585" label="Tek tyrosine kinase receptor inhibitor"></FilterOption><FilterOption id="3762" count="583" label="EPH family tyrosine kinase inhibitor"></FilterOption><FilterOption id="38286" count="583" label="Poly ADP ribose polymerase 2 inhibitor"></FilterOption><FilterOption id="1001" count="580" label="Cyclooxygenase 2 inhibitor"></FilterOption><FilterOption id="675" count="573" label="Hepatocyte growth factor receptor antagonist"></FilterOption><FilterOption id="1092" count="567" label="GNRH receptor agonist"></FilterOption><FilterOption id="1919" count="566" label="Insulin sensitizer"></FilterOption><FilterOption id="15" count="562" label="5-HT 3 receptor antagonist"></FilterOption><FilterOption id="4762" count="550" label="MEK-1 protein kinase inhibitor"></FilterOption><FilterOption id="431" count="538" label="DNA gyrase inhibitor"></FilterOption><FilterOption id="7841" count="533" label="Histone deacetylase-1 inhibitor"></FilterOption><FilterOption id="410" count="532" label="GM-CSF receptor agonist"></FilterOption><FilterOption id="7844" count="532" label="Histone deacetylase-2 inhibitor"></FilterOption><FilterOption id="4764" count="531" label="MEK-2 protein kinase inhibitor"></FilterOption><FilterOption id="214" count="516" label="Interferon alpha 2 ligand"></FilterOption><FilterOption id="6512" count="515" label="DNA methyltransferase inhibitor"></FilterOption><FilterOption id="7847" count="513" label="Histone deacetylase-3 inhibitor"></FilterOption><FilterOption id="4314" count="509" label="Cyclin-dependent kinase-4 inhibitor"></FilterOption><FilterOption id="814" count="509" label="Tubulin modulator"></FilterOption><FilterOption id="40" count="502" label="Beta 2 adrenoceptor agonist"></FilterOption><FilterOption id="5537" count="484" label="Dipeptidyl peptidase IV inhibitor"></FilterOption><FilterOption id="3574" count="479" label="Fyn tyrosine kinase inhibitor"></FilterOption><FilterOption id="4318" count="478" label="Cyclin-dependent kinase-6 inhibitor"></FilterOption><FilterOption id="3592" count="476" label="Btk tyrosine kinase inhibitor"></FilterOption><FilterOption id="293" count="453" label="Opioid receptor mu agonist"></FilterOption><FilterOption id="2507" count="442" label="PARP inhibitor"></FilterOption><FilterOption id="2480" count="442" label="PPAR gamma agonist"></FilterOption><FilterOption id="23014" count="432" label="Insulin ligand"></FilterOption><FilterOption id="400" count="432" label="Insulin receptor agonist"></FilterOption><FilterOption id="420" count="429" label="CSF-1 agonist"></FilterOption><FilterOption id="7856" count="428" label="Histone deacetylase-6 inhibitor"></FilterOption></Filter><Filter label="Trial Company Collaborator" name="trialCompaniesCollaborator" total="100"><FilterOption id="20519" count="8230" label="National Cancer Institute"></FilterOption><FilterOption id="20518" count="1037" label="National Institutes of Health"></FilterOption><FilterOption id="1069368" count="1022" label="National Institutes of Health Clinical Center"></FilterOption><FilterOption id="23137" count="968" label="Novartis AG"></FilterOption><FilterOption id="15065" count="811" label="Bristol-Myers Squibb Co"></FilterOption><FilterOption id="18767" count="745" label="Pfizer Inc"></FilterOption><FilterOption id="19453" count="728" label="Genentech Inc"></FilterOption><FilterOption id="14190" count="688" label="AstraZeneca plc"></FilterOption><FilterOption id="1059823" count="617" label="Merck Sharp &amp; Dohme Corp"></FilterOption><FilterOption id="1009547" count="586" label="Sanofi SA"></FilterOption><FilterOption id="15331" count="556" label="Celgene Corp"></FilterOption><FilterOption id="28355" count="555" label="GlaxoSmithKline plc"></FilterOption><FilterOption id="1003240" count="503" label="National Heart Lung and Blood Institute"></FilterOption><FilterOption id="19446" count="488" label="Roche Holding AG"></FilterOption><FilterOption id="29469" count="385" label="Cancer Research UK"></FilterOption><FilterOption id="14455" count="384" label="Bayer AG"></FilterOption><FilterOption id="14109" count="359" label="Amgen Inc"></FilterOption><FilterOption id="17810" count="353" label="Eli Lilly &amp; Co"></FilterOption><FilterOption id="1041701" count="323" label="Japanese Ministry of Health, Labor and Welfare"></FilterOption><FilterOption id="1039740" count="316" label="National Natural Science Foundation of China"></FilterOption><FilterOption id="26334" count="304" label="National Institute of Diabetes, Digestive and Kidney Diseases"></FilterOption><FilterOption id="21048" count="271" label="Brigham &amp; Women's Hospital"></FilterOption><FilterOption id="1013295" count="266" label="Astellas Pharma Inc"></FilterOption><FilterOption id="20520" count="263" label="National Institute of Allergy and Infectious Diseases"></FilterOption><FilterOption id="1043068" count="249" label="Eunice Kennedy Shriver National Institute of Child Health &amp; Human Development"></FilterOption><FilterOption id="20300" count="244" label="Takeda Pharmaceutical Co Ltd"></FilterOption><FilterOption id="21569" count="243" label="Massachusetts General Hospital"></FilterOption><FilterOption id="1107695" count="241" label="Japan Agency for Medical Research and Development"></FilterOption><FilterOption id="1065861" count="213" label="Ministry of Education, Culture, Sports, Science and Technology of Japan"></FilterOption><FilterOption id="18077" count="212" label="Merck &amp; Co Inc"></FilterOption><FilterOption id="1041928" count="207" label="National Institute on Aging"></FilterOption><FilterOption id="15615" count="192" label="Dana-Farber Cancer Institute Inc"></FilterOption><FilterOption id="24877" count="175" label="Beth Israel Deaconess Medical Center"></FilterOption><FilterOption id="1042032" count="175" label="National Institute for Health Research (NIHR)"></FilterOption><FilterOption id="1036091" count="162" label="National Institute of Neurological Disorders and Stroke"></FilterOption><FilterOption id="21991" count="155" label="Takeda Oncology"></FilterOption><FilterOption id="23382" count="153" label="MD Anderson Cancer Center"></FilterOption><FilterOption id="18101" count="150" label="Merck KGaA"></FilterOption><FilterOption id="18681" count="147" label="Ono Pharmaceutical Co Ltd"></FilterOption><FilterOption id="19620" count="146" label="Eisai Inc"></FilterOption><FilterOption id="1041243" count="146" label="US Department of Defense"></FilterOption><FilterOption id="1034426" count="145" label="Canadian Institutes of Health Research"></FilterOption><FilterOption id="17332" count="145" label="Johnson &amp; Johnson"></FilterOption><FilterOption id="1039583" count="144" label="The National Institute of Mental Health"></FilterOption><FilterOption id="13601" count="137" label="Abbott Laboratories"></FilterOption><FilterOption id="DOL1000129" count="134" label="Texas Children's Hospital"></FilterOption><FilterOption id="14881" count="130" label="Boehringer Ingelheim International GmbH"></FilterOption><FilterOption id="19601" count="128" label="National Institute on Drug Abuse"></FilterOption><FilterOption id="18438" count="119" label="Medical Research Council"></FilterOption><FilterOption id="24771" count="118" label="Eastern Cooperative Oncology Group"></FilterOption><FilterOption id="16299" count="118" label="Sanofi Genzyme"></FilterOption><FilterOption id="1006925" count="117" label="Jiangsu Hengrui Medicine Co Ltd"></FilterOption><FilterOption id="1038146" count="113" label="National Health and Medical Research Council"></FilterOption><FilterOption id="20596" count="111" label="Johns Hopkins University"></FilterOption><FilterOption id="16450" count="107" label="Gilead Sciences Inc"></FilterOption><FilterOption id="20348" count="105" label="Teva Pharmaceutical Industries Ltd"></FilterOption><FilterOption id="20567" count="103" label="Duke University"></FilterOption><FilterOption id="1041019" count="103" label="National Center for Research Resources"></FilterOption><FilterOption id="18614" count="102" label="Novo Nordisk A/S"></FilterOption><FilterOption id="24773" count="102" label="University of California San Francisco"></FilterOption><FilterOption id="1003755" count="101" label="Japan Society for the Promotion of Science (JSPS)"></FilterOption><FilterOption id="1072507" count="100" label="AbbVie Inc"></FilterOption><FilterOption id="20701" count="97" label="University of Washington"></FilterOption><FilterOption id="1041750" count="94" label="National Comprehensive Cancer Network"></FilterOption><FilterOption id="1040754" count="94" label="The Netherlands Organisation for Health Research and Development"></FilterOption><FilterOption id="1046733" count="91" label="Dutch Cancer Society"></FilterOption><FilterOption id="DOL1000375" count="91" label="Fudan University"></FilterOption><FilterOption id="19461" count="90" label="Hoffmann-La Roche Inc"></FilterOption><FilterOption id="20559" count="87" label="Columbia University"></FilterOption><FilterOption id="1039403" count="87" label="German Federal Ministry of Education and Research"></FilterOption><FilterOption id="1040381" count="85" label="Cancer and Leukemia Group B"></FilterOption><FilterOption id="22122" count="85" label="Memorial Sloan-Kettering Cancer Center"></FilterOption><FilterOption id="20658" count="84" label="University of Pennsylvania"></FilterOption><FilterOption id="1043079" count="83" label="FDA Office of Orphan Products Development"></FilterOption><FilterOption id="18720" count="82" label="Taiho Pharmaceutical Co Ltd"></FilterOption><FilterOption id="1034427" count="81" label="Juvenile Diabetes Research Foundation"></FilterOption><FilterOption id="1041623" count="79" label="Houston Methodist"></FilterOption><FilterOption id="21111" count="79" label="Mayo Clinic Foundation"></FilterOption><FilterOption id="1004360" count="79" label="Sun Yat-Sen University"></FilterOption><FilterOption id="25623" count="79" label="University of California Los Angeles"></FilterOption><FilterOption id="20623" count="79" label="University of Michigan"></FilterOption><FilterOption id="1081121" count="78" label="Center for Cell and Gene Therapy"></FilterOption><FilterOption id="1039415" count="78" label="Ministry of Science and Technology of the People´s Republic of China"></FilterOption><FilterOption id="1028858" count="78" label="Southwest Oncology Group"></FilterOption><FilterOption id="20659" count="78" label="University of Pittsburgh"></FilterOption><FilterOption id="17216" count="77" label="Incyte Corp"></FilterOption><FilterOption id="1101929" count="77" label="IQVIA Holdings Inc"></FilterOption><FilterOption id="1036410" count="77" label="National Center for Complementary and Alternative Medicine"></FilterOption><FilterOption id="1033116" count="77" label="PAREXEL International"></FilterOption><FilterOption id="19711" count="76" label="Schering-Plough Corp"></FilterOption><FilterOption id="1034431" count="74" label="National Institute of Arthritis and Musculoskeletal and Skin Diseases"></FilterOption><FilterOption id="DOL1000190" count="72" label="Aarhus University Hospital"></FilterOption><FilterOption id="1005244" count="72" label="Biogen Inc"></FilterOption><FilterOption id="20685" count="72" label="Thomas Jefferson University"></FilterOption><FilterOption id="26113" count="72" label="Washington University in St Louis"></FilterOption><FilterOption id="17229" count="71" label="INSERM"></FilterOption><FilterOption id="1004516" count="70" label="Deutsche Forschungsgemeinschaft (DFG)"></FilterOption><FilterOption id="26178" count="69" label="F Hoffmann-La Roche AG"></FilterOption><FilterOption id="1097941" count="69" label="NRG Oncology"></FilterOption><FilterOption id="1059977" count="68" label="European Commission"></FilterOption></Filter><Filter label="Trial Actions Secondary Interventions Control" name="trialActionsSecondaryInterventionsControl" total="100"><FilterOption id="1545" count="4734" label="Anticancer"></FilterOption><FilterOption id="767" count="1658" label="Cell cycle inhibitor"></FilterOption><FilterOption id="2953" count="1468" label="Anti-inflammatory"></FilterOption><FilterOption id="140" count="1310" label="DNA synthesis inhibitor"></FilterOption><FilterOption id="1569" count="1160" label="Anticancer antimetabolite"></FilterOption><FilterOption id="50" count="1110" label="Anticancer alkylating agent"></FilterOption><FilterOption id="55685" count="1001" label="Anticancer monoclonal antibody"></FilterOption><FilterOption id="62255" count="840" label="Anticancer protein kinase inhibitor"></FilterOption><FilterOption id="991" count="800" label="Antiviral"></FilterOption><FilterOption id="2575" count="689" label="Microtubule inhibitor"></FilterOption><FilterOption id="2576" count="688" label="Microtubule stabilizer"></FilterOption><FilterOption id="61" count="636" label="Angiogenesis inhibitor"></FilterOption><FilterOption id="2660" count="601" label="Vasoprotectant"></FilterOption><FilterOption id="399" count="591" label="Hypoglycemic agent"></FilterOption><FilterOption id="2946" count="489" label="Analgesic"></FilterOption><FilterOption id="1589" count="477" label="Apoptosis stimulator"></FilterOption><FilterOption id="1594" count="470" label="Antibacterial"></FilterOption><FilterOption id="396" count="324" label="Immunosuppressant"></FilterOption><FilterOption id="2657" count="322" label="Antihypertensive"></FilterOption><FilterOption id="7293" count="287" label="Synergist"></FilterOption><FilterOption id="750" count="282" label="DNA intercalator"></FilterOption><FilterOption id="12378" count="266" label="Prophylactic vaccine"></FilterOption><FilterOption id="646" count="247" label="Bronchodilator"></FilterOption><FilterOption id="15187" count="245" label="Systemic dermatological antibacterial product"></FilterOption><FilterOption id="38206" count="223" label="Biguanide antidiabetic product"></FilterOption><FilterOption id="59620" count="206" label="Unspecified drug target"></FilterOption><FilterOption id="2970" count="202" label="Anti-emetic"></FilterOption><FilterOption id="393" count="198" label="Immunostimulant"></FilterOption><FilterOption id="805" count="195" label="Folate modulator"></FilterOption><FilterOption id="15184" count="195" label="Systemic antipsoriatic product"></FilterOption><FilterOption id="1596" count="188" label="Immunomodulator"></FilterOption><FilterOption id="7761" count="179" label="T-lymphocyte stimulator"></FilterOption><FilterOption id="38200" count="178" label="Acid pump inhibitor antiulcerant product"></FilterOption><FilterOption id="104" count="174" label="Bacterial cell wall synthesis inhibitor"></FilterOption><FilterOption id="1669" count="174" label="Local anesthetic"></FilterOption><FilterOption id="71" count="172" label="Antihypercholesterolemic agent"></FilterOption><FilterOption id="2667" count="156" label="Antiarteriosclerotic"></FilterOption><FilterOption id="610" count="153" label="Hematopoietic stimulator"></FilterOption><FilterOption id="7760" count="152" label="T-lymphocyte inhibitor"></FilterOption><FilterOption id="2954" count="150" label="Steroidal anti-inflammatory"></FilterOption><FilterOption id="3189" count="147" label="Corticosteroid agonist"></FilterOption><FilterOption id="72" count="145" label="Antihyperlipidemic agent"></FilterOption><FilterOption id="62254" count="142" label="Anticancer hormone antagonist"></FilterOption><FilterOption id="2942" count="139" label="Anxiolytic"></FilterOption><FilterOption id="182" count="139" label="Gastric secretion inhibitor"></FilterOption><FilterOption id="38215" count="131" label="Human insulin long acting product"></FilterOption><FilterOption id="312" count="130" label="Platelet aggregation inhibitor"></FilterOption><FilterOption id="2659" count="128" label="Cardioprotectant"></FilterOption><FilterOption id="747" count="123" label="HIV replication inhibitor"></FilterOption><FilterOption id="1668" count="115" label="General anesthetic"></FilterOption><FilterOption id="2947" count="114" label="Antiparkinsonian"></FilterOption><FilterOption id="3984" count="113" label="Bacterial nucleic acid synthesis inhibitor"></FilterOption><FilterOption id="1615" count="112" label="Neuroprotectant"></FilterOption><FilterOption id="388" count="112" label="Vasodilator"></FilterOption><FilterOption id="70" count="110" label="Anticonvulsant agent"></FilterOption><FilterOption id="89" count="105" label="Bone resorption inhibitor"></FilterOption><FilterOption id="382" count="104" label="TNF alpha synthesis inhibitor"></FilterOption><FilterOption id="2941" count="103" label="Antidepressant"></FilterOption><FilterOption id="659" count="100" label="Coagulation inhibitor"></FilterOption><FilterOption id="2955" count="99" label="Non-steroidal anti-inflammatory"></FilterOption><FilterOption id="12367" count="96" label="Inactivated viral vaccine"></FilterOption><FilterOption id="38211" count="93" label="Human insulin fast acting product"></FilterOption><FilterOption id="1538" count="92" label="Bacterial protein synthesis inhibitor"></FilterOption><FilterOption id="1532" count="91" label="Viral replication inhibitor"></FilterOption><FilterOption id="32411" count="88" label="Hepatitis B virus replication inhibitor"></FilterOption><FilterOption id="463" count="80" label="Ribosome binding agent"></FilterOption><FilterOption id="664" count="79" label="Fibrosuppressant"></FilterOption><FilterOption id="1748" count="77" label="Fungicide"></FilterOption><FilterOption id="3" count="72" label="5-HT uptake inhibitor"></FilterOption><FilterOption id="12372" count="72" label="Protein subunit vaccine"></FilterOption><FilterOption id="3246" count="71" label="Insulin release stimulator"></FilterOption><FilterOption id="38439" count="68" label="DPP IV inhibitor antidiabetic product"></FilterOption><FilterOption id="38205" count="68" label="Sulphonylurea antidiabetic product"></FilterOption><FilterOption id="1540" count="64" label="Macrolide antibiotic"></FilterOption><FilterOption id="12596" count="62" label="Osteoclast inhibitor"></FilterOption><FilterOption id="285" count="61" label="Norepinephrine uptake inhibitor"></FilterOption><FilterOption id="1332" count="59" label="Gastrointestinal system agent"></FilterOption><FilterOption id="2944" count="58" label="Hypnotic"></FilterOption><FilterOption id="1129" count="57" label="Non-steroid hormone receptor antagonist"></FilterOption><FilterOption id="3313" count="55" label="Glucagon-like peptide 1 metabolism modulator"></FilterOption><FilterOption id="12364" count="55" label="Live attenuated viral vaccine"></FilterOption><FilterOption id="1535" count="52" label="Beta lactam antibiotic"></FilterOption><FilterOption id="695" count="50" label="Metastasis inhibitor"></FilterOption><FilterOption id="12373" count="50" label="Polysaccharide subunit vaccine"></FilterOption><FilterOption id="449" count="48" label="Antiarrhythmic agent"></FilterOption><FilterOption id="7251" count="48" label="Female contraceptive"></FilterOption><FilterOption id="15178" count="47" label="Systemic dermatological antifungal product"></FilterOption><FilterOption id="439" count="46" label="RNA synthesis inhibitor"></FilterOption><FilterOption id="2943" count="45" label="Antipsychotic"></FilterOption><FilterOption id="7018" count="44" label="Antihypertriglyceridemic agent"></FilterOption><FilterOption id="73547" count="43" label="Carbapenem"></FilterOption><FilterOption id="3272" count="40" label="Growth hormone release inhibitor"></FilterOption><FilterOption id="7220" count="40" label="Neoplasm diagnostic agent"></FilterOption><FilterOption id="12371" count="39" label="Subunit vaccine"></FilterOption><FilterOption id="15148" count="38" label="Ocular antineovascularisation agent"></FilterOption><FilterOption id="1479" count="36" label="RNA synthesis modulator"></FilterOption><FilterOption id="937" count="34" label="Androgen synthesis inhibitor"></FilterOption><FilterOption id="12379" count="34" label="Therapeutic vaccine"></FilterOption><FilterOption id="1537" count="32" label="Cephalosporin"></FilterOption><FilterOption id="7210" count="31" label="Cardiovascular diagnostic agent"></FilterOption></Filter><Filter label="Biomarker Type" name="trialBiomarkerTypes" total="7"><FilterOption id="37" count="47547" label="Proteomic"></FilterOption><FilterOption id="38" count="46350" label="Genomic"></FilterOption><FilterOption id="32" count="19744" label="Biochemical"></FilterOption><FilterOption id="31" count="19671" label="Physiological"></FilterOption><FilterOption id="75" count="14287" label="Cellular"></FilterOption><FilterOption id="40" count="8087" label="Structural (imaging)"></FilterOption><FilterOption id="39" count="7411" label="Anthropomorphic"></FilterOption></Filter><Filter label="Biomarker Role" name="trialBiomarkerRoles" total="4"><FilterOption id="695863716" count="51098" label="Therapeutic effect marker"></FilterOption><FilterOption id="1571666123" count="23181" label="Disease marker"></FilterOption><FilterOption id="730490367" count="7677" label="Toxic effect marker"></FilterOption><FilterOption id="3242045531" count="423" label="Not determined"></FilterOption></Filter><Filter label="Interventions" name="trialInterventions" total="100"><FilterOption id="3199" count="3492" label="gemcitabine"></FilterOption><FilterOption id="44383" count="3445" label="carboplatin"></FilterOption><FilterOption id="3803" count="3429" label="paclitaxel"></FilterOption><FilterOption id="2953" count="3290" label="docetaxel"></FilterOption><FilterOption id="3792" count="2841" label="oxaliplatin"></FilterOption><FilterOption id="8047" count="2561" label="bevacizumab"></FilterOption><FilterOption id="12205" count="2296" label="capecitabine"></FilterOption><FilterOption id="2871" count="2172" label="irinotecan"></FilterOption><FilterOption id="6736" count="2152" label="rituximab"></FilterOption><FilterOption id="3072" count="1989" label="etoposide phosphate"></FilterOption><FilterOption id="6156" count="1565" label="fludarabine"></FilterOption><FilterOption id="54804" count="1316" label="nivolumab"></FilterOption><FilterOption id="10084" count="1287" label="tegafur + gimeracil + oteracil potassium"></FilterOption><FilterOption id="70667" count="1208" label="pembrolizumab"></FilterOption><FilterOption id="6386" count="1165" label="trastuzumab"></FilterOption><FilterOption id="3130" count="1142" label="filgrastim"></FilterOption><FilterOption id="4529" count="1133" label="temozolomide"></FilterOption><FilterOption id="10388" count="1115" label="cetuximab"></FilterOption><FilterOption id="3536" count="1113" label="pemetrexed disodium"></FilterOption><FilterOption id="11961" count="1098" label="erlotinib"></FilterOption><FilterOption id="29831" count="1037" label="sorafenib"></FilterOption><FilterOption id="15954" count="975" label="bortezomib"></FilterOption><FilterOption id="29016" count="962" label="paclitaxel (albumin-bound nanoparticle, intravenous), Celgene"></FilterOption><FilterOption id="27572" count="952" label="lenalidomide"></FilterOption><FilterOption id="13022" count="867" label="epirubicin"></FilterOption><FilterOption id="6050" count="855" label="metformin hydrochloride"></FilterOption><FilterOption id="13340" count="780" label="everolimus"></FilterOption><FilterOption id="4510" count="740" label="tacrolimus"></FilterOption><FilterOption id="6408" count="726" label="vinorelbine"></FilterOption><FilterOption id="3669" count="701" label="mycophenolate mofetil"></FilterOption><FilterOption id="11460" count="693" label="imatinib"></FilterOption><FilterOption id="36630" count="683" label="ipilimumab"></FilterOption><FilterOption id="12973" count="667" label="sunitinib"></FilterOption><FilterOption id="11603" count="608" label="gefitinib"></FilterOption><FilterOption id="44314" count="563" label="tamoxifen"></FilterOption><FilterOption id="54452" count="503" label="rivoceranib mesylate"></FilterOption><FilterOption id="2784" count="483" label="letrozole"></FilterOption><FilterOption id="6306" count="463" label="aldesleukin"></FilterOption><FilterOption id="7934" count="455" label="doxorubicin (liposomal, STEALTH), Alza"></FilterOption><FilterOption id="4577" count="451" label="topotecan"></FilterOption><FilterOption id="4200" count="438" label="sirolimus"></FilterOption><FilterOption id="37370" count="429" label="azacitidine"></FilterOption><FilterOption id="12135" count="423" label="celecoxib"></FilterOption><FilterOption id="7121" count="415" label="sargramostim"></FilterOption><FilterOption id="9298" count="405" label="Thymoglobulin"></FilterOption><FilterOption id="11519" count="401" label="mitoxantrone"></FilterOption><FilterOption id="2765" count="399" label="zoledronic acid"></FilterOption><FilterOption id="81193" count="394" label="durvalumab"></FilterOption><FilterOption id="48946" count="392" label="dasatinib"></FilterOption><FilterOption id="21374" count="392" label="pegfilgrastim"></FilterOption><FilterOption id="47000" count="382" label="bendamustine"></FilterOption><FilterOption id="72699" count="369" label="atezolizumab"></FilterOption><FilterOption id="33591" count="364" label="lapatinib"></FilterOption><FilterOption id="43738" count="347" label="pazopanib"></FilterOption><FilterOption id="2716" count="337" label="alemtuzumab"></FilterOption><FilterOption id="3321" count="335" label="anastrozole"></FilterOption><FilterOption id="8050" count="334" label="thalidomide, Celgene"></FilterOption><FilterOption id="10309" count="331" label="abiraterone"></FilterOption><FilterOption id="44403" count="328" label="lidocaine"></FilterOption><FilterOption id="5369" count="328" label="ribavirin"></FilterOption><FilterOption id="2807" count="325" label="atorvastatin"></FilterOption><FilterOption id="55237" count="321" label="ibrutinib"></FilterOption><FilterOption id="3081" count="318" label="exemestane"></FilterOption><FilterOption id="12646" count="314" label="panitumumab"></FilterOption><FilterOption id="53981" count="297" label="enzalutamide"></FilterOption><FilterOption id="3313" count="295" label="fulvestrant"></FilterOption><FilterOption id="2836" count="287" label="clopidogrel"></FilterOption><FilterOption id="48945" count="285" label="bupivacaine, AstraZeneca"></FilterOption><FilterOption id="12150" count="284" label="vincristine sulfate (liposomal injection), Spectrum Pharmaceuticals"></FilterOption><FilterOption id="7286" count="280" label="goserelin acetate"></FilterOption><FilterOption id="14163" count="279" label="adalimumab"></FilterOption><FilterOption id="5999" count="275" label="ciclosporin, Novartis"></FilterOption><FilterOption id="23625" count="270" label="peginterferon alfa-2a"></FilterOption><FilterOption id="13239" count="269" label="decitabine"></FilterOption><FilterOption id="24142" count="256" label="mesna"></FilterOption><FilterOption id="16063" count="256" label="olaparib"></FilterOption><FilterOption id="4126" count="255" label="pioglitazone"></FilterOption><FilterOption id="22965" count="251" label="temsirolimus"></FilterOption><FilterOption id="54449" count="248" label="afatinib"></FilterOption><FilterOption id="17625" count="247" label="vorinostat (oral), Merck &amp; Co"></FilterOption><FilterOption id="51388" count="243" label="nilotinib"></FilterOption><FilterOption id="44279" count="242" label="amoxicillin"></FilterOption><FilterOption id="5267" count="239" label="leuprorelin acetate"></FilterOption><FilterOption id="44308" count="237" label="propofol, AstraZeneca/Fresenius"></FilterOption><FilterOption id="2829" count="233" label="clarithromycin"></FilterOption><FilterOption id="8783" count="232" label="dexmedetomidine"></FilterOption><FilterOption id="5148" count="230" label="liraglutide"></FilterOption><FilterOption id="44316" count="230" label="zidovudine"></FilterOption><FilterOption id="4271" count="229" label="ropivacaine"></FilterOption><FilterOption id="4567" count="224" label="etanercept"></FilterOption><FilterOption id="28773" count="222" label="eribulin mesylate"></FilterOption><FilterOption id="44303" count="220" label="midazolam hydrochloride"></FilterOption><FilterOption id="3311" count="218" label="bicalutamide"></FilterOption><FilterOption id="54601" count="217" label="carfilzomib"></FilterOption><FilterOption id="6850" count="213" label="infliximab"></FilterOption><FilterOption id="44305" count="212" label="omeprazole"></FilterOption><FilterOption id="3474" count="209" label="lamivudine"></FilterOption><FilterOption id="12420" count="209" label="rosuvastatin"></FilterOption><FilterOption id="28532" count="207" label="pertuzumab"></FilterOption><FilterOption id="16748" count="205" label="aprepitant"></FilterOption></Filter><Filter label="Endpoint Index Primary" name="trialEndpointIndexPrimary" total="100"><FilterOption id="15285" count="1737" label="Solid tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="15312" count="1588" label="Solid tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="15293" count="1448" label="Solid tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"></FilterOption><FilterOption id="15287" count="1440" label="Solid tumor - Assessment of adverse events"></FilterOption><FilterOption id="8489" count="1392" label="Lung tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="8639" count="1177" label="Lung tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="8077" count="1147" label="Leukemia - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="8078" count="916" label="Leukemia - Assessment of adverse events"></FilterOption><FilterOption id="7679" count="916" label="Lymphoma - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="8670" count="886" label="Lung tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters - Assessment of maximum tolerated dose (MTD)"></FilterOption><FilterOption id="9122" count="869" label="Breast tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="8140" count="851" label="Leukemia - Protocol Specified Other Endpoints - Assessment of Clinical Efficacy"></FilterOption><FilterOption id="7563" count="849" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Complete Response"></FilterOption><FilterOption id="7987" count="834" label="Leukemia - Assessment of Pharmacokinetic/Pharmacodynamic Parameters - Assessment of maximum tolerated dose (MTD)"></FilterOption><FilterOption id="8998" count="827" label="Breast tumor - Assessment of adverse events"></FilterOption><FilterOption id="25874" count="827" label="Pain - Assessment of Intensity of Pain - Based on Visual analog scale[VAS]"></FilterOption><FilterOption id="8996" count="803" label="Breast tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="19282" count="788" label="Cancer supportive care - Patient Reported Outcomes/Quality of Life Assessments"></FilterOption><FilterOption id="8481" count="786" label="Lung tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="7908" count="779" label="Leukemia - Assessment of Response Rates (RR) - Assessment of Complete Response"></FilterOption><FilterOption id="9155" count="772" label="Lung tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"></FilterOption><FilterOption id="19412" count="771" label="Cancer supportive care - Protocol Specified Other Endpoints - Assessment of Other Treatment or Procedure Related Outcomes"></FilterOption><FilterOption id="9133" count="767" label="Lymphoma - Assessment of Pharmacokinetic/Pharmacodynamic Parameters - Assessment of maximum tolerated dose (MTD)"></FilterOption><FilterOption id="7680" count="761" label="Lymphoma - Assessment of adverse events"></FilterOption><FilterOption id="8640" count="749" label="Lung tumor - Assessment of Safety and Tolerability - Adverse events as graded by CTCAE/CTC"></FilterOption><FilterOption id="8713" count="743" label="Breast tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="8505" count="729" label="Lung tumor - Assessment of Objective Response - Assessment of objective response rate(ORR)"></FilterOption><FilterOption id="7569" count="728" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"></FilterOption><FilterOption id="8719" count="720" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"></FilterOption><FilterOption id="8090" count="701" label="Leukemia - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"></FilterOption><FilterOption id="7704" count="692" label="Lymphoma - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"></FilterOption><FilterOption id="9153" count="688" label="Lung tumor - Imaging/Radiological Assessments - Assessment by Response Evaluation Criteria in Solid Tumors (RECIST) Criteria"></FilterOption><FilterOption id="8430" count="679" label="Colorectal tumor - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"></FilterOption><FilterOption id="8508" count="675" label="Lung tumor - Assessment of Overall Response"></FilterOption><FilterOption id="8451" count="664" label="Colorectal tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="1" count="660" label="Hypertension - Assessment of Blood Pressure (BP)"></FilterOption><FilterOption id="8721" count="655" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"></FilterOption><FilterOption id="19407" count="642" label="Cancer supportive care - Assessment of Laboratory/Diagnostic Measures"></FilterOption><FilterOption id="1359" count="631" label="Non-insulin dependent diabetes - Assessment of Hemoglobin A1c (HbA1c) Levels - Change in HbA1c"></FilterOption><FilterOption id="7189" count="613" label="Prostate tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="9246" count="605" label="HIV infection - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="8663" count="590" label="Lung tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="7564" count="589" label="Lymphoma - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"></FilterOption><FilterOption id="9008" count="587" label="Breast tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"></FilterOption><FilterOption id="19374" count="587" label="Cancer supportive care - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="9218" count="586" label="HIV infection - Assessment of Immune Response"></FilterOption><FilterOption id="8163" count="582" label="Colorectal tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="9247" count="559" label="HIV infection - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"></FilterOption><FilterOption id="7547" count="556" label="Lymphoma - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="8187" count="551" label="Colorectal tumor - Assessment of Response Rates (RR) - Assessment of Objective/Overall Response Rate (ORR)"></FilterOption><FilterOption id="7879" count="547" label="Leukemia - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="15288" count="545" label="Solid tumor - Assessment of Safety and Tolerability - Assessment of safety as measured by NCI CTCAE/NCI-CTC criteria"></FilterOption><FilterOption id="1358" count="533" label="Non-insulin dependent diabetes - Assessment of Hemoglobin A1c (HbA1c) Levels"></FilterOption><FilterOption id="37159" count="525" label="Breast tumor - Assessment of Laboratory/Diagnostic Measures"></FilterOption><FilterOption id="8513" count="525" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"></FilterOption><FilterOption id="2" count="517" label="Hypertension - Assessment of Blood Pressure (BP) - BP control rate"></FilterOption><FilterOption id="12048" count="507" label="Hepatobiliary system tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="8514" count="506" label="Lung tumor - Assessment of Response Rates (RR) - Assessment of Complete Response"></FilterOption><FilterOption id="8436" count="503" label="Colorectal tumor - Assessment of Safety and Tolerability - Assessment of dose limiting toxicity"></FilterOption><FilterOption id="7311" count="501" label="Head and neck tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="7312" count="501" label="Head and neck tumor - Assessment of adverse events"></FilterOption><FilterOption id="7026" count="500" label="Melanoma - Assessment of Safety and Tolerability - Assessment of toxicity profile"></FilterOption><FilterOption id="9152" count="494" label="Lung tumor - Assessment of Other/Unspecified Efficacy Parameters"></FilterOption><FilterOption id="15309" count="488" label="Solid tumor - Assessment of Laboratory/Diagnostic Measures"></FilterOption><FilterOption id="13344" count="485" label="Pancreas tumor - Assessment of Overall Survival (OS)"></FilterOption><FilterOption id="7190" count="484" label="Prostate tumor - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"></FilterOption><FilterOption id="43393" count="482" label="Other gastrointestinal disease - Assessment of Laboratory/Diagnostic Measures"></FilterOption><FilterOption id="8523" count="481" label="Lung tumor - Assessment of Disease Progression"></FilterOption><FilterOption id="25875" count="481" label="Pain - Assessment of Intensity of Pain - Based on Numerical Rating Scale [NRS]"></FilterOption><FilterOption id="13433" count="479" label="Pancreas tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="25873" count="475" label="Pain - Assessment of Intensity of Pain"></FilterOption><FilterOption id="17462" count="472" label="Stem cell transplantation - Assessment of Safety and Tolerability - Assessment of treatment toxicities"></FilterOption><FilterOption id="7218" count="469" label="Prostate tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters - Assessment of maximum tolerated dose (MTD)"></FilterOption><FilterOption id="8429" count="468" label="Colorectal tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="7188" count="464" label="Prostate tumor - Assessment of Laboratory/Diagnostic Measures - Assessments by radiography/imaging"></FilterOption><FilterOption id="7025" count="462" label="Melanoma - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="7014" count="456" label="Melanoma - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="17460" count="454" label="Stem cell transplantation - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="10900" count="451" label="Ovary tumor - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="7906" count="450" label="Leukemia - Assessment of Response Rates (RR)"></FilterOption><FilterOption id="8651" count="448" label="Lung tumor - Assessment of Laboratory/Diagnostic Measures"></FilterOption><FilterOption id="10939" count="446" label="Ovary tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="6940" count="445" label="Melanoma - Assessment of Response Rates (RR) - Assessment of overall/objective response rate"></FilterOption><FilterOption id="7027" count="440" label="Melanoma - Assessment of adverse events"></FilterOption><FilterOption id="26044" count="431" label="Pain - Assessment of Therapy Related Outcomes - Assessment of analgesic use/rescue medication"></FilterOption><FilterOption id="7909" count="428" label="Leukemia - Assessment of Response Rates (RR) - Assessment of Overall/Objective Response Rate (ORR)"></FilterOption><FilterOption id="17461" count="427" label="Stem cell transplantation - Assessment of Safety and Tolerability - Assessment of adverse events/serious adverse events"></FilterOption><FilterOption id="7520" count="422" label="Multiple myeloma - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="17220" count="419" label="Anemia - Hematological Assessments - Assessment of hemoglobin status"></FilterOption><FilterOption id="7230" count="419" label="Prostate tumor - Protocol Specified Other Endpoints - Assessment of Other Efficacy Outcomes"></FilterOption><FilterOption id="7981" count="409" label="Leukemia - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="8720" count="406" label="Breast tumor - Assessment of Response Rates (RR) - Assessment of Partial Response (PR)"></FilterOption><FilterOption id="7988" count="400" label="Leukemia - Assessment of Laboratory/Diagnostic Measures"></FilterOption><FilterOption id="26033" count="399" label="Pain - Assessment of adverse events"></FilterOption><FilterOption id="15212" count="399" label="Solid tumor - Assessment of Response Rates (RR) - Assessment of objective response rate (ORR)"></FilterOption><FilterOption id="7488" count="398" label="Multiple myeloma - Assessment of Safety and Tolerability"></FilterOption><FilterOption id="7340" count="394" label="Head and neck tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters"></FilterOption><FilterOption id="10830" count="394" label="Ovary tumor - Assessment of Progression Free Survival (PFS)"></FilterOption><FilterOption id="9043" count="390" label="Breast tumor - Protocol Specified Other Endpoints"></FilterOption><FilterOption id="17031" count="387" label="Influenza Vaccine - Assessment of Immune Response - Assessment of anti-influenza antibodies"></FilterOption></Filter><Filter label="Sponsors/Collaborators" name="trialCompanies" total="100"><FilterOption id="20519" count="10897" label="National Cancer Institute"></FilterOption><FilterOption id="23137" count="2590" label="Novartis AG"></FilterOption><FilterOption id="18767" count="2011" label="Pfizer Inc"></FilterOption><FilterOption id="28355" count="1911" label="GlaxoSmithKline plc"></FilterOption><FilterOption id="23382" count="1882" label="MD Anderson Cancer Center"></FilterOption><FilterOption id="15065" count="1726" label="Bristol-Myers Squibb Co"></FilterOption><FilterOption id="14190" count="1725" label="AstraZeneca plc"></FilterOption><FilterOption id="19446" count="1628" label="Roche Holding AG"></FilterOption><FilterOption id="1009547" count="1482" label="Sanofi SA"></FilterOption><FilterOption id="1059823" count="1453" label="Merck Sharp &amp; Dohme Corp"></FilterOption><FilterOption id="20520" count="1434" label="National Institute of Allergy and Infectious Diseases"></FilterOption><FilterOption id="17810" count="1399" label="Eli Lilly &amp; Co"></FilterOption><FilterOption id="20518" count="1322" label="National Institutes of Health"></FilterOption><FilterOption id="22122" count="1183" label="Memorial Sloan-Kettering Cancer Center"></FilterOption><FilterOption id="19453" count="1154" label="Genentech Inc"></FilterOption><FilterOption id="1069368" count="1100" label="National Institutes of Health Clinical Center"></FilterOption><FilterOption id="21569" count="1057" label="Massachusetts General Hospital"></FilterOption><FilterOption id="15331" count="991" label="Celgene Corp"></FilterOption><FilterOption id="14455" count="935" label="Bayer AG"></FilterOption><FilterOption id="14109" count="917" label="Amgen Inc"></FilterOption><FilterOption id="21111" count="849" label="Mayo Clinic Foundation"></FilterOption><FilterOption id="15615" count="816" label="Dana-Farber Cancer Institute Inc"></FilterOption><FilterOption id="1004360" count="699" label="Sun Yat-Sen University"></FilterOption><FilterOption id="14881" count="695" label="Boehringer Ingelheim International GmbH"></FilterOption><FilterOption id="1003240" count="670" label="National Heart Lung and Blood Institute"></FilterOption><FilterOption id="20300" count="576" label="Takeda Pharmaceutical Co Ltd"></FilterOption><FilterOption id="29469" count="571" label="Cancer Research UK"></FilterOption><FilterOption id="1013295" count="559" label="Astellas Pharma Inc"></FilterOption><FilterOption id="1039740" count="546" label="National Natural Science Foundation of China"></FilterOption><FilterOption id="18077" count="527" label="Merck &amp; Co Inc"></FilterOption><FilterOption id="20567" count="521" label="Duke University"></FilterOption><FilterOption id="26113" count="512" label="Washington University in St Louis"></FilterOption><FilterOption id="20679" count="497" label="Stanford University"></FilterOption><FilterOption id="24773" count="491" label="University of California San Francisco"></FilterOption><FilterOption id="26334" count="489" label="National Institute of Diabetes, Digestive and Kidney Diseases"></FilterOption><FilterOption id="DOL1000375" count="473" label="Fudan University"></FilterOption><FilterOption id="1040381" count="472" label="Cancer and Leukemia Group B"></FilterOption><FilterOption id="16450" count="445" label="Gilead Sciences Inc"></FilterOption><FilterOption id="26013" count="431" label="University of Chicago"></FilterOption><FilterOption id="20659" count="429" label="University of Pittsburgh"></FilterOption><FilterOption id="1042135" count="427" label="Sidney Kimmel Comprehensive Cancer Center"></FilterOption><FilterOption id="21048" count="419" label="Brigham &amp; Women's Hospital"></FilterOption><FilterOption id="20645" count="415" label="Northwestern University"></FilterOption><FilterOption id="20658" count="412" label="University of Pennsylvania"></FilterOption><FilterOption id="1041701" count="409" label="Japanese Ministry of Health, Labor and Welfare"></FilterOption><FilterOption id="1004334" count="395" label="Samsung Medical Center (SMC)"></FilterOption><FilterOption id="13601" count="394" label="Abbott Laboratories"></FilterOption><FilterOption id="20534" count="382" label="Baylor College of Medicine"></FilterOption><FilterOption id="16218" count="382" label="Fred Hutchinson Cancer Research Center"></FilterOption><FilterOption id="1003017" count="371" label="Seoul National University Hospital"></FilterOption><FilterOption id="20701" count="371" label="University of Washington"></FilterOption><FilterOption id="1072507" count="368" label="AbbVie Inc"></FilterOption><FilterOption id="18101" count="368" label="Merck KGaA"></FilterOption><FilterOption id="1028858" count="367" label="Southwest Oncology Group"></FilterOption><FilterOption id="28443" count="362" label="The University Health Network"></FilterOption><FilterOption id="25760" count="354" label="University of Texas Southwestern Medical Center"></FilterOption><FilterOption id="1038961" count="351" label="National Taiwan University Hospital"></FilterOption><FilterOption id="29603" count="348" label="H Lee Moffitt Cancer Center and Research Institute"></FilterOption><FilterOption id="21991" count="344" label="Takeda Oncology"></FilterOption><FilterOption id="20524" count="344" label="University of Alabama at Birmingham"></FilterOption><FilterOption id="20573" count="343" label="Emory University"></FilterOption><FilterOption id="20623" count="336" label="University of Michigan"></FilterOption><FilterOption id="23119" count="333" label="European Organisation for Research and Treatment of Cancer (EORTC)"></FilterOption><FilterOption id="23948" count="328" label="Assistance Publique Hopitaux de Paris"></FilterOption><FilterOption id="20559" count="328" label="Columbia University"></FilterOption><FilterOption id="24771" count="320" label="Eastern Cooperative Oncology Group"></FilterOption><FilterOption id="1043068" count="318" label="Eunice Kennedy Shriver National Institute of Child Health &amp; Human Development"></FilterOption><FilterOption id="1041378" count="314" label="Children's Oncology Group"></FilterOption><FilterOption id="19620" count="313" label="Eisai Inc"></FilterOption><FilterOption id="DOL1000742" count="312" label="University of Wisconsin-Madison"></FilterOption><FilterOption id="1036320" count="308" label="Asan Medical Center"></FilterOption><FilterOption id="1039242" count="308" label="Case Comprehensive Cancer Center"></FilterOption><FilterOption id="26178" count="308" label="F Hoffmann-La Roche AG"></FilterOption><FilterOption id="20634" count="304" label="University of North Carolina"></FilterOption><FilterOption id="1051922" count="298" label="City of Hope Medical Center"></FilterOption><FilterOption id="1060642" count="295" label="National Cancer Center Hospital"></FilterOption><FilterOption id="18614" count="294" label="Novo Nordisk A/S"></FilterOption><FilterOption id="20631" count="293" label="Mount Sinai School of Medicine"></FilterOption><FilterOption id="1006925" count="292" label="Jiangsu Hengrui Medicine Co Ltd"></FilterOption><FilterOption id="21099" count="289" label="Roswell Park Comprehensive Cancer Center"></FilterOption><FilterOption id="1067538" count="286" label="Janssen Research &amp; Development LLC"></FilterOption><FilterOption id="20596" count="285" label="Johns Hopkins University"></FilterOption><FilterOption id="1107695" count="282" label="Japan Agency for Medical Research and Development"></FilterOption><FilterOption id="24877" count="281" label="Beth Israel Deaconess Medical Center"></FilterOption><FilterOption id="1065861" count="274" label="Ministry of Education, Culture, Sports, Science and Technology of Japan"></FilterOption><FilterOption id="17332" count="270" label="Johnson &amp; Johnson"></FilterOption><FilterOption id="18438" count="270" label="Medical Research Council"></FilterOption><FilterOption id="18720" count="269" label="Taiho Pharmaceutical Co Ltd"></FilterOption><FilterOption id="20703" count="267" label="Yale University"></FilterOption><FilterOption id="16299" count="265" label="Sanofi Genzyme"></FilterOption><FilterOption id="25184" count="263" label="Yonsei University"></FilterOption><FilterOption id="20673" count="256" label="University of Southern California"></FilterOption><FilterOption id="1041928" count="255" label="National Institute on Aging"></FilterOption><FilterOption id="20653" count="253" label="Osaka University"></FilterOption><FilterOption id="1007827" count="246" label="University Medical Center Groningen"></FilterOption><FilterOption id="20669" count="245" label="University of Rochester"></FilterOption><FilterOption id="18681" count="244" label="Ono Pharmaceutical Co Ltd"></FilterOption><FilterOption id="1040917" count="243" label="Weill Medical College of Cornell University"></FilterOption><FilterOption id="1021685" count="239" label="Chinese PLA General Hospital"></FilterOption><FilterOption id="26109" count="237" label="Jonsson Comprehensive Cancer Center"></FilterOption></Filter><Filter label="Last Changed Date By Day" name="trialDateChangeLastByDay" total="100"><FilterOption count="3262" label="2019-01-26"></FilterOption><FilterOption count="3117" label="2019-03-07"></FilterOption><FilterOption count="2880" label="2018-10-15"></FilterOption><FilterOption count="2840" label="2019-01-25"></FilterOption><FilterOption count="2621" label="2018-10-14"></FilterOption><FilterOption count="2530" label="2019-01-24"></FilterOption><FilterOption count="2169" label="2018-10-13"></FilterOption><FilterOption count="2168" label="2018-10-12"></FilterOption><FilterOption count="1243" label="2013-12-02"></FilterOption><FilterOption count="1240" label="2018-10-16"></FilterOption><FilterOption count="652" label="2018-07-07"></FilterOption><FilterOption count="584" label="2018-06-09"></FilterOption><FilterOption count="556" label="2019-07-03"></FilterOption><FilterOption count="523" label="2013-09-14"></FilterOption><FilterOption count="487" label="2019-06-07"></FilterOption><FilterOption count="474" label="2019-06-26"></FilterOption><FilterOption count="459" label="2013-09-13"></FilterOption><FilterOption count="452" label="2019-06-27"></FilterOption><FilterOption count="445" label="2019-06-28"></FilterOption><FilterOption count="420" label="2019-06-20"></FilterOption><FilterOption count="419" label="2019-06-12"></FilterOption><FilterOption count="414" label="2019-06-06"></FilterOption><FilterOption count="411" label="2019-07-02"></FilterOption><FilterOption count="410" label="2019-06-13"></FilterOption><FilterOption count="406" label="2018-06-30"></FilterOption><FilterOption count="387" label="2019-06-14"></FilterOption><FilterOption count="378" label="2018-06-23"></FilterOption><FilterOption count="376" label="2019-05-31"></FilterOption><FilterOption count="376" label="2019-06-21"></FilterOption><FilterOption count="371" label="2019-06-19"></FilterOption><FilterOption count="367" label="2017-08-04"></FilterOption><FilterOption count="364" label="2019-04-15"></FilterOption><FilterOption count="360" label="2017-08-05"></FilterOption><FilterOption count="354" label="2019-06-25"></FilterOption><FilterOption count="345" label="2019-06-18"></FilterOption><FilterOption count="342" label="2019-07-01"></FilterOption><FilterOption count="339" label="2019-06-10"></FilterOption><FilterOption count="330" label="2019-04-22"></FilterOption><FilterOption count="326" label="2019-05-15"></FilterOption><FilterOption count="326" label="2019-05-24"></FilterOption><FilterOption count="325" label="2018-07-14"></FilterOption><FilterOption count="321" label="2019-04-17"></FilterOption><FilterOption count="320" label="2019-05-14"></FilterOption><FilterOption count="319" label="2019-05-16"></FilterOption><FilterOption count="315" label="2019-05-30"></FilterOption><FilterOption count="315" label="2019-06-11"></FilterOption><FilterOption count="314" label="2018-06-02"></FilterOption><FilterOption count="312" label="2018-11-20"></FilterOption><FilterOption count="309" label="2017-08-03"></FilterOption><FilterOption count="300" label="2019-06-17"></FilterOption><FilterOption count="298" label="2018-11-29"></FilterOption><FilterOption count="298" label="2019-05-22"></FilterOption><FilterOption count="296" label="2017-03-30"></FilterOption><FilterOption count="295" label="2018-12-12"></FilterOption><FilterOption count="295" label="2019-06-03"></FilterOption><FilterOption count="294" label="2019-04-23"></FilterOption><FilterOption count="287" label="2014-03-25"></FilterOption><FilterOption count="287" label="2019-05-27"></FilterOption><FilterOption count="286" label="2019-05-23"></FilterOption><FilterOption count="285" label="2018-05-26"></FilterOption><FilterOption count="280" label="2018-05-23"></FilterOption><FilterOption count="280" label="2019-05-21"></FilterOption><FilterOption count="278" label="2019-05-17"></FilterOption><FilterOption count="276" label="2018-12-17"></FilterOption><FilterOption count="275" label="2019-06-04"></FilterOption><FilterOption count="274" label="2019-05-10"></FilterOption><FilterOption count="273" label="2018-12-05"></FilterOption><FilterOption count="270" label="2019-04-09"></FilterOption><FilterOption count="269" label="2018-12-10"></FilterOption><FilterOption count="267" label="2018-05-12"></FilterOption><FilterOption count="261" label="2019-04-24"></FilterOption><FilterOption count="259" label="2019-04-05"></FilterOption><FilterOption count="256" label="2018-05-29"></FilterOption><FilterOption count="255" label="2018-11-27"></FilterOption><FilterOption count="253" label="2019-05-07"></FilterOption><FilterOption count="249" label="2018-12-06"></FilterOption><FilterOption count="247" label="2016-09-14"></FilterOption><FilterOption count="246" label="2018-12-13"></FilterOption><FilterOption count="246" label="2018-12-20"></FilterOption><FilterOption count="242" label="2018-12-11"></FilterOption><FilterOption count="241" label="2018-05-19"></FilterOption><FilterOption count="240" label="2018-12-14"></FilterOption><FilterOption count="238" label="2019-04-12"></FilterOption><FilterOption count="238" label="2019-05-13"></FilterOption><FilterOption count="238" label="2019-06-24"></FilterOption><FilterOption count="237" label="2018-12-19"></FilterOption><FilterOption count="236" label="2019-04-11"></FilterOption><FilterOption count="230" label="2019-05-29"></FilterOption><FilterOption count="227" label="2019-03-14"></FilterOption><FilterOption count="225" label="2018-12-18"></FilterOption><FilterOption count="225" label="2019-05-02"></FilterOption><FilterOption count="224" label="2019-05-08"></FilterOption><FilterOption count="220" label="2018-04-28"></FilterOption><FilterOption count="220" label="2019-04-25"></FilterOption><FilterOption count="219" label="2018-07-06"></FilterOption><FilterOption count="219" label="2018-07-11"></FilterOption><FilterOption count="218" label="2018-01-28"></FilterOption><FilterOption count="217" label="2019-04-26"></FilterOption><FilterOption count="216" label="2019-04-10"></FilterOption><FilterOption count="215" label="2018-05-09"></FilterOption></Filter><Filter label="Trial Date End By Month" name="trialDateEndByMonth" total="100"><FilterOption count="2475" label="201912"></FilterOption><FilterOption count="2037" label="202012"></FilterOption><FilterOption count="1691" label="201812"></FilterOption><FilterOption count="1276" label="201712"></FilterOption><FilterOption count="1076" label="202112"></FilterOption><FilterOption count="1069" label="201612"></FilterOption><FilterOption count="952" label="201906"></FilterOption><FilterOption count="950" label="202006"></FilterOption><FilterOption count="856" label="201512"></FilterOption><FilterOption count="836" label="201412"></FilterOption><FilterOption count="727" label="201312"></FilterOption><FilterOption count="726" label="202001"></FilterOption><FilterOption count="714" label="201909"></FilterOption><FilterOption count="705" label="202003"></FilterOption><FilterOption count="691" label="201212"></FilterOption><FilterOption count="651" label="201706"></FilterOption><FilterOption count="641" label="201806"></FilterOption><FilterOption count="635" label="201907"></FilterOption><FilterOption count="633" label="202212"></FilterOption><FilterOption count="632" label="201910"></FilterOption><FilterOption count="628" label="201903"></FilterOption><FilterOption count="619" label="202007"></FilterOption><FilterOption count="613" label="202005"></FilterOption><FilterOption count="605" label="201908"></FilterOption><FilterOption count="601" label="201803"></FilterOption><FilterOption count="597" label="201809"></FilterOption><FilterOption count="588" label="201606"></FilterOption><FilterOption count="585" label="202009"></FilterOption><FilterOption count="582" label="201112"></FilterOption><FilterOption count="582" label="201807"></FilterOption><FilterOption count="576" label="201901"></FilterOption><FilterOption count="571" label="202106"></FilterOption><FilterOption count="563" label="201703"></FilterOption><FilterOption count="552" label="201905"></FilterOption><FilterOption count="552" label="202004"></FilterOption><FilterOption count="551" label="201805"></FilterOption><FilterOption count="547" label="201810"></FilterOption><FilterOption count="545" label="201904"></FilterOption><FilterOption count="537" label="202008"></FilterOption><FilterOption count="536" label="201808"></FilterOption><FilterOption count="531" label="201012"></FilterOption><FilterOption count="528" label="201506"></FilterOption><FilterOption count="517" label="200912"></FilterOption><FilterOption count="514" label="201801"></FilterOption><FilterOption count="500" label="201603"></FilterOption><FilterOption count="500" label="201707"></FilterOption><FilterOption count="497" label="201811"></FilterOption><FilterOption count="490" label="201609"></FilterOption><FilterOption count="490" label="201709"></FilterOption><FilterOption count="488" label="201710"></FilterOption><FilterOption count="485" label="202103"></FilterOption><FilterOption count="482" label="201911"></FilterOption><FilterOption count="480" label="202101"></FilterOption><FilterOption count="475" label="201704"></FilterOption><FilterOption count="468" label="201306"></FilterOption><FilterOption count="467" label="201804"></FilterOption><FilterOption count="467" label="202010"></FilterOption><FilterOption count="465" label="201701"></FilterOption><FilterOption count="458" label="201708"></FilterOption><FilterOption count="458" label="201711"></FilterOption><FilterOption count="458" label="202002"></FilterOption><FilterOption count="445" label="201406"></FilterOption><FilterOption count="445" label="201601"></FilterOption><FilterOption count="443" label="201503"></FilterOption><FilterOption count="443" label="201607"></FilterOption><FilterOption count="441" label="201902"></FilterOption><FilterOption count="440" label="201206"></FilterOption><FilterOption count="439" label="201705"></FilterOption><FilterOption count="434" label="202011"></FilterOption><FilterOption count="432" label="201410"></FilterOption><FilterOption count="430" label="201510"></FilterOption><FilterOption count="430" label="201604"></FilterOption><FilterOption count="428" label="201608"></FilterOption><FilterOption count="425" label="200812"></FilterOption><FilterOption count="423" label="201605"></FilterOption><FilterOption count="422" label="201610"></FilterOption><FilterOption count="417" label="201409"></FilterOption><FilterOption count="416" label="201802"></FilterOption><FilterOption count="415" label="201508"></FilterOption><FilterOption count="413" label="201403"></FilterOption><FilterOption count="413" label="201611"></FilterOption><FilterOption count="410" label="201407"></FilterOption><FilterOption count="408" label="201305"></FilterOption><FilterOption count="408" label="201404"></FilterOption><FilterOption count="406" label="201405"></FilterOption><FilterOption count="405" label="201303"></FilterOption><FilterOption count="405" label="201501"></FilterOption><FilterOption count="405" label="201507"></FilterOption><FilterOption count="402" label="202107"></FilterOption><FilterOption count="398" label="201210"></FilterOption><FilterOption count="396" label="201509"></FilterOption><FilterOption count="394" label="201702"></FilterOption><FilterOption count="392" label="201203"></FilterOption><FilterOption count="386" label="201201"></FilterOption><FilterOption count="386" label="201505"></FilterOption><FilterOption count="385" label="201309"></FilterOption><FilterOption count="382" label="202109"></FilterOption><FilterOption count="379" label="201106"></FilterOption><FilterOption count="374" label="201310"></FilterOption><FilterOption count="371" label="201006"></FilterOption></Filter><Filter label="Trial Date Start By Month" name="trialDateStartByMonth" total="100"><FilterOption count="1071" label="201906"></FilterOption><FilterOption count="1068" label="201901"></FilterOption><FilterOption count="1009" label="201801"></FilterOption><FilterOption count="997" label="201701"></FilterOption><FilterOption count="944" label="201601"></FilterOption><FilterOption count="943" label="201810"></FilterOption><FilterOption count="906" label="201903"></FilterOption><FilterOption count="900" label="201812"></FilterOption><FilterOption count="898" label="201803"></FilterOption><FilterOption count="895" label="201806"></FilterOption><FilterOption count="889" label="201501"></FilterOption><FilterOption count="888" label="201905"></FilterOption><FilterOption count="887" label="201712"></FilterOption><FilterOption count="877" label="201904"></FilterOption><FilterOption count="873" label="201710"></FilterOption><FilterOption count="852" label="201707"></FilterOption><FilterOption count="847" label="201703"></FilterOption><FilterOption count="841" label="201809"></FilterOption><FilterOption count="835" label="201711"></FilterOption><FilterOption count="833" label="201807"></FilterOption><FilterOption count="827" label="201804"></FilterOption><FilterOption count="822" label="201609"></FilterOption><FilterOption count="822" label="201706"></FilterOption><FilterOption count="822" label="201808"></FilterOption><FilterOption count="820" label="201611"></FilterOption><FilterOption count="817" label="201805"></FilterOption><FilterOption count="810" label="201603"></FilterOption><FilterOption count="802" label="201606"></FilterOption><FilterOption count="796" label="201709"></FilterOption><FilterOption count="793" label="201612"></FilterOption><FilterOption count="793" label="201705"></FilterOption><FilterOption count="793" label="201811"></FilterOption><FilterOption count="790" label="201401"></FilterOption><FilterOption count="789" label="201610"></FilterOption><FilterOption count="775" label="201506"></FilterOption><FilterOption count="774" label="201708"></FilterOption><FilterOption count="766" label="201802"></FilterOption><FilterOption count="764" label="201604"></FilterOption><FilterOption count="757" label="201608"></FilterOption><FilterOption count="753" label="201704"></FilterOption><FilterOption count="752" label="201510"></FilterOption><FilterOption count="749" label="201605"></FilterOption><FilterOption count="739" label="201201"></FilterOption><FilterOption count="738" label="201503"></FilterOption><FilterOption count="731" label="201512"></FilterOption><FilterOption count="726" label="201504"></FilterOption><FilterOption count="718" label="201509"></FilterOption><FilterOption count="710" label="201505"></FilterOption><FilterOption count="710" label="201507"></FilterOption><FilterOption count="703" label="201511"></FilterOption><FilterOption count="701" label="201902"></FilterOption><FilterOption count="700" label="201607"></FilterOption><FilterOption count="697" label="201702"></FilterOption><FilterOption count="692" label="201101"></FilterOption><FilterOption count="690" label="201602"></FilterOption><FilterOption count="689" label="201301"></FilterOption><FilterOption count="674" label="201410"></FilterOption><FilterOption count="671" label="201001"></FilterOption><FilterOption count="669" label="201210"></FilterOption><FilterOption count="663" label="201207"></FilterOption><FilterOption count="663" label="201309"></FilterOption><FilterOption count="641" label="201206"></FilterOption><FilterOption count="639" label="201103"></FilterOption><FilterOption count="636" label="201412"></FilterOption><FilterOption count="630" label="201310"></FilterOption><FilterOption count="624" label="201109"></FilterOption><FilterOption count="624" label="201409"></FilterOption><FilterOption count="623" label="201304"></FilterOption><FilterOption count="620" label="200901"></FilterOption><FilterOption count="619" label="201203"></FilterOption><FilterOption count="619" label="201205"></FilterOption><FilterOption count="613" label="201303"></FilterOption><FilterOption count="610" label="201204"></FilterOption><FilterOption count="608" label="201307"></FilterOption><FilterOption count="606" label="201208"></FilterOption><FilterOption count="605" label="201502"></FilterOption><FilterOption count="604" label="200909"></FilterOption><FilterOption count="601" label="201403"></FilterOption><FilterOption count="599" label="201212"></FilterOption><FilterOption count="599" label="201907"></FilterOption><FilterOption count="598" label="201404"></FilterOption><FilterOption count="597" label="201311"></FilterOption><FilterOption count="596" label="201106"></FilterOption><FilterOption count="593" label="201006"></FilterOption><FilterOption count="592" label="201209"></FilterOption><FilterOption count="591" label="201411"></FilterOption><FilterOption count="588" label="201508"></FilterOption><FilterOption count="583" label="201305"></FilterOption><FilterOption count="582" label="200801"></FilterOption><FilterOption count="581" label="201312"></FilterOption><FilterOption count="579" label="201306"></FilterOption><FilterOption count="577" label="201110"></FilterOption><FilterOption count="576" label="201010"></FilterOption><FilterOption count="573" label="201107"></FilterOption><FilterOption count="569" label="201211"></FilterOption><FilterOption count="567" label="201111"></FilterOption><FilterOption count="565" label="201405"></FilterOption><FilterOption count="561" label="201407"></FilterOption><FilterOption count="560" label="201004"></FilterOption><FilterOption count="559" label="201009"></FilterOption></Filter><Filter label="Trial Phase" name="trialPhase" total="15"><FilterOption id="C2" count="39989" label="Phase 2 Clinical"></FilterOption><FilterOption id="C1" count="19119" label="Phase 1 Clinical"></FilterOption><FilterOption id="PNA" count="18451" label="Phase Not Applicable"></FilterOption><FilterOption id="C3" count="16195" label="Phase 3 Clinical"></FilterOption><FilterOption id="NS" count="14306" label="Phase not specified"></FilterOption><FilterOption id="C4" count="10423" label="Phase 4 Clinical"></FilterOption><FilterOption id="C12" count="9195" label="Phase 1/Phase 2 Clinical"></FilterOption><FilterOption id="C23" count="2410" label="Phase 2/Phase 3 Clinical"></FilterOption><FilterOption id="C1B" count="1614" label="Phase 1b Clinical"></FilterOption><FilterOption id="C2A" count="1072" label="Phase 2a Clinical"></FilterOption><FilterOption id="C0" count="1071" label="Phase 0 Clinical"></FilterOption><FilterOption id="C2B" count="924" label="Phase 2b Clinical"></FilterOption><FilterOption id="C3B" count="484" label="Phase 3b Clinical"></FilterOption><FilterOption id="C1A" count="164" label="Phase 1a Clinical"></FilterOption><FilterOption id="C3A" count="57" label="Phase 3a Clinical"></FilterOption></Filter><Filter label="Inclusion Criteria Index" name="trialInclusionCriteriaIndex" total="100"><FilterOption id="3976" count="5649" label="Lung tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"></FilterOption><FilterOption id="3977" count="5635" label="Lung tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"></FilterOption><FilterOption id="3900" count="5593" label="Lung tumor - Subjects with Non Small Cell Lung Cancer (NSCLC)"></FilterOption><FilterOption id="3957" count="5344" label="Lung tumor - Subjects Confirmed of Lung Cancer by Specific Modes - Subjects with cytologically/histologically confirmed diagnosis of lung cancer"></FilterOption><FilterOption id="4879" count="4720" label="Breast tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"></FilterOption><FilterOption id="4880" count="4706" label="Breast tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"></FilterOption><FilterOption id="4024" count="4361" label="Lung tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable liver function"></FilterOption><FilterOption id="4032" count="4207" label="Lung tumor - Subjects with Protocol Specified Renal Function - Subjects with normal/acceptable renal function"></FilterOption><FilterOption id="3936" count="4181" label="Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with stage IV lung cancer"></FilterOption><FilterOption id="4074" count="4176" label="Lung tumor - Subjects with Protocol Specified Compliance Status - Subjects able to comply with the study protocol procedures/ requirements"></FilterOption><FilterOption id="13096" count="4139" label="Solid tumor - Subjects with Advanced/Metastatic Cancer"></FilterOption><FilterOption id="4840" count="4068" label="Breast tumor - Subjects with Advanced/Metastatic Cancer"></FilterOption><FilterOption id="3940" count="3758" label="Lung tumor - Subjects with Advanced/Metastatic Cancer"></FilterOption><FilterOption id="3537" count="3559" label="Lymphoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"></FilterOption><FilterOption id="3538" count="3558" label="Lymphoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"></FilterOption><FilterOption id="4483" count="3448" label="Colorectal tumor - Subjects with Advanced/Metastatic Cancer"></FilterOption><FilterOption id="4527" count="3385" label="Colorectal tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"></FilterOption><FilterOption id="4528" count="3372" label="Colorectal tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"></FilterOption><FilterOption id="13129" count="3350" label="Solid tumor - Subjects with Treatment Refractory Disease"></FilterOption><FilterOption id="3622" count="3210" label="Lymphoma - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable liver function"></FilterOption><FilterOption id="22381" count="3204" label="Lung tumor - Protocol Specified Other Inclusion Criteria - Protocol specified inclusion criteria for females"></FilterOption><FilterOption id="5087" count="3203" label="Leukemia - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"></FilterOption><FilterOption id="5086" count="3202" label="Leukemia - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"></FilterOption><FilterOption id="5073" count="3192" label="Leukemia - Subjects with Normal/Acceptable Organ Function - Subjects with normal/adequate liver function"></FilterOption><FilterOption id="3938" count="3180" label="Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with advanced stage lung cancer"></FilterOption><FilterOption id="4073" count="3171" label="Lung tumor - Protocol Specified Other Inclusion Criteria"></FilterOption><FilterOption id="3628" count="3107" label="Lymphoma - Subjects with Protocol Specified Renal Function - Subjects with normal/acceptable renal function"></FilterOption><FilterOption id="4509" count="3101" label="Colorectal tumor - Subjects with Histologically Confirmed Colorectal Cancer"></FilterOption><FilterOption id="584" count="3075" label="Non-insulin dependent diabetes - Subjects with Diabetes Mellitus - Subjects with type 2 diabetes mellitus"></FilterOption><FilterOption id="5074" count="3074" label="Leukemia - Subjects with Protocol Specified Renal Function - Subjects with normal/acceptable renal function"></FilterOption><FilterOption id="13110" count="2860" label="Solid tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"></FilterOption><FilterOption id="13111" count="2856" label="Solid tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"></FilterOption><FilterOption id="4569" count="2826" label="Colorectal tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable hematopoetic/marrow function"></FilterOption><FilterOption id="3548" count="2826" label="Lymphoma - Subjects Diagnosed Based on Histo-Pathological Examination"></FilterOption><FilterOption id="5088" count="2805" label="Leukemia - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 2"></FilterOption><FilterOption id="4564" count="2784" label="Colorectal tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable liver function"></FilterOption><FilterOption id="3642" count="2757" label="Lymphoma - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable hematological functions"></FilterOption><FilterOption id="3539" count="2742" label="Lymphoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 2"></FilterOption><FilterOption id="13377" count="2739" label="Cancer supportive care - Subjects with Protocol Specified Participation Status - Subjects willing/able to provide informed consent/assent"></FilterOption><FilterOption id="3978" count="2728" label="Lung tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 2"></FilterOption><FilterOption id="4981" count="2672" label="Leukemia - Subjects with Acute Myeloid Leukemia (AML)"></FilterOption><FilterOption id="4565" count="2668" label="Colorectal tumor - Subjects with Protocol Specified Renal Function - Subjects with normal/acceptable renal function"></FilterOption><FilterOption id="3971" count="2648" label="Lung tumor - Subjects with Protocol Specified Life Expectancy - Subjects with life expectancy of three months or more"></FilterOption><FilterOption id="4106" count="2495" label="Lung tumor - Subjects with Protocol Specified Reproductive Status - Men with adequate contraception"></FilterOption><FilterOption id="3989" count="2460" label="Lung tumor - Subjects with History of Anti Cancer Therapy - Subjects with history of anti-cancer chemotherapy"></FilterOption><FilterOption id="32043" count="2460" label="Lung tumor - Subjects with Protocol Specified Participation Status - Subjects able/willing to provide written informed consent"></FilterOption><FilterOption id="13369" count="2433" label="Cancer supportive care - Protocol Specified Other Inclusion Criteria"></FilterOption><FilterOption id="3933" count="2414" label="Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with stage III lung cancer"></FilterOption><FilterOption id="3464" count="2404" label="Lymphoma - Subjects with B Cell Non Hodgkin's Lymphoma"></FilterOption><FilterOption id="7091" count="2394" label="Prostate tumor - Subjects with Advanced/Metastatic Cancer"></FilterOption><FilterOption id="4955" count="2374" label="Breast tumor - Subjects with Protocol Specified Participation Status - Subjects willing/able to provide informed consent/assent"></FilterOption><FilterOption id="4467" count="2356" label="Colorectal tumor - Subjects with Rectal Cancer"></FilterOption><FilterOption id="3935" count="2355" label="Lung tumor - Subjects with Protocol Specified Stages of Lung Cancer(TNM staging) - Subjects with stage IIIB lung cancer"></FilterOption><FilterOption id="4881" count="2348" label="Breast tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 2"></FilterOption><FilterOption id="4877" count="2291" label="Breast tumor - Subjects with Protocol Specified Life Expectancy"></FilterOption><FilterOption id="13131" count="2285" label="Solid tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable hematological functions"></FilterOption><FilterOption id="3914" count="2275" label="Lung tumor - Subjects with Measurable Disease - Subjects with measurable disease as per RECIST criteria"></FilterOption><FilterOption id="4894" count="2227" label="Breast tumor - Subjects with History of Anti Cancer Therapy - Subjects with history of anti-cancer chemotherapy"></FilterOption><FilterOption id="4468" count="2214" label="Colorectal tumor - Subjects with Colon Cancer"></FilterOption><FilterOption id="13132" count="2207" label="Solid tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable liver function"></FilterOption><FilterOption id="3614" count="2157" label="Lymphoma - Subjects with Progressive/Treatment Refractory Disease"></FilterOption><FilterOption id="13133" count="2140" label="Solid tumor - Subjects with Protocol Specified Renal Function - Subjects with normal/acceptable renal function"></FilterOption><FilterOption id="3738" count="2135" label="Prostate tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod status 0-2"></FilterOption><FilterOption id="22417" count="2074" label="Breast tumor - Subjects with Locally Advanced Cancer/Tumor"></FilterOption><FilterOption id="17850" count="2034" label="Stem cell transplantation - Subjects with History of/Indicated for Hematopoietic Stem Cell Transplantation(HSCT)"></FilterOption><FilterOption id="4398" count="2008" label="Head and neck tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"></FilterOption><FilterOption id="4397" count="2007" label="Head and neck tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"></FilterOption><FilterOption id="4973" count="1960" label="Leukemia - Subjects with Acute Leukemia Unspecified Type"></FilterOption><FilterOption id="3987" count="1919" label="Lung tumor - Treatment Naive Subjects"></FilterOption><FilterOption id="22262" count="1903" label="Pain - Protocol Specified Other Inclusion Criteria"></FilterOption><FilterOption id="3609" count="1896" label="Lymphoma - Subjects with Relapsed/Recurrent Disease"></FilterOption><FilterOption id="3695" count="1888" label="Prostate tumor - Subjects with Stage IV Prostate Cancer"></FilterOption><FilterOption id="3913" count="1845" label="Lung tumor - Subjects with Measurable Disease"></FilterOption><FilterOption id="3561" count="1844" label="Lymphoma - Subjects with History of Anti Cancer Therapy - Subjects with history of anti-cancer chemotherapy"></FilterOption><FilterOption id="4545" count="1836" label="Colorectal tumor - Subjects with History of Anti Cancer Therapy - Subjects with history of anti-cancer chemotherapy"></FilterOption><FilterOption id="3726" count="1812" label="Prostate tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable liver function"></FilterOption><FilterOption id="4985" count="1782" label="Leukemia - Subjects with Acute Lymphocytic Leukemia (ALL)"></FilterOption><FilterOption id="4416" count="1781" label="Head and neck tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable hematological functions"></FilterOption><FilterOption id="3994" count="1778" label="Lung tumor - Subjects with History of Anti Cancer Therapy - Subjects with history of anti-cancer radiotherapy"></FilterOption><FilterOption id="3724" count="1777" label="Prostate tumor - Subjects with acceptable hematological value"></FilterOption><FilterOption id="5164" count="1761" label="Leukemia - Subjects with Progressive/Treatment Refractory Disease"></FilterOption><FilterOption id="4041" count="1761" label="Lung tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable hematological functions"></FilterOption><FilterOption id="4893" count="1758" label="Breast tumor - Subjects with History of Anti Cancer Therapy"></FilterOption><FilterOption id="3727" count="1750" label="Prostate tumor - Subjects with Protocol Specified Renal Function - Subjects with normal/acceptable renal function"></FilterOption><FilterOption id="3715" count="1743" label="Prostate tumor - Subjects with Histologically/Cytologically Confirmed Prostate Cancer - Subjects with adenocarcinoma of prostate"></FilterOption><FilterOption id="3465" count="1734" label="Lymphoma - Subjects with T Cell Non Hodgkin's Lymphoma"></FilterOption><FilterOption id="4856" count="1731" label="Breast tumor - Subjects with Measurable Disease"></FilterOption><FilterOption id="5102" count="1723" label="Leukemia - Subjects with History of Anti Cancer Therapy - Subjects with history of anti-cancer chemotherapy"></FilterOption><FilterOption id="4922" count="1720" label="Breast tumor - Subjects with Progressive/Treatment Refractory Disease"></FilterOption><FilterOption id="7864" count="1705" label="Hepatobiliary system tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"></FilterOption><FilterOption id="13138" count="1704" label="Solid tumor - Subjects with Protocol Specified Participation Status - Subjects willing/able to provide informed consent/assent"></FilterOption><FilterOption id="8835" count="1688" label="Pancreas tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"></FilterOption><FilterOption id="5173" count="1687" label="Leukemia - Subjects with Relapsed/Recurrent Disease"></FilterOption><FilterOption id="8836" count="1687" label="Pancreas tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"></FilterOption><FilterOption id="4169" count="1684" label="Melanoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 0"></FilterOption><FilterOption id="4417" count="1682" label="Head and neck tumor - Subjects with Normal/Acceptable Organ Function - Subjects with normal/acceptable liver function"></FilterOption><FilterOption id="4419" count="1677" label="Head and neck tumor - Subjects with Protocol Specified Renal Function - Subjects with normal/acceptable renal function"></FilterOption><FilterOption id="4170" count="1674" label="Melanoma - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"></FilterOption><FilterOption id="7865" count="1673" label="Hepatobiliary system tumor - Subjects with Protocol Specified Performance Status - Subjects with ECOG/WHO/Zubrod score performance status of 1"></FilterOption><FilterOption id="4794" count="1667" label="Head and neck tumor - Subjects with Specific Histological Sub-type of Head and Neck Cancer - Subjects with squamous cell head and neck carcinoma"></FilterOption></Filter><Filter label="Trial Interventions Control Alone Name Display" name="trialInterventionsControlAloneNameDisplay" total="100"><FilterOption id="2953" count="226" label="docetaxel"></FilterOption><FilterOption id="3199" count="180" label="gemcitabine"></FilterOption><FilterOption id="3803" count="154" label="paclitaxel"></FilterOption><FilterOption id="12205" count="140" label="capecitabine"></FilterOption><FilterOption id="6050" count="101" label="metformin hydrochloride"></FilterOption><FilterOption id="29831" count="83" label="sorafenib"></FilterOption><FilterOption id="4529" count="82" label="temozolomide"></FilterOption><FilterOption id="8047" count="66" label="bevacizumab"></FilterOption><FilterOption id="6736" count="65" label="rituximab"></FilterOption><FilterOption id="2807" count="63" label="atorvastatin"></FilterOption><FilterOption id="11961" count="60" label="erlotinib"></FilterOption><FilterOption id="44314" count="58" label="tamoxifen"></FilterOption><FilterOption id="8165" count="58" label="tiotropium bromide"></FilterOption><FilterOption id="11460" count="57" label="imatinib"></FilterOption><FilterOption id="10252" count="57" label="insulin glargine"></FilterOption><FilterOption id="14163" count="54" label="adalimumab"></FilterOption><FilterOption id="4510" count="54" label="tacrolimus"></FilterOption><FilterOption id="70667" count="49" label="pembrolizumab"></FilterOption><FilterOption id="48945" count="48" label="bupivacaine, AstraZeneca"></FilterOption><FilterOption id="3536" count="48" label="pemetrexed disodium"></FilterOption><FilterOption id="2784" count="47" label="letrozole"></FilterOption><FilterOption id="5267" count="46" label="leuprorelin acetate"></FilterOption><FilterOption id="7934" count="45" label="doxorubicin (liposomal, STEALTH), Alza"></FilterOption><FilterOption id="21374" count="45" label="pegfilgrastim"></FilterOption><FilterOption id="3313" count="44" label="fulvestrant"></FilterOption><FilterOption id="2871" count="44" label="irinotecan"></FilterOption><FilterOption id="12978" count="43" label="moxifloxacin"></FilterOption><FilterOption id="2836" count="42" label="clopidogrel"></FilterOption><FilterOption id="44375" count="42" label="warfarin"></FilterOption><FilterOption id="11603" count="41" label="gefitinib"></FilterOption><FilterOption id="12973" count="41" label="sunitinib"></FilterOption><FilterOption id="6408" count="40" label="vinorelbine"></FilterOption><FilterOption id="3130" count="39" label="filgrastim"></FilterOption><FilterOption id="14336" count="39" label="fluticasone propionate + salmeterol (asthma and COPD), GlaxoSmithKline"></FilterOption><FilterOption id="6386" count="39" label="trastuzumab"></FilterOption><FilterOption id="3321" count="38" label="anastrozole"></FilterOption><FilterOption id="44409" count="38" label="Fluzone"></FilterOption><FilterOption id="4513" count="37" label="tamsulosin hydrochloride"></FilterOption><FilterOption id="2500" count="36" label="amlodipine"></FilterOption><FilterOption id="12135" count="36" label="celecoxib"></FilterOption><FilterOption id="4577" count="36" label="topotecan"></FilterOption><FilterOption id="13486" count="35" label="entecavir"></FilterOption><FilterOption id="6140" count="35" label="formoterol"></FilterOption><FilterOption id="54804" count="34" label="nivolumab"></FilterOption><FilterOption id="13928" count="33" label="enoxaparin sodium"></FilterOption><FilterOption id="14493" count="33" label="tenofovir disoproxil fumarate"></FilterOption><FilterOption id="10084" count="32" label="tegafur + gimeracil + oteracil potassium"></FilterOption><FilterOption id="10388" count="31" label="cetuximab"></FilterOption><FilterOption id="44305" count="31" label="omeprazole"></FilterOption><FilterOption id="3750" count="31" label="ondansetron"></FilterOption><FilterOption id="37370" count="30" label="azacitidine"></FilterOption><FilterOption id="3081" count="30" label="exemestane"></FilterOption><FilterOption id="7286" count="30" label="goserelin acetate"></FilterOption><FilterOption id="8832" count="29" label="glimepiride"></FilterOption><FilterOption id="4271" count="29" label="ropivacaine"></FilterOption><FilterOption id="44499" count="29" label="sitagliptin"></FilterOption><FilterOption id="27572" count="28" label="lenalidomide"></FilterOption><FilterOption id="44403" count="28" label="lidocaine"></FilterOption><FilterOption id="29016" count="28" label="paclitaxel (albumin-bound nanoparticle, intravenous), Celgene"></FilterOption><FilterOption id="44312" count="28" label="salmeterol"></FilterOption><FilterOption id="44313" count="28" label="simvastatin"></FilterOption><FilterOption id="2765" count="28" label="zoledronic acid"></FilterOption><FilterOption id="4567" count="27" label="etanercept"></FilterOption><FilterOption id="44401" count="27" label="vancomycin"></FilterOption><FilterOption id="16026" count="26" label="esomeprazole"></FilterOption><FilterOption id="7413" count="25" label="darbepoetin alfa"></FilterOption><FilterOption id="22395" count="25" label="ranibizumab"></FilterOption><FilterOption id="13340" count="24" label="everolimus"></FilterOption><FilterOption id="44383" count="23" label="carboplatin"></FilterOption><FilterOption id="5148" count="23" label="liraglutide"></FilterOption><FilterOption id="44303" count="23" label="midazolam hydrochloride"></FilterOption><FilterOption id="4126" count="23" label="pioglitazone"></FilterOption><FilterOption id="44308" count="23" label="propofol, AstraZeneca/Fresenius"></FilterOption><FilterOption id="3492" count="22" label="levofloxacin"></FilterOption><FilterOption id="17814" count="22" label="pregabalin"></FilterOption><FilterOption id="3311" count="21" label="bicalutamide"></FilterOption><FilterOption id="3159" count="21" label="fluticasone propionate"></FilterOption><FilterOption id="6850" count="21" label="infliximab"></FilterOption><FilterOption id="3517" count="21" label="losartan"></FilterOption><FilterOption id="3669" count="21" label="mycophenolate mofetil"></FilterOption><FilterOption id="7607" count="20" label="follitropin alfa"></FilterOption><FilterOption id="3353" count="20" label="insulin lispro"></FilterOption><FilterOption id="6104" count="20" label="lansoprazole"></FilterOption><FilterOption id="5800" count="20" label="pantoprazole"></FilterOption><FilterOption id="43738" count="20" label="pazopanib"></FilterOption><FilterOption id="2773" count="20" label="valsartan"></FilterOption><FilterOption id="10411" count="19" label="insulin aspart"></FilterOption><FilterOption id="13460" count="19" label="oseltamivir"></FilterOption><FilterOption id="67892" count="18" label="epoetin alfa (Procrit/Eprex), Johnson &amp; Johnson"></FilterOption><FilterOption id="44292" count="18" label="fluconazole"></FilterOption><FilterOption id="3616" count="18" label="meropenem"></FilterOption><FilterOption id="23625" count="18" label="peginterferon alfa-2a"></FilterOption><FilterOption id="12420" count="18" label="rosuvastatin"></FilterOption><FilterOption id="6893" count="17" label="alteplase"></FilterOption><FilterOption id="53981" count="17" label="enzalutamide"></FilterOption><FilterOption id="7080" count="17" label="Pneumovax 23"></FilterOption><FilterOption id="4579" count="17" label="tramadol hydrochloride"></FilterOption><FilterOption id="72699" count="16" label="atezolizumab"></FilterOption><FilterOption id="36630" count="16" label="ipilimumab"></FilterOption><FilterOption id="54624" count="16" label="regorafenib"></FilterOption></Filter><Filter label="Trial Actions Primary Interventions Control" name="trialActionsPrimaryInterventionsControl" total="100"><FilterOption id="372" count="532" label="Thymidylate synthase inhibitor"></FilterOption><FilterOption id="142" count="394" label="Topoisomerase II inhibitor"></FilterOption><FilterOption id="138" count="273" label="DNA polymerase inhibitor"></FilterOption><FilterOption id="3808" count="258" label="Kit tyrosine kinase inhibitor"></FilterOption><FilterOption id="141" count="244" label="Topoisomerase I inhibitor"></FilterOption><FilterOption id="3848" count="242" label="VEGF-2 receptor antagonist"></FilterOption><FilterOption id="5085" count="234" label="B-lymphocyte antigen CD20 inhibitor"></FilterOption><FilterOption id="740" count="233" label="Epidermal growth factor receptor antagonist"></FilterOption><FilterOption id="12521" count="228" label="VEGF ligand inhibitor"></FilterOption><FilterOption id="8805" count="227" label="AMP activated protein kinase stimulator"></FilterOption><FilterOption id="3846" count="224" label="VEGF-1 receptor antagonist"></FilterOption><FilterOption id="135" count="207" label="DHFR inhibitor"></FilterOption><FilterOption id="374" count="198" label="Transferase inhibitor"></FilterOption><FilterOption id="3850" count="197" label="VEGF-3 receptor antagonist"></FilterOption><FilterOption id="181" count="195" label="GAR transformylase inhibitor"></FilterOption><FilterOption id="23014" count="195" label="Insulin ligand"></FilterOption><FilterOption id="400" count="195" label="Insulin receptor agonist"></FilterOption><FilterOption id="40" count="187" label="Beta 2 adrenoceptor agonist"></FilterOption><FilterOption id="948" count="187" label="PDGF receptor antagonist"></FilterOption><FilterOption id="3756" count="186" label="Erbb2 tyrosine kinase receptor inhibitor"></FilterOption><FilterOption id="4010" count="179" label="Calcineurin inhibitor"></FilterOption><FilterOption id="208" count="178" label="H+ K+ ATPase inhibitor"></FilterOption><FilterOption id="48492" count="174" label="PDGF receptor beta antagonist"></FilterOption><FilterOption id="205" count="159" label="HMG CoA reductase inhibitor"></FilterOption><FilterOption id="3816" count="159" label="RET tyrosine kinase receptor family inhibitor"></FilterOption><FilterOption id="82444" count="151" label="DNA helicase inhibitor"></FilterOption><FilterOption id="3806" count="151" label="Flt3 tyrosine kinase inhibitor"></FilterOption><FilterOption id="498" count="150" label="Sodium channel inhibitor"></FilterOption><FilterOption id="1016" count="146" label="HIV-1 reverse transcriptase inhibitor"></FilterOption><FilterOption id="1722" count="144" label="VEGF receptor antagonist"></FilterOption><FilterOption id="1832" count="143" label="Nucleoside reverse transcriptase inhibitor"></FilterOption><FilterOption id="3754" count="141" label="EGFR family tyrosine kinase receptor inhibitor"></FilterOption><FilterOption id="721" count="139" label="TNF binding agent"></FilterOption><FilterOption id="3151" count="135" label="GCSF receptor agonist"></FilterOption><FilterOption id="76" count="133" label="Aromatase inhibitor"></FilterOption><FilterOption id="286" count="130" label="Estrogen receptor antagonist"></FilterOption><FilterOption id="1092" count="124" label="GNRH receptor agonist"></FilterOption><FilterOption id="15" count="123" label="5-HT 3 receptor antagonist"></FilterOption><FilterOption id="4548" count="122" label="Raf B protein kinase inhibitor"></FilterOption><FilterOption id="629" count="120" label="Inosine monophosphate dehydrogenase inhibitor"></FilterOption><FilterOption id="67136" count="115" label="Programmed cell death protein 1 inhibitor"></FilterOption><FilterOption id="381" count="115" label="TNF alpha ligand inhibitor"></FilterOption><FilterOption id="431" count="114" label="DNA gyrase inhibitor"></FilterOption><FilterOption id="4550" count="110" label="Raf 1 protein kinase inhibitor"></FilterOption><FilterOption id="262" count="106" label="Muscarinic M3 receptor antagonist"></FilterOption><FilterOption id="9320" count="103" label="Topoisomerase IV inhibitor"></FilterOption><FilterOption id="11778" count="102" label="PurH purine biosynthesis protein inhibitor"></FilterOption><FilterOption id="4913" count="101" label="P2Y12 purinoceptor antagonist"></FilterOption><FilterOption id="259" count="94" label="Muscarinic receptor antagonist"></FilterOption><FilterOption id="4542" count="94" label="Raf protein kinase inhibitor"></FilterOption><FilterOption id="64" count="87" label="Angiotensin II receptor antagonist"></FilterOption><FilterOption id="13571" count="86" label="Bcr protein inhibitor"></FilterOption><FilterOption id="3524" count="81" label="Abl tyrosine kinase inhibitor"></FilterOption><FilterOption id="48489" count="81" label="PDGF receptor alpha antagonist"></FilterOption><FilterOption id="782" count="80" label="Dihydropyrimidine dehydrogenase inhibitor"></FilterOption><FilterOption id="6661" count="80" label="Orotate phosphoribosyltransferase inhibitor"></FilterOption><FilterOption id="4917" count="74" label="Proteasome inhibitor"></FilterOption><FilterOption id="346" count="74" label="Ribonucleotide reductase inhibitor"></FilterOption><FilterOption id="261" count="72" label="Muscarinic M1 receptor antagonist"></FilterOption><FilterOption id="51708" count="71" label="DNA polymerase alpha inhibitor"></FilterOption><FilterOption id="6830" count="71" label="DNA primase inhibitor"></FilterOption><FilterOption id="624" count="70" label="Progesterone receptor agonist"></FilterOption><FilterOption id="788" count="68" label="Angiotensin II AT-1 receptor antagonist"></FilterOption><FilterOption id="5537" count="68" label="Dipeptidyl peptidase IV inhibitor"></FilterOption><FilterOption id="111" count="68" label="Factor IIa antagonist"></FilterOption><FilterOption id="60" count="67" label="Androgen receptor antagonist"></FilterOption><FilterOption id="7025" count="64" label="Signal transduction inhibitor"></FilterOption><FilterOption id="293" count="63" label="Opioid receptor mu agonist"></FilterOption><FilterOption id="3154" count="62" label="CSF-1 antagonist"></FilterOption><FilterOption id="76469" count="60" label="26S proteasome complex inhibitor"></FilterOption><FilterOption id="12162" count="59" label="Erythropoietin ligand"></FilterOption><FilterOption id="113" count="57" label="Factor IX antagonist"></FilterOption><FilterOption id="114" count="57" label="Factor VII antagonist"></FilterOption><FilterOption id="119" count="57" label="Factor X antagonist"></FilterOption><FilterOption id="2585" count="57" label="Glucagon-like peptide 1 receptor agonist"></FilterOption><FilterOption id="10583" count="57" label="Vitamin K epoxide reductase inhibitor"></FilterOption><FilterOption id="2588" count="56" label="Calcium channel inhibitor L-type"></FilterOption><FilterOption id="1001" count="56" label="Cyclooxygenase 2 inhibitor"></FilterOption><FilterOption id="214" count="56" label="Interferon alpha 2 ligand"></FilterOption><FilterOption id="204" count="54" label="HIV protease inhibitor"></FilterOption><FilterOption id="814" count="54" label="Tubulin modulator"></FilterOption><FilterOption id="81" count="53" label="Benzodiazepine receptor agonist"></FilterOption><FilterOption id="385" count="48" label="Protein tyrosine kinase inhibitor"></FilterOption><FilterOption id="10240" count="47" label="mTOR inhibitor"></FilterOption><FilterOption id="768" count="46" label="HIV-1 protease inhibitor"></FilterOption><FilterOption id="1919" count="46" label="Insulin sensitizer"></FilterOption><FilterOption id="1833" count="46" label="Non-nucleoside reverse transcriptase inhibitor"></FilterOption><FilterOption id="6909" count="44" label="Alpha 1A adrenoceptor antagonist"></FilterOption><FilterOption id="1741" count="44" label="Low molecular weight heparin"></FilterOption><FilterOption id="132" count="43" label="Cyclooxygenase inhibitor"></FilterOption><FilterOption id="777" count="43" label="Lanosterol-14 demethylase inhibitor"></FilterOption><FilterOption id="66340" count="43" label="Penicillin binding protein inhibitor"></FilterOption><FilterOption id="6512" count="42" label="DNA methyltransferase inhibitor"></FilterOption><FilterOption id="3688" count="42" label="FGF3 receptor antagonist"></FilterOption><FilterOption id="2506" count="42" label="PARP modulator"></FilterOption><FilterOption id="14007" count="42" label="Programmed cell death ligand 1 inhibitor"></FilterOption><FilterOption id="5482" count="41" label="Cytotoxic T-lymphocyte protein-4 inhibitor"></FilterOption><FilterOption id="150" count="41" label="Dopamine D2 receptor antagonist"></FilterOption><FilterOption id="3682" count="41" label="FGF1 receptor antagonist"></FilterOption><FilterOption id="3584" count="41" label="Lck tyrosine kinase inhibitor"></FilterOption></Filter><Filter label="Trial Indications Adverse" name="trialIndicationsAdverse" total="100"><FilterOption id="226" count="7827" label="Nausea"></FilterOption><FilterOption id="829" count="7760" label="Fatigue"></FilterOption><FilterOption id="102" count="7515" label="Diarrhea"></FilterOption><FilterOption id="1991" count="6929" label="Neutropenia"></FilterOption><FilterOption id="110" count="5067" label="Emesis"></FilterOption><FilterOption id="17" count="4903" label="Anemia"></FilterOption><FilterOption id="324" count="4754" label="Thrombocytopenia"></FilterOption><FilterOption id="148" count="3421" label="Headache"></FilterOption><FilterOption id="3038" count="3234" label="Appetite loss"></FilterOption><FilterOption id="3020" count="3188" label="Skin rash"></FilterOption><FilterOption id="1833" count="2721" label="Fever"></FilterOption><FilterOption id="680" count="2461" label="Leukopenia"></FilterOption><FilterOption id="404" count="2195" label="Constipation"></FilterOption><FilterOption id="178" count="1936" label="Hypertension"></FilterOption><FilterOption id="746" count="1709" label="Infectious disease"></FilterOption><FilterOption id="20" count="1682" label="Pain"></FilterOption><FilterOption id="3795" count="1592" label="Febrile neutropenia"></FilterOption><FilterOption id="3062" count="1588" label="Death"></FilterOption><FilterOption id="360" count="1547" label="Pneumonia"></FilterOption><FilterOption id="2400" count="1522" label="Dyspnea"></FilterOption><FilterOption id="3472" count="1227" label="Abdominal pain"></FilterOption><FilterOption id="402" count="1200" label="Edema"></FilterOption><FilterOption id="13" count="1191" label="Alopecia"></FilterOption><FilterOption id="2439" count="1188" label="Arthralgia"></FilterOption><FilterOption id="1263" count="1155" label="Mucositis"></FilterOption><FilterOption id="1016" count="1124" label="Stomatitis"></FilterOption><FilterOption id="82" count="1103" label="Cough"></FilterOption><FilterOption id="279" count="1084" label="Pruritus"></FilterOption><FilterOption id="1992" count="1015" label="Lymphocytopenia"></FilterOption><FilterOption id="1039" count="970" label="Myalgia"></FilterOption><FilterOption id="516" count="932" label="Upper respiratory tract infection"></FilterOption><FilterOption id="2274" count="920" label="Rhinopharyngitis"></FilterOption><FilterOption id="1821" count="911" label="Hyperglycemia"></FilterOption><FilterOption id="3454" count="888" label="Dizziness"></FilterOption><FilterOption id="129" count="830" label="Gastrointestinal disease"></FilterOption><FilterOption id="259" count="825" label="Peripheral neuropathy"></FilterOption><FilterOption id="678" count="808" label="Neuropathy"></FilterOption><FilterOption id="181" count="763" label="Hypokalemia"></FilterOption><FilterOption id="3221" count="761" label="Back pain"></FilterOption><FilterOption id="552" count="722" label="Bleeding"></FilterOption><FilterOption id="1256" count="682" label="Hyponatremia"></FilterOption><FilterOption id="3050" count="627" label="Chill"></FilterOption><FilterOption id="408" count="610" label="Hypotension"></FilterOption><FilterOption id="1009" count="607" label="Urinary tract infection"></FilterOption><FilterOption id="1280" count="557" label="Hypophosphatemia"></FilterOption><FilterOption id="114" count="551" label="Sepsis"></FilterOption><FilterOption id="750" count="525" label="Insomnia"></FilterOption><FilterOption id="277" count="513" label="Proteinuria"></FilterOption><FilterOption id="2955" count="482" label="Weight loss"></FilterOption><FilterOption id="2024" count="442" label="Erythema"></FilterOption><FilterOption id="1078" count="425" label="Lung embolism"></FilterOption><FilterOption id="2576" count="411" label="Dysgeusia"></FilterOption><FilterOption id="1063" count="406" label="Xerostomia"></FilterOption><FilterOption id="432" count="405" label="Dyspepsia"></FilterOption><FilterOption id="2434" count="395" label="Vertigo"></FilterOption><FilterOption id="3073" count="380" label="Drowsiness"></FilterOption><FilterOption id="172" count="376" label="Hyperbilirubinemia"></FilterOption><FilterOption id="201" count="360" label="Liver disease"></FilterOption><FilterOption id="94" count="349" label="Dermatitis"></FilterOption><FilterOption id="95" count="328" label="Dermatological disease"></FilterOption><FilterOption id="505" count="325" label="Hypersensitivity"></FilterOption><FilterOption id="69" count="324" label="Renal failure"></FilterOption><FilterOption id="445" count="318" label="Hypoglycemia"></FilterOption><FilterOption id="224" count="311" label="Myocardial infarction"></FilterOption><FilterOption id="2529" count="305" label="Hot flashes"></FilterOption><FilterOption id="1835" count="304" label="Epistaxis"></FilterOption><FilterOption id="142" count="295" label="Hematological disease"></FilterOption><FilterOption id="325" count="293" label="Thromboembolism"></FilterOption><FilterOption id="574" count="287" label="Deep vein thrombosis"></FilterOption><FilterOption id="668" count="279" label="Muscle weakness"></FilterOption><FilterOption id="182" count="273" label="Hypothyroidism"></FilterOption><FilterOption id="2733" count="264" label="Hypomagnesemia"></FilterOption><FilterOption id="3868" count="255" label="Xerosis"></FilterOption><FilterOption id="1072" count="254" label="Colitis"></FilterOption><FilterOption id="1076" count="252" label="Thrombosis"></FilterOption><FilterOption id="191" count="250" label="Influenza virus infection"></FilterOption><FilterOption id="3098" count="244" label="Hypoalbuminemia"></FilterOption><FilterOption id="2184" count="239" label="Gastrointestinal bleeding"></FilterOption><FilterOption id="50" count="237" label="Bronchitis"></FilterOption><FilterOption id="1876" count="234" label="Syncope"></FilterOption><FilterOption id="93" count="230" label="Depression"></FilterOption><FilterOption id="444" count="220" label="Hypocalcemia"></FilterOption><FilterOption id="3826" count="218" label="Bone marrow depression"></FilterOption><FilterOption id="1542" count="211" label="Atrial fibrillation"></FilterOption><FilterOption id="2854" count="211" label="Ostealgia"></FilterOption><FilterOption id="2469" count="207" label="Paresthesia"></FilterOption><FilterOption id="12" count="204" label="Allergy"></FilterOption><FilterOption id="2085" count="203" label="Dysphagia"></FilterOption><FilterOption id="1061" count="203" label="Sinusitis"></FilterOption><FilterOption id="810" count="200" label="Esophagitis"></FilterOption><FilterOption id="188" count="199" label="Inflammatory disease"></FilterOption><FilterOption id="25" count="194" label="Anxiety disorder"></FilterOption><FilterOption id="250" count="194" label="Pancreatitis"></FilterOption><FilterOption id="3209" count="193" label="Oral mucositis"></FilterOption><FilterOption id="55" count="187" label="Cardiac failure"></FilterOption><FilterOption id="735" count="186" label="Toxicity"></FilterOption><FilterOption id="358" count="184" label="Muscle spasm"></FilterOption><FilterOption id="2440" count="184" label="Musculoskeletal pain"></FilterOption><FilterOption id="2291" count="182" label="Hematuria"></FilterOption><FilterOption id="2236" count="177" label="Hypertriglyceridemia"></FilterOption></Filter></Filters><SearchResults><Trial Id="4155"><Indications><Indication>Rheumatoid arthritis</Indication></Indications><ActionsPrimaryInterventionsPrimary><Action>ICE inhibitor</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsPrimary><Action>Anti-inflammatory</Action><Action>Anticancer</Action><Action>Metastasis inhibitor</Action><Action>Systemic antipsoriatic product</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Immuno-oncology</Technology><Technology>Oral formulation</Technology><Technology>Small molecule therapeutic</Technology></Technologies><CompaniesSponsor><Company>Aventis SA</Company><Company>Vertex Pharmaceuticals Inc</Company></CompaniesSponsor><Countries><Country>US</Country></Countries><DateChangeLast>2007-09-13T00:00:00Z</DateChangeLast><DateEnd>2002-04-24T00:00:00Z</DateEnd><DateStart>2001-03-31T00:00:00Z</DateStart><IndicationsAdverse><Indication>Diarrhea</Indication><Indication>Nausea</Indication></IndicationsAdverse><InterventionsPrimaryDisplay><Intervention>pralnacasan alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>285</PatientCountEnrollment><Phase>Phase 2a Clinical</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>The aim of this 12-week, double-blind, randomized, placebo-controlled, parallel group trial is to evaluate the safety, efficacy and pharmacokinetics of pralnacasan either alone or in combination with additional rheumatoid arthritis (RA) treatment in 250 adult patients with active RA. Subjects enrolled in the study were able to continue their current anti-inflammatory treatment including concomitant disease-modifying anti-rheumatic drugs (DMARDs), methotrexate or corticosteroids. Patients were</Teaser><TrialCategories><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Multiple Blind</Term><Term>Placebo Control</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term><Term>Pharmacokinetics</Term></TermsEndpoint><TitleDisplay>A safety, efficacy and pharmacokinetic study of pralnacasan in patients with rheumatoid arthritis</TitleDisplay><PrimaryCompletionDate></PrimaryCompletionDate><TrialDuration>12 Months</TrialDuration><NumberOfSites>1</NumberOfSites><ContactNames><Name>Frank Douglas</Name><Name>Karel Pavelka</Name></ContactNames></Trial><Trial Id="5003"><Indications><Indication>Acute myelogenous leukemia</Indication><Indication>Cancer</Indication></Indications><ActionsPrimaryInterventionsPrimary><Action>Flt3 tyrosine kinase inhibitor</Action><Action>VEGF receptor antagonist</Action><Action>VEGF-2 receptor antagonist</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsPrimary><Action>Angiogenesis inhibitor</Action><Action>Anticancer</Action><Action>Anticancer protein kinase inhibitor</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Oral formulation</Technology><Technology>Small molecule therapeutic</Technology></Technologies><CompaniesSponsor><Company>Merck Research Laboratories</Company></CompaniesSponsor><DateChangeLast>2007-10-22T00:00:00Z</DateChangeLast><DateStart>2004-03-31T00:00:00Z</DateStart><InterventionsPrimaryDisplay><Intervention>L-000021649 alone</Intervention></InterventionsPrimaryDisplay><Phase>Phase 1 Clinical</Phase><RecruitmentStatus>Status not specified</RecruitmentStatus><Teaser> Inhibition of the vascular endothelial growth factor/tyrosine kinase domain receptor (VEGF/KDR [VEGFR-2]) pathway, which is known to be involved in tumor progression, has been shown to have efficacy in various pre-clinical &lt;b&gt;cancer&lt;/b&gt; models. Consequently, Merck has developed L-000021649 , a small molecule indolyl quinolinone inhibitor of KDR and of its related receptors (Flt-3, PDGFR, Fms and Kit). Although KDR expression is restricted to endothelial cells and to a small population</Teaser><TrialCategories><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Placebo Control</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term><Term>Pharmacokinetics</Term><Term>Pharmacodynamics</Term></TermsEndpoint><TermsPatientSelection><Term>Healthy volunteers accepted</Term><Term>Male</Term></TermsPatientSelection><TitleDisplay>Safety, Tolerability, Pharmacokinetic and Pharmacodynamic study of an indolyl quinolinone KDR/Flt-3 kinase inhibitor in normal healthy volunteers</TitleDisplay><PrimaryCompletionDate></PrimaryCompletionDate><NumberOfSites>0</NumberOfSites><ContactNames><Name>Mark Fraley</Name></ContactNames></Trial><Trial Id="5102"><Indications><Indication>Ischemic heart disease</Indication><Indication>Reperfusion injury</Indication></Indications><ActionsPrimaryInterventionsPrimary><Action>CXCR4 chemokine modulator</Action><Action>Cathepsin G inhibitor</Action><Action>Complement cascade inhibitor</Action><Action>Elastase inhibitor</Action><Action>Heparin agonist</Action><Action>High mobility group protein B1 inhibitor</Action><Action>L selectin antagonist</Action><Action>P selectin antagonist</Action><Action>Stromal cell-derived factor 1 ligand modulator</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsPrimary><Action>Anti-inflammatory</Action><Action>Anticancer</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Infusion</Technology><Technology>Intravenous formulation</Technology><Technology>Oligosaccharide</Technology><Technology>Small molecule therapeutic</Technology></Technologies><CompaniesSponsor><Company>Cantex Pharmaceuticals Inc</Company></CompaniesSponsor><DateChangeLast>2007-10-23T00:00:00Z</DateChangeLast><DateStart>2005-02-10T00:00:00Z</DateStart><InterventionsPrimaryDisplay><Intervention>dociparstat (intravenous, cancer/bone marrow transplantation/traumatic brain injury/thrombocytopenia), Cantex Pharmaceuticals alone</Intervention></InterventionsPrimaryDisplay><Phase>Phase 1 Clinical</Phase><RecruitmentStatus>Status not specified</RecruitmentStatus><Teaser>This study was designed to examine the safety, pharmacokinetics and dosing regimens of PGX-100 in healthy volunteers. PGX-100 , is an intravenous (iv) formulation of 2-O, 3-O desulfated heparin (ODSH), developed by ParinGenix to ameliorate cardiac ischemia-reperfusion injury following myocardial infarction, including both ST-elevated and non-Q-wave myocardial infarctions. Pre-clinical data have reported that PGX-100 significantly reduced damage to the heart following myocardial infarction in a</Teaser><TrialCategories><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Pharmacokinetics</Term></TermsEndpoint><TermsPatientSelection><Term>Healthy volunteers accepted</Term></TermsPatientSelection><TitleDisplay>Phase I safety study of PGX-100 in healthy subjects</TitleDisplay><PrimaryCompletionDate></PrimaryCompletionDate><NumberOfSites>0</NumberOfSites><ContactNames><Name>Jay Foust</Name></ContactNames></Trial><Trial Id="5496"><Indications><Indication>Cancer</Indication><Indication>Cardiovascular disease</Indication><Indication>Diabetic complication</Indication><Indication>Proteinuria</Indication><Indication>Renal disease</Indication></Indications><ActionsPrimaryInterventionsPrimary><Action>ADAM-10 inhibitor</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsPrimary><Action>Angiogenesis inhibitor</Action><Action>Anticancer</Action><Action>Renal system agent</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Capsule formulation</Technology><Technology>Small molecule therapeutic</Technology></Technologies><CompaniesSponsor><Company>Exelixis Inc</Company></CompaniesSponsor><DateChangeLast>2007-11-13T00:00:00Z</DateChangeLast><DateEnd>2005-12-31T00:00:00Z</DateEnd><DateStart>2005-09-22T00:00:00Z</DateStart><InterventionsPrimaryDisplay><Intervention>XL-784 alone</Intervention></InterventionsPrimaryDisplay><Phase>Phase 1 Clinical</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>A 14 day, repeat dose, phase I, safety study in XL-784 in healthy volunteers [ 624488 ].</Teaser><TrialCategories><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term></TermsEndpoint><TermsPatientSelection><Term>Healthy volunteers accepted</Term></TermsPatientSelection><TitleDisplay>A phase I, safety study of XL-784 in healthy volunteers</TitleDisplay><PrimaryCompletionDate></PrimaryCompletionDate><TrialDuration>3 Months</TrialDuration><NumberOfSites>0</NumberOfSites></Trial><Trial Id="5495"><Indications><Indication>Cancer</Indication><Indication>Cardiovascular disease</Indication><Indication>Diabetic complication</Indication><Indication>Proteinuria</Indication><Indication>Renal disease</Indication></Indications><ActionsPrimaryInterventionsPrimary><Action>ADAM-10 inhibitor</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsPrimary><Action>Angiogenesis inhibitor</Action><Action>Anticancer</Action><Action>Renal system agent</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Capsule formulation</Technology><Technology>Small molecule therapeutic</Technology></Technologies><CompaniesSponsor><Company>Exelixis Inc</Company></CompaniesSponsor><DateChangeLast>2007-11-13T00:00:00Z</DateChangeLast><DateEnd>2004-01-13T00:00:00Z</DateEnd><DateStart>2003-06-18T00:00:00Z</DateStart><InterventionsPrimaryDisplay><Intervention>XL-784 alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>70</PatientCountEnrollment><Phase>Phase 1 Clinical</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>A phase I, dose-escalating, safety, pharmacokinetic and pharmacodynamic study of oral XL-784 in 70 healthy volunteers [ 493990 ].</Teaser><TrialCategories><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Pharmacokinetics</Term><Term>Pharmacodynamics</Term></TermsEndpoint><TermsPatientSelection><Term>Healthy volunteers accepted</Term></TermsPatientSelection><TitleDisplay>A phase I, dose-escalating, safety, pharmacokinetic and pharmacodynamic study of XL-784 in healthy volunteers</TitleDisplay><PrimaryCompletionDate></PrimaryCompletionDate><TrialDuration>6 Months</TrialDuration><NumberOfSites>0</NumberOfSites></Trial><Trial Id="5006"><Indications><Indication>Acute myelogenous leukemia</Indication><Indication>Solid tumor</Indication></Indications><ActionsPrimaryInterventionsPrimary><Action>Flt3 tyrosine kinase inhibitor</Action><Action>VEGF receptor antagonist</Action><Action>VEGF-2 receptor antagonist</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsPrimary><Action>Angiogenesis inhibitor</Action><Action>Anticancer</Action><Action>Anticancer protein kinase inhibitor</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Oral formulation</Technology><Technology>Small molecule therapeutic</Technology></Technologies><CompaniesCollaborator><Company>The Cancer Institute of New Jersey</Company></CompaniesCollaborator><CompaniesSponsor><Company>Merck Research Laboratories</Company></CompaniesSponsor><Countries><Country>US</Country></Countries><DateChangeLast>2007-12-20T00:00:00Z</DateChangeLast><DateStart>2005-07-31T00:00:00Z</DateStart><InterventionsPrimaryDisplay><Intervention>L-000021649 alone</Intervention></InterventionsPrimaryDisplay><Phase>Phase 1 Clinical</Phase><RecruitmentStatus>Status not specified</RecruitmentStatus><Teaser>This trial was designed to test the safety of an experimental drug, L-21649 that blocks the growth of new blood vessels. L-21649 is an experimental drug developed at Merck Research Laboratories , which is designed to block the functioning the kinase insert-containing receptor (KDR). This protein is important in new blood vessel formation in tumors. Preclinical studies showed tumor growth regression in animals administered L-21649 [ 614808 ].</Teaser><TrialCategories><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Placebo Control</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Pharmacokinetics</Term></TermsEndpoint><TitleDisplay>Phase I study evaluating the safety, tolerability and maximally tolerated dose of L-000021649 administered in multiple doses</TitleDisplay><BiomarkerNames><BiomarkerName>Beta-type platelet-derived growth factor receptor</BiomarkerName></BiomarkerNames><PrimaryCompletionDate></PrimaryCompletionDate><NumberOfSites>1</NumberOfSites><ContactNames><Name>Margorzata Wojtowicz</Name><Name>Stephanie Beers</Name></ContactNames></Trial><Trial Id="5819"><Indications><Indication>Hypertension</Indication></Indications><ActionsPrimaryInterventionsControl><Action>ACE inhibitor</Action></ActionsPrimaryInterventionsControl><ActionsPrimaryInterventionsPrimary><Action>Endothelin ET-A receptor antagonist</Action><Action>Endothelin ET-B receptor antagonist</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsControl><Action>Antihypertensive</Action></ActionsSecondaryInterventionsControl><ActionsSecondaryInterventionsPrimary><Action>Anticancer</Action><Action>Antihypertensive</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Film coating</Technology><Technology>Oral formulation</Technology><Technology>Prodrug</Technology><Technology>Small molecule therapeutic</Technology><Technology>Tablet formulation</Technology></Technologies><CompaniesSponsor><Company>Actelion Ltd</Company></CompaniesSponsor><DateChangeLast>2007-12-21T00:00:00Z</DateChangeLast><DateEnd>2006-12-11T00:00:00Z</DateEnd><DateStart>2005-08-09T00:00:00Z</DateStart><InterventionsControlDisplay><Intervention>enalapril alone</Intervention></InterventionsControlDisplay><InterventionsPrimaryDisplay><Intervention>macitentan alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>379</PatientCountEnrollment><Phase>Phase 2 Clinical</Phase><RecruitmentStatus>Status not specified</RecruitmentStatus><Teaser>placebo group. In this study, there were five cases of increased liver enzymes above three times the upper limit of normal and were evenly distributed over all four doses of Actelion-1 . In three cases, there were concomitant disease states (pancreatic &lt;b&gt;cancer&lt;/b&gt;, anesthesia for prostatectomy and urinary tract infection treated with antibiotics) that complicated interpretation of those changes [ 750572 ].</Teaser><TrialCategories><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Active Control</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term></TermsEndpoint><TitleDisplay>A phase II, randomized, placebo-controlled, active-controlled, parallel group, safety study of Actelion-1 for the potential treatment of hypertension</TitleDisplay><PrimaryCompletionDate></PrimaryCompletionDate><TrialDuration>16 Months</TrialDuration><NumberOfSites>0</NumberOfSites><ContactNames><Name>Jean-Paul Clozel</Name></ContactNames></Trial><Trial Id="7146"><Indications><Indication>Stroke</Indication></Indications><ActionsSecondaryInterventionsPrimary><Action>Blood substitute</Action><Action>Unspecified drug target</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Small molecule therapeutic</Technology></Technologies><CompaniesSponsor><Company>Neuron Therapeutics Inc</Company></CompaniesSponsor><Countries><Country>US</Country></Countries><DateChangeLast>2008-01-22T00:00:00Z</DateChangeLast><DateStart>2001-01-29T00:00:00Z</DateStart><InterventionsPrimaryDisplay><Intervention>OFNE, Thomas Jefferson Univ/Neuron alone</Intervention></InterventionsPrimaryDisplay><Phase>Phase 1 Clinical</Phase><RecruitmentStatus>Recruiting</RecruitmentStatus><Teaser>This phase I trial was designed to investigate the safety of Revoxyn in treating patients suffering from severe ischemic stroke [ 397191 ].</Teaser><TrialCategories><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term></TermsEndpoint><TitleDisplay>A phase I safety trial for Revoxyn in patients suffering from severe ischemic stroke</TitleDisplay><PrimaryCompletionDate></PrimaryCompletionDate><NumberOfSites>1</NumberOfSites></Trial><Trial Id="3764"><Indications><Indication>Insulin dependent diabetes</Indication><Indication>Non-insulin dependent diabetes</Indication></Indications><ActionsPrimaryInterventionsPrimary><Action>NAD-dependent deacetylase sirtuin-1 stimulator</Action><Action>PPAR gamma coactivator 1-alpha stimulator</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsPrimary><Action>Anticancer</Action><Action>Hypoglycemic agent</Action><Action>Lipid metabolism stimulator</Action><Action>Neuroprotectant</Action><Action>Nootropic agent</Action><Action>Superoxide synthesis inhibitor</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Oral formulation</Technology><Technology>Small molecule therapeutic</Technology></Technologies><CompaniesSponsor><Company>Sirtris Pharmaceuticals Inc</Company></CompaniesSponsor><DateChangeLast>2008-01-29T00:00:00Z</DateChangeLast><DateEnd>2006-06-07T00:00:00Z</DateEnd><DateStart>2006-06-07T00:00:00Z</DateStart><InterventionsPrimaryDisplay><Intervention>resveratrol (oral, metabolic disorders/MELAS/cancer), Sirtris alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>85</PatientCountEnrollment><Phase>Phase 1 Clinical</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>SRT-501 is an oral small-molecule SIRT1 ( class III protein deacetylase) activator with the ability to decrease the Km value of SIRT1[ 683851 ]. SRT-501 or placebo has been administered orally, once daily in single ascending doses for seven consecutive days across several cohorts. SRT-501 was evaluated for safety, tolerability, and pharmacokinetics [ 672155 ].</Teaser><TrialCategories><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Placebo Control</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Pharmacokinetics</Term></TermsEndpoint><TermsPatientSelection><Term>Healthy volunteers accepted</Term><Term>Male</Term></TermsPatientSelection><TitleDisplay>A Safety and Pharmacokinetics Study of SRT-501 (Reservatrol) for the Treatment of Diabetes</TitleDisplay><PrimaryCompletionDate></PrimaryCompletionDate><NumberOfSites>0</NumberOfSites></Trial><Trial Id="7370"><Indications><Indication>MELAS syndrome</Indication></Indications><ActionsPrimaryInterventionsPrimary><Action>NAD-dependent deacetylase sirtuin-1 stimulator</Action><Action>PPAR gamma coactivator 1-alpha stimulator</Action></ActionsPrimaryInterventionsPrimary><ActionsSecondaryInterventionsPrimary><Action>Anticancer</Action><Action>Hypoglycemic agent</Action><Action>Lipid metabolism stimulator</Action><Action>Neuroprotectant</Action><Action>Nootropic agent</Action><Action>Superoxide synthesis inhibitor</Action></ActionsSecondaryInterventionsPrimary><Technologies><Technology>Oral formulation</Technology><Technology>Small molecule therapeutic</Technology></Technologies><CompaniesSponsor><Company>Sirtris Pharmaceuticals Inc</Company></CompaniesSponsor><DateChangeLast>2008-01-30T00:00:00Z</DateChangeLast><DateStart>2007-08-09T00:00:00Z</DateStart><InterventionsPrimaryDisplay><Intervention>resveratrol (oral, metabolic disorders/MELAS/cancer), Sirtris alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>30</PatientCountEnrollment><Phase>Phase 1b Clinical</Phase><RecruitmentStatus>Status not specified</RecruitmentStatus><Teaser>This was a phase Ib safety and pharmacokinetics study of SRT-501 for the treatment of MELAS syndrome (Mitochondrial Encephalopathy Lactic Acidosis and Stroke-like episodes). SRT-501 or placebo would be administered to patients qd for 3 months [ 821049 ].</Teaser><TrialCategories><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Placebo Control</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Pharmacokinetics</Term></TermsEndpoint><TitleDisplay>A phase Ib safety and pharmacokinetics study of SRT-501 for treatment of MELAS syndrome</TitleDisplay><PrimaryCompletionDate></PrimaryCompletionDate><NumberOfSites>0</NumberOfSites></Trial></SearchResults></ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.TrialResultsOutput>